Breast Invasive Carcinoma: PARADIGM pathway analysis of mRNA expression data
Maintained by TCGA GDAC Team (Broad Institute/Dana-Farber Cancer Institute/Harvard Medical School)
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 67 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
Signaling events regulated by Ret tyrosine kinase 117
Signaling events mediated by Stem cell factor receptor (c-Kit) 114
EGFR-dependent Endothelin signaling events 94
FOXM1 transcription factor network 94
IGF1 pathway 84
Endothelins 83
Wnt signaling 83
HIF-1-alpha transcription factor network 81
Syndecan-1-mediated signaling events 80
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 79
Results

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway.

Pathway.Name Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
Signaling events regulated by Ret tyrosine kinase 117 9600 82 -0.23 0.018 1000 -1000 -0.051 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 114 8900 78 -0.39 0.17 1000 -1000 -0.049 -1000
EGFR-dependent Endothelin signaling events 94 1984 21 -0.17 0.024 1000 -1000 -0.041 -1000
FOXM1 transcription factor network 94 4799 51 -0.43 0.024 1000 -1000 -0.1 -1000
IGF1 pathway 84 4826 57 -0.14 0.057 1000 -1000 -0.053 -1000
Endothelins 83 8049 96 -0.25 0.018 1000 -1000 -0.044 -1000
Wnt signaling 83 582 7 -0.13 -0.011 1000 -1000 -0.01 -1000
HIF-1-alpha transcription factor network 81 6160 76 -0.25 0.025 1000 -1000 -0.051 -1000
Syndecan-1-mediated signaling events 80 2743 34 -0.19 0.018 1000 -1000 -0.017 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 79 5393 68 -0.43 0.22 1000 -1000 -0.072 -1000
Plasma membrane estrogen receptor signaling 76 6543 86 -0.2 0.19 1000 -1000 -0.057 -1000
IL4-mediated signaling events 71 6505 91 -0.52 0.39 1000 -1000 -0.1 -1000
TCGA08_retinoblastoma 70 562 8 -0.052 0.026 1000 -1000 -0.003 -1000
FAS signaling pathway (CD95) 69 3262 47 -0.16 0.072 1000 -1000 -0.027 -1000
Glucocorticoid receptor regulatory network 68 7835 114 -0.54 0.28 1000 -1000 -0.048 -1000
IL6-mediated signaling events 68 5114 75 -0.18 0.043 1000 -1000 -0.029 -1000
TCR signaling in naïve CD8+ T cells 67 6315 93 -0.13 0.07 1000 -1000 -0.043 -1000
IL27-mediated signaling events 64 3286 51 -0.27 0.17 1000 -1000 -0.049 -1000
Noncanonical Wnt signaling pathway 62 1625 26 -0.13 0.018 1000 -1000 -0.029 -1000
Fc-epsilon receptor I signaling in mast cells 62 6051 97 -0.15 0.038 1000 -1000 -0.053 -1000
IL12-mediated signaling events 61 5312 87 -0.3 0.029 1000 -1000 -0.087 -1000
Osteopontin-mediated events 59 2264 38 -0.15 0.018 1000 -1000 -0.03 -1000
Arf6 signaling events 59 3677 62 -0.15 0.034 1000 -1000 -0.008 -1000
IL23-mediated signaling events 58 3537 60 -0.27 0.017 1000 -1000 -0.086 -1000
Thromboxane A2 receptor signaling 54 5751 105 -0.14 0.038 1000 -1000 -0.049 -1000
Nongenotropic Androgen signaling 54 2839 52 -0.13 0.064 1000 -1000 -0.029 -1000
Signaling events mediated by the Hedgehog family 53 2761 52 -0.16 0.056 1000 -1000 -0.015 -1000
Stabilization and expansion of the E-cadherin adherens junction 51 3804 74 -0.14 0.03 1000 -1000 -0.058 -1000
PLK2 and PLK4 events 49 149 3 -0.049 0.008 1000 -1000 -0.006 -1000
E-cadherin signaling events 49 249 5 -0.049 0.011 1000 -1000 -0.006 -1000
Syndecan-4-mediated signaling events 48 3263 67 -0.08 0.022 1000 -1000 -0.017 -1000
ErbB4 signaling events 46 3207 69 -0.17 0.097 1000 -1000 -0.057 -1000
BMP receptor signaling 46 3763 81 -0.23 0.046 1000 -1000 -0.064 -1000
Caspase cascade in apoptosis 42 3113 74 -0.085 0.044 1000 -1000 -0.021 -1000
Ephrin B reverse signaling 42 2062 48 -0.14 0.021 1000 -1000 -0.042 -1000
IL2 signaling events mediated by PI3K 41 2383 58 -0.23 0.018 1000 -1000 -0.048 -1000
LPA receptor mediated events 41 4261 102 -0.13 0.018 1000 -1000 -0.046 -1000
Syndecan-2-mediated signaling events 40 2796 69 -0.072 0.022 1000 -1000 -0.016 -1000
amb2 Integrin signaling 40 3346 82 -0.12 0.023 1000 -1000 -0.048 -1000
Visual signal transduction: Rods 40 2087 52 -0.1 0.027 1000 -1000 -0.05 -1000
TCGA08_p53 39 277 7 -0.037 0.028 1000 -1000 -0.004 -1000
Integrins in angiogenesis 39 3284 84 -0.18 0.031 1000 -1000 -0.059 -1000
Signaling events mediated by PTP1B 38 2933 76 -0.15 0.055 1000 -1000 -0.044 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 37 1682 45 -0.13 0.018 1000 -1000 -0.054 -1000
Canonical Wnt signaling pathway 37 1920 51 -0.25 0.098 1000 -1000 -0.036 -1000
Calcium signaling in the CD4+ TCR pathway 37 1147 31 -0.14 0.026 1000 -1000 -0.049 -1000
BCR signaling pathway 36 3646 99 -0.16 0.043 1000 -1000 -0.057 -1000
Ras signaling in the CD4+ TCR pathway 35 602 17 -0.038 0.013 1000 -1000 -0.015 -1000
Glypican 1 network 34 1635 48 -0.064 0.017 1000 -1000 -0.015 -1000
Glypican 2 network 34 138 4 -0.016 0 1000 -1000 -0.003 -1000
E-cadherin signaling in the nascent adherens junction 34 2610 76 -0.078 0.024 1000 -1000 -0.054 -1000
Coregulation of Androgen receptor activity 33 2576 76 -0.18 0.029 1000 -1000 -0.021 -1000
IL1-mediated signaling events 33 2086 62 -0.082 0.051 1000 -1000 -0.05 -1000
E-cadherin signaling in keratinocytes 33 1445 43 -0.079 0.018 1000 -1000 -0.017 -1000
Class IB PI3K non-lipid kinase events 33 99 3 -0.004 -1000 1000 -1000 0 -1000
Cellular roles of Anthrax toxin 32 1263 39 -0.14 0.018 1000 -1000 -0.009 -1000
Signaling mediated by p38-gamma and p38-delta 32 488 15 -0.07 0.014 1000 -1000 -0.012 -1000
Regulation of nuclear SMAD2/3 signaling 31 4238 136 -0.2 0.066 1000 -1000 -0.029 -1000
Presenilin action in Notch and Wnt signaling 31 1939 61 -0.22 0.036 1000 -1000 -0.045 -1000
TRAIL signaling pathway 31 1528 48 -0.05 0.018 1000 -1000 -0.042 -1000
Syndecan-3-mediated signaling events 31 1099 35 -0.099 0.033 1000 -1000 -0.027 -1000
Nectin adhesion pathway 30 1949 63 -0.11 0.024 1000 -1000 -0.048 -1000
Regulation of Telomerase 30 3093 102 -0.2 0.044 1000 -1000 -0.065 -1000
PDGFR-alpha signaling pathway 29 1310 44 -0.18 0.028 1000 -1000 -0.024 -1000
Visual signal transduction: Cones 28 1098 38 -0.072 0.025 1000 -1000 -0.008 -1000
Class I PI3K signaling events 28 2097 73 -0.089 0.031 1000 -1000 -0.029 -1000
Insulin Pathway 27 2036 74 -0.16 0.05 1000 -1000 -0.049 -1000
IFN-gamma pathway 26 1819 68 -0.086 0.023 1000 -1000 -0.057 -1000
Ceramide signaling pathway 26 2007 76 -0.14 0.055 1000 -1000 -0.014 -1000
Reelin signaling pathway 26 1465 56 -0.089 0.038 1000 -1000 -0.053 -1000
Effects of Botulinum toxin 26 679 26 -0.17 0.019 1000 -1000 -0.011 -1000
IL2 signaling events mediated by STAT5 26 589 22 -0.073 0.021 1000 -1000 -0.016 -1000
FOXA2 and FOXA3 transcription factor networks 25 1160 46 -0.2 0.074 1000 -1000 -0.028 -1000
RXR and RAR heterodimerization with other nuclear receptor 25 1346 52 -0.11 0.037 1000 -1000 -0.034 -1000
TCGA08_rtk_signaling 25 665 26 -0.079 0.039 1000 -1000 -0.008 -1000
Aurora B signaling 25 1736 67 -0.095 0.02 1000 -1000 -0.046 -1000
p75(NTR)-mediated signaling 24 3114 125 -0.13 0.036 1000 -1000 -0.059 -1000
Regulation of Androgen receptor activity 23 1667 70 -0.18 0.026 1000 -1000 -0.03 -1000
Sphingosine 1-phosphate (S1P) pathway 22 624 28 -0.079 0.021 1000 -1000 -0.014 -1000
JNK signaling in the CD4+ TCR pathway 21 362 17 -0.036 0.029 1000 -1000 -0.013 -1000
Arf6 downstream pathway 21 933 43 -0.022 0.019 1000 -1000 -0.026 -1000
PLK1 signaling events 21 1861 85 -0.1 0.028 1000 -1000 -0.038 -1000
Angiopoietin receptor Tie2-mediated signaling 21 1878 88 -0.16 0.052 1000 -1000 -0.076 -1000
S1P1 pathway 20 742 36 -0.061 0.018 1000 -1000 -0.052 -1000
Atypical NF-kappaB pathway 20 639 31 -0.074 0.028 1000 -1000 -0.012 -1000
EPHB forward signaling 20 1756 85 -0.039 0.038 1000 -1000 -0.056 -1000
VEGFR1 specific signals 20 1125 56 -0.035 0.026 1000 -1000 -0.02 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 20 677 33 -0.074 0.049 1000 -1000 -0.007 -1000
mTOR signaling pathway 19 1047 53 -0.037 0.035 1000 -1000 -0.041 -1000
ceramide signaling pathway 19 931 49 -0.11 0.037 1000 -1000 -0.016 -1000
HIF-2-alpha transcription factor network 19 846 43 -0.081 0.082 1000 -1000 -0.058 -1000
PDGFR-beta signaling pathway 19 1895 97 -0.082 0.036 1000 -1000 -0.046 -1000
Signaling events mediated by PRL 19 663 34 -0.095 0.026 1000 -1000 -0.021 -1000
ErbB2/ErbB3 signaling events 18 1173 65 -0.059 0.024 1000 -1000 -0.046 -1000
Aurora A signaling 18 1122 60 -0.037 0.034 1000 -1000 -0.017 -1000
p38 MAPK signaling pathway 18 805 44 -0.078 0.034 1000 -1000 -0.051 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 17 955 54 -0.092 0.031 1000 -1000 -0.063 -1000
Hedgehog signaling events mediated by Gli proteins 17 1168 65 -0.051 0.041 1000 -1000 -0.046 -1000
Regulation of p38-alpha and p38-beta 17 945 54 -0.074 0.043 1000 -1000 -0.04 -1000
S1P3 pathway 17 743 42 -0.079 0.021 1000 -1000 -0.014 -1000
BARD1 signaling events 16 951 57 -0.041 0.04 1000 -1000 -0.02 -1000
Paxillin-independent events mediated by a4b1 and a4b7 16 599 37 -0.023 0.028 1000 -1000 -0.014 -1000
Signaling events mediated by HDAC Class III 16 668 40 -0.077 0.034 1000 -1000 -0.015 -1000
Signaling mediated by p38-alpha and p38-beta 16 720 44 -0.09 0.025 1000 -1000 -0.014 -1000
Neurotrophic factor-mediated Trk receptor signaling 16 2029 120 -0.12 0.053 1000 -1000 -0.045 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 15 1245 83 -0.11 0.057 1000 -1000 -0.029 -1000
Retinoic acid receptors-mediated signaling 15 914 58 -0.085 0.04 1000 -1000 -0.059 -1000
Signaling events mediated by VEGFR1 and VEGFR2 15 1895 125 -0.06 0.055 1000 -1000 -0.071 -1000
LPA4-mediated signaling events 14 174 12 -0.03 0.015 1000 -1000 -0.009 -1000
a4b1 and a4b7 Integrin signaling 14 70 5 -0.007 0.018 1000 -1000 -0.003 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 14 1234 85 -0.14 0.039 1000 -1000 -0.049 -1000
Signaling events mediated by HDAC Class II 12 949 75 -0.16 0.039 1000 -1000 -0.029 -1000
Paxillin-dependent events mediated by a4b1 12 432 36 -0.032 0.035 1000 -1000 -0.039 -1000
EPO signaling pathway 11 649 55 -0.15 0.024 1000 -1000 -0.052 -1000
Nephrin/Neph1 signaling in the kidney podocyte 10 361 34 -0.009 0.035 1000 -1000 -0.014 -1000
Aurora C signaling 10 70 7 -0.007 0.016 1000 -1000 -0.03 -1000
Canonical NF-kappaB pathway 9 353 39 -0.056 0.06 1000 -1000 -0.047 -1000
Circadian rhythm pathway 9 201 22 -0.046 0.042 1000 -1000 -0.026 -1000
S1P5 pathway 9 161 17 -0.017 0.018 1000 -1000 -0.012 -1000
FoxO family signaling 9 634 64 -0.12 0.068 1000 -1000 -0.022 -1000
Alternative NF-kappaB pathway 9 117 13 0 0.034 1000 -1000 -0.008 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 8 184 23 -0.03 0.033 1000 -1000 -0.015 -1000
Ephrin A reverse signaling 8 60 7 0 0.015 1000 -1000 -0.003 -1000
Insulin-mediated glucose transport 6 201 32 -0.015 0.033 1000 -1000 -0.011 -1000
Class I PI3K signaling events mediated by Akt 6 418 68 -0.038 0.052 1000 -1000 -0.018 -1000
Arf6 trafficking events 6 452 71 -0.021 0.031 1000 -1000 -0.04 -1000
S1P4 pathway 6 166 25 -0.017 0.021 1000 -1000 -0.016 -1000
Signaling events mediated by HDAC Class I 5 543 104 -0.033 0.053 1000 -1000 -0.031 -1000
Rapid glucocorticoid signaling 5 118 20 -0.005 0.02 1000 -1000 -0.004 -1000
Arf1 pathway 3 165 54 -0.001 0.036 1000 -1000 -0.017 -1000
Sumoylation by RanBP2 regulates transcriptional repression 1 40 27 -0.001 0.04 1000 -1000 -0.036 -1000
Total 4472 264886 7203 -15 -990 131000 -131000 -4.5 -131000
Signaling events regulated by Ret tyrosine kinase

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.057 0.13 -9999 0 -0.74 13 13
Crk/p130 Cas/Paxillin -0.17 0.18 -9999 0 -0.39 173 173
JUN -0.17 0.21 -9999 0 -0.42 172 172
HRAS 0.012 0.051 -9999 0 -0.41 7 7
RET51/GFRalpha1/GDNF/GRB10 -0.21 0.22 -9999 0 -0.38 277 277
RAP1A 0.012 0.057 -9999 0 -0.52 6 6
FRS2 0.011 0.047 -9999 0 -0.27 13 13
RAP1A/GDP 0.009 0.041 -9999 0 -0.38 6 6
RET51/GFRalpha1/GDNF/DOK1 -0.21 0.22 -9999 0 -0.41 242 242
EntrezGene:5979 0 0 -9999 0 -10000 0 0
PTPN11 0.017 0.023 -9999 0 -0.52 1 1
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.016 0.033 -9999 0 -0.52 2 2
RET9/GFRalpha1/GDNF/Enigma -0.1 0.14 -9999 0 -0.28 188 188
RHOA 0.005 0.08 -9999 0 -0.52 12 12
RAP1A/GTP -0.18 0.19 -9999 0 -0.36 245 245
GRB7 -0.017 0.1 -9999 0 -0.29 59 59
RET51/GFRalpha1/GDNF -0.2 0.21 -9999 0 -0.38 265 265
MAPKKK cascade -0.18 0.19 -9999 0 -0.45 145 145
BCAR1 0.017 0.012 -9999 0 -0.25 1 1
RET9/GFRalpha1/GDNF/IRS1 -0.14 0.19 -9999 0 -0.35 199 199
lamellipodium assembly -0.16 0.16 -9999 0 -0.33 219 219
RET51/GFRalpha1/GDNF/SHC -0.2 0.21 -9999 0 -0.38 266 266
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
RET9/GFRalpha1/GDNF/SHC -0.1 0.14 -9999 0 -0.28 189 189
RET9/GFRalpha1/GDNF/Shank3 -0.1 0.14 -9999 0 -0.28 190 190
MAPK3 -0.16 0.18 -9999 0 -0.43 135 135
DOK1 0.002 0.083 -9999 0 -0.41 19 19
DOK6 -0.028 0.14 -9999 0 -0.44 52 52
PXN 0.018 0 -9999 0 -10000 0 0
neurite development -0.16 0.19 -9999 0 -0.41 144 144
DOK5 -0.028 0.14 -9999 0 -0.38 60 60
GFRA1 -0.22 0.24 -9999 0 -0.43 282 282
MAPK8 -0.16 0.2 -9999 0 -0.43 145 145
HRAS/GTP -0.21 0.22 -9999 0 -0.52 145 145
tube development -0.091 0.13 -9999 0 -0.26 193 193
MAPK1 -0.17 0.18 -9999 0 -0.43 135 135
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.079 0.12 -9999 0 -0.24 189 189
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
SRC 0.015 0.035 -9999 0 -0.43 3 3
PDLIM7 0.017 0.012 -9999 0 -0.25 1 1
RET51/GFRalpha1/GDNF/Dok6 -0.2 0.23 -9999 0 -0.4 251 251
SHC1 0.017 0.023 -9999 0 -0.52 1 1
RET51/GFRalpha1/GDNF/Dok4 -0.2 0.21 -9999 0 -0.38 269 269
RET51/GFRalpha1/GDNF/Dok5 -0.22 0.23 -9999 0 -0.41 277 277
PRKCA 0.014 0.033 -9999 0 -0.25 8 8
HRAS/GDP 0.009 0.036 -9999 0 -0.29 7 7
CREB1 -0.14 0.19 -9999 0 -0.38 189 189
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.083 0.14 -9999 0 -0.25 192 192
RET51/GFRalpha1/GDNF/Grb7 -0.22 0.22 -9999 0 -0.4 275 275
mol:GDP 0 0 -9999 0 -10000 0 0
RET -0.18 0.23 -9999 0 -0.41 247 247
DOK4 0.013 0.047 -9999 0 -0.37 7 7
JNK cascade -0.16 0.2 -9999 0 -0.41 172 172
RET9/GFRalpha1/GDNF/FRS2 -0.11 0.14 -9999 0 -0.28 190 190
SHANK3 0.016 0.033 -9999 0 -0.52 2 2
RASA1 0.004 0.078 -9999 0 -0.42 16 16
NCK1 0.011 0.045 -9999 0 -0.28 12 12
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.077 0.12 -9999 0 -0.23 189 189
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.16 0.19 -9999 0 -0.43 133 133
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK -0.17 0.21 -9999 0 -0.46 143 143
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.18 0.23 -9999 0 -0.39 242 242
PI3K -0.23 0.28 -9999 0 -0.52 220 220
SOS1 0.017 0.023 -9999 0 -0.52 1 1
RET9/GFRalpha1/GDNF/Shank3/Grb2 -0.09 0.14 -9999 0 -0.26 193 193
GRB10 -0.003 0.097 -9999 0 -0.43 24 24
activation of MAPKK activity -0.13 0.16 -9999 0 -0.37 122 122
RET51/GFRalpha1/GDNF/FRS2 -0.2 0.21 -9999 0 -0.38 268 268
GAB1 0.006 0.074 -9999 0 -0.43 14 14
IRS1 -0.048 0.17 -9999 0 -0.49 68 68
IRS2 -0.026 0.13 -9999 0 -0.39 57 57
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.19 0.24 -9999 0 -0.41 242 242
RET51/GFRalpha1/GDNF/PKC alpha -0.2 0.21 -9999 0 -0.38 265 265
GRB2 0.016 0.024 -9999 0 -0.25 4 4
PRKACA 0.018 0 -9999 0 -10000 0 0
GDNF 0.014 0.042 -9999 0 -0.45 4 4
RAC1 0.018 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 -0.23 0.26 -9999 0 -0.43 274 274
Rac1/GTP -0.19 0.2 -9999 0 -0.4 217 217
RET9/GFRalpha1/GDNF -0.12 0.15 -9999 0 -0.32 188 188
GFRalpha1/GDNF -0.15 0.18 -9999 0 -0.37 188 188
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.15 0.21 -10000 0 -0.42 161 161
CRKL -0.16 0.22 -10000 0 -0.45 165 165
HRAS -0.12 0.19 -10000 0 -0.38 148 148
mol:PIP3 -0.15 0.2 0.24 1 -0.43 154 155
SPRED1 -0.002 0.098 -10000 0 -0.47 21 21
SPRED2 -0.003 0.1 -10000 0 -0.5 21 21
GAB1 -0.17 0.23 -10000 0 -0.47 168 168
FOXO3 -0.14 0.2 -10000 0 -0.42 155 155
AKT1 -0.16 0.21 -10000 0 -0.44 163 163
BAD -0.14 0.2 -10000 0 -0.41 154 154
megakaryocyte differentiation -0.17 0.23 -10000 0 -0.47 166 166
GSK3B -0.14 0.2 -10000 0 -0.41 152 152
RAF1 -0.088 0.16 -10000 0 -0.3 143 143
SHC1 0.017 0.023 -10000 0 -0.52 1 1
STAT3 -0.17 0.22 -10000 0 -0.47 163 163
STAT1 -0.37 0.49 -10000 0 -0.92 204 204
HRAS/SPRED1 -0.095 0.17 -10000 0 -0.32 146 146
cell proliferation -0.17 0.22 -10000 0 -0.46 164 164
PIK3CA 0.015 0.029 -10000 0 -0.34 3 3
TEC 0.013 0.052 -10000 0 -0.52 5 5
RPS6KB1 -0.17 0.22 -10000 0 -0.46 168 168
HRAS/SPRED2 -0.095 0.17 -10000 0 -0.32 146 146
LYN/TEC/p62DOK -0.15 0.22 -10000 0 -0.46 155 155
MAPK3 -0.053 0.12 -10000 0 -0.25 60 60
STAP1 -0.19 0.24 -10000 0 -0.48 174 174
GRAP2 0.012 0.042 -10000 0 -0.28 10 10
JAK2 -0.31 0.4 -10000 0 -0.8 182 182
STAT1 (dimer) -0.36 0.47 -10000 0 -0.89 205 205
mol:Gleevec 0.005 0.008 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.16 0.23 -10000 0 -0.45 168 168
actin filament polymerization -0.17 0.22 -10000 0 -0.46 164 164
LYN 0.014 0.031 -10000 0 -0.25 7 7
STAP1/STAT5A (dimer) -0.24 0.31 -10000 0 -0.64 166 166
PIK3R1 -0.01 0.11 -10000 0 -0.42 33 33
CBL/CRKL/GRB2 -0.13 0.2 -10000 0 -0.41 153 153
PI3K -0.16 0.23 -10000 0 -0.45 169 169
PTEN -0.001 0.1 -10000 0 -0.52 19 19
SCF/KIT/EPO/EPOR -0.39 0.54 -10000 0 -1.2 141 141
MAPK8 -0.17 0.22 -10000 0 -0.46 164 164
STAT3 (dimer) -0.17 0.22 -10000 0 -0.46 163 163
positive regulation of transcription -0.042 0.1 -10000 0 -0.21 60 60
mol:GDP -0.12 0.2 -10000 0 -0.39 153 153
PIK3C2B -0.17 0.22 -10000 0 -0.47 164 164
CBL/CRKL -0.14 0.21 -10000 0 -0.42 159 159
FER -0.17 0.22 -10000 0 -0.47 162 162
SH2B3 -0.17 0.22 -10000 0 -0.46 163 163
PDPK1 -0.14 0.18 -10000 0 -0.4 149 149
SNAI2 -0.19 0.25 -10000 0 -0.5 177 177
positive regulation of cell proliferation -0.27 0.36 -10000 0 -0.67 210 210
KITLG -0.096 0.2 -10000 0 -0.45 123 123
cell motility -0.27 0.36 -10000 0 -0.67 210 210
PTPN6 0.023 0.037 -10000 0 -0.43 3 3
EPOR -0.091 0.16 -10000 0 -0.96 2 2
STAT5A (dimer) -0.22 0.3 -10000 0 -0.6 176 176
SOCS1 0.015 0.031 -10000 0 -0.32 4 4
cell migration 0.17 0.22 0.46 170 -10000 0 170
SOS1 0.017 0.023 -10000 0 -0.52 1 1
EPO -0.03 0.099 -10000 0 -0.26 80 80
VAV1 -0.014 0.12 -10000 0 -0.39 42 42
GRB10 -0.18 0.23 -10000 0 -0.47 167 167
PTPN11 0.022 0.024 -10000 0 -0.5 1 1
SCF/KIT -0.18 0.23 -10000 0 -0.49 164 164
GO:0007205 0.008 0.011 -10000 0 -10000 0 0
MAP2K1 -0.063 0.13 -10000 0 -0.26 89 89
CBL 0.017 0.012 -10000 0 -0.25 1 1
KIT -0.33 0.53 -10000 0 -1.2 120 120
MAP2K2 -0.064 0.13 -10000 0 -0.26 88 88
SHC/Grb2/SOS1 -0.14 0.22 -10000 0 -0.43 161 161
STAT5A -0.23 0.31 -10000 0 -0.62 175 175
GRB2 0.016 0.024 -10000 0 -0.25 4 4
response to radiation -0.19 0.24 -10000 0 -0.49 177 177
SHC/GRAP2 0.022 0.034 -10000 0 -0.37 2 2
PTPRO -0.18 0.23 -10000 0 -0.48 166 166
SH2B2 -0.18 0.22 -10000 0 -0.47 164 164
DOK1 0.002 0.083 -10000 0 -0.41 19 19
MATK -0.18 0.23 -10000 0 -0.47 170 170
CREBBP 0.003 0.059 -10000 0 -0.54 2 2
BCL2 -0.33 0.55 -10000 0 -1.3 117 117
EGFR-dependent Endothelin signaling events

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.012 0.051 -9999 0 -0.41 7 7
EGFR -0.079 0.18 -9999 0 -0.35 139 139
EGF/EGFR -0.17 0.21 -9999 0 -0.36 244 244
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.085 0.16 -9999 0 -0.29 169 169
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA -0.03 0.15 -9999 0 -0.5 49 49
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF -0.14 0.23 -9999 0 -0.42 193 193
EGF/EGFR dimer/SHC -0.12 0.18 -9999 0 -0.35 174 174
mol:GDP -0.086 0.15 -9999 0 -0.29 169 169
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 -0.097 0.21 -9999 0 -0.43 135 135
GRB2/SOS1 0.024 0.023 -9999 0 -0.37 1 1
HRAS/GTP -0.1 0.12 -9999 0 -0.34 63 63
SHC1 0.017 0.023 -9999 0 -0.52 1 1
HRAS/GDP -0.081 0.14 -9999 0 -0.27 173 173
FRAP1 -0.078 0.14 -9999 0 -0.27 169 169
EGF/EGFR dimer -0.15 0.2 -9999 0 -0.42 173 173
SOS1 0.017 0.023 -9999 0 -0.52 1 1
GRB2 0.016 0.024 -9999 0 -0.25 4 4
ETA receptor/Endothelin-1 -0.089 0.19 -9999 0 -0.41 120 120
FOXM1 transcription factor network

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 -0.24 0.57 -9999 0 -1.1 111 111
PLK1 0.024 0.058 -9999 0 -10000 0 0
BIRC5 -0.092 0.39 -9999 0 -1.4 40 40
HSPA1B -0.25 0.56 -9999 0 -1.1 129 129
MAP2K1 0.018 0.047 -9999 0 -0.3 1 1
BRCA2 -0.26 0.59 -9999 0 -1.1 124 124
FOXM1 -0.4 0.94 -9999 0 -1.7 127 127
XRCC1 -0.24 0.57 -9999 0 -1.1 119 119
FOXM1B/p19 -0.42 0.55 -9999 0 -1.2 142 142
Cyclin D1/CDK4 -0.3 0.57 -9999 0 -1 160 160
CDC2 -0.27 0.62 -9999 0 -1.2 118 118
TGFA -0.29 0.55 -9999 0 -1 151 151
SKP2 -0.24 0.57 -9999 0 -1.1 111 111
CCNE1 -0.019 0.1 -9999 0 -0.29 64 64
CKS1B -0.24 0.57 -9999 0 -1.1 115 115
RB1 -0.22 0.32 -9999 0 -0.88 75 75
FOXM1C/SP1 -0.31 0.67 -9999 0 -1.3 134 134
AURKB 0.011 0.13 -9999 0 -1.4 3 3
CENPF -0.26 0.6 -9999 0 -1.2 118 118
CDK4 0.013 0.032 -9999 0 -0.26 5 5
MYC -0.22 0.52 -9999 0 -0.95 139 139
CHEK2 0.011 0.073 -9999 0 -0.41 9 9
ONECUT1 -0.28 0.57 -9999 0 -1.1 144 144
CDKN2A -0.056 0.15 -9999 0 -0.33 108 108
LAMA4 -0.24 0.58 -9999 0 -1.1 119 119
FOXM1B/HNF6 -0.37 0.71 -9999 0 -1.3 147 147
FOS -0.34 0.64 -9999 0 -1.2 153 153
SP1 0.017 0.024 -9999 0 -0.52 1 1
CDC25B -0.24 0.57 -9999 0 -1.1 115 115
response to radiation 0 0.039 -9999 0 -10000 0 0
CENPB -0.24 0.57 -9999 0 -1.1 111 111
CENPA -0.27 0.61 -9999 0 -1.2 119 119
NEK2 -0.29 0.62 -9999 0 -1.2 135 135
HIST1H2BA -0.24 0.57 -9999 0 -1.1 122 122
CCNA2 -0.027 0.14 -9999 0 -0.4 57 57
EP300 0.014 0.047 -9999 0 -0.52 4 4
CCNB1/CDK1 -0.32 0.7 -9999 0 -1.5 108 108
CCNB2 -0.25 0.59 -9999 0 -1.1 116 116
CCNB1 -0.27 0.62 -9999 0 -1.2 118 118
ETV5 -0.25 0.58 -9999 0 -1.1 115 115
ESR1 -0.43 0.71 -9999 0 -1.2 219 219
CCND1 -0.31 0.6 -9999 0 -1.1 160 160
GSK3A 0.019 0.037 -9999 0 -10000 0 0
Cyclin A-E1/CDK1-2 -0.014 0.13 -9999 0 -0.35 53 53
CDK2 0.011 0.048 -9999 0 -0.31 10 10
G2/M transition of mitotic cell cycle 0 0.046 -9999 0 -10000 0 0
FOXM1B/Cbp/p300 -0.38 0.53 -9999 0 -1.2 133 133
GAS1 -0.32 0.64 -9999 0 -1.2 156 156
MMP2 -0.28 0.62 -9999 0 -1.2 125 125
RB1/FOXM1C -0.31 0.6 -9999 0 -1.1 154 154
CREBBP 0.016 0.033 -9999 0 -0.52 2 2
IGF1 pathway

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0.015 0.026 -10000 0 -0.25 5 5
PTK2 0.016 0.029 -10000 0 -0.34 3 3
CRKL -0.1 0.19 -10000 0 -0.37 154 154
GRB2/SOS1/SHC 0.034 0.025 -10000 0 -0.3 2 2
HRAS 0.012 0.051 -10000 0 -0.41 7 7
IRS1/Crk -0.1 0.19 -10000 0 -0.36 154 154
IGF-1R heterotetramer/IGF1/PTP1B -0.11 0.18 -10000 0 -0.37 155 155
AKT1 -0.086 0.18 -10000 0 -0.42 86 86
BAD -0.075 0.17 -10000 0 -0.39 84 84
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.1 0.19 -10000 0 -0.36 154 154
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.1 0.19 -10000 0 -0.37 152 152
RAF1 -0.063 0.16 -10000 0 -0.39 70 70
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos -0.088 0.19 -10000 0 -0.34 153 153
YWHAZ 0.017 0.017 -10000 0 -0.25 2 2
IGF-1R heterotetramer/IGF1/IRS1 -0.12 0.2 -10000 0 -0.38 169 169
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
RPS6KB1 -0.086 0.18 -10000 0 -0.42 85 85
GNB2L1 0.015 0.04 -10000 0 -0.52 3 3
positive regulation of MAPKKK cascade -0.058 0.14 0.22 1 -0.34 70 71
PXN 0.018 0 -10000 0 -10000 0 0
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0.024 0.023 -10000 0 -0.37 1 1
HRAS/GTP -0.099 0.15 -10000 0 -0.43 73 73
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc -0.06 0.15 -10000 0 -0.28 153 153
IGF-1R heterotetramer -0.1 0.22 -10000 0 -0.51 110 110
IGF-1R heterotetramer/IGF1/IRS/Nck -0.1 0.19 -10000 0 -0.37 152 152
Crk/p130 Cas/Paxillin -0.078 0.18 -10000 0 -0.32 154 154
IGF1R -0.1 0.22 -10000 0 -0.51 110 110
IGF1 -0.12 0.22 -10000 0 -0.44 146 146
IRS2/Crk -0.11 0.2 -10000 0 -0.36 166 166
PI3K -0.1 0.2 -10000 0 -0.36 164 164
apoptosis 0.057 0.15 0.34 84 -10000 0 84
HRAS/GDP 0.009 0.036 -10000 0 -0.29 7 7
PRKCD -0.096 0.21 -10000 0 -0.44 117 117
RAF1/14-3-3 E -0.048 0.14 -10000 0 -0.34 70 70
BAD/14-3-3 -0.061 0.16 -10000 0 -0.36 84 84
PRKCZ -0.09 0.18 -10000 0 -0.32 164 164
Crk/p130 Cas/Paxillin/FAK1 -0.087 0.14 -10000 0 -0.37 75 75
PTPN1 0.002 0.07 -10000 0 -0.28 28 28
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 -0.11 0.22 -10000 0 -0.41 153 153
BCAR1 0.017 0.012 -10000 0 -0.25 1 1
IGF-1R heterotetramer/IGF1/SHC/GRB10 -0.086 0.17 -10000 0 -0.32 163 163
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0.017 0.023 -10000 0 -0.52 1 1
IRS1/NCK2 -0.1 0.19 -10000 0 -0.37 152 152
GRB10 -0.003 0.097 -10000 0 -0.43 24 24
PTPN11 -0.1 0.19 -10000 0 -0.37 152 152
IRS1 -0.12 0.2 -10000 0 -0.38 169 169
IRS2 -0.12 0.21 -10000 0 -0.39 165 165
IGF-1R heterotetramer/IGF1 -0.14 0.22 -10000 0 -0.47 153 153
GRB2 0.016 0.024 -10000 0 -0.25 4 4
PDPK1 -0.094 0.18 -10000 0 -0.33 164 164
YWHAE 0.016 0.029 -10000 0 -0.34 3 3
PRKD1 -0.12 0.23 -10000 0 -0.48 118 118
SHC1 0.017 0.023 -10000 0 -0.52 1 1
Endothelins

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.043 0.26 0.28 59 -0.46 98 157
PTK2B 0.017 0.017 -10000 0 -0.25 2 2
mol:Ca2+ -0.071 0.26 -10000 0 -0.68 54 54
EDN1 -0.065 0.24 0.23 32 -0.5 98 130
EDN3 -0.1 0.18 -10000 0 -0.32 190 190
EDN2 -0.13 0.22 -10000 0 -0.41 185 185
HRAS/GDP -0.11 0.24 -10000 0 -0.48 115 115
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.087 0.22 -10000 0 -0.44 109 109
ADCY4 -0.043 0.21 -10000 0 -0.52 59 59
ADCY5 -0.06 0.22 -10000 0 -0.48 75 75
ADCY6 -0.041 0.21 -10000 0 -0.5 61 61
ADCY7 -0.046 0.22 -10000 0 -0.52 61 61
ADCY1 -0.04 0.21 -10000 0 -0.5 60 60
ADCY2 -0.075 0.24 -10000 0 -0.49 92 92
ADCY3 -0.044 0.21 -10000 0 -0.5 64 64
ADCY8 -0.043 0.21 -10000 0 -0.5 61 61
ADCY9 -0.05 0.22 -10000 0 -0.5 68 68
arachidonic acid secretion -0.12 0.26 -10000 0 -0.51 126 126
ETB receptor/Endothelin-1/Gq/GTP -0.079 0.18 -10000 0 -0.35 115 115
GNAO1 0.016 0.024 -10000 0 -0.25 4 4
HRAS 0.011 0.051 -10000 0 -0.41 7 7
ETA receptor/Endothelin-1/G12/GTP -0.002 0.27 0.35 77 -0.5 69 146
ETA receptor/Endothelin-1/Gs/GTP -0.007 0.26 0.33 77 -0.49 69 146
mol:GTP -0.001 0.006 -10000 0 -10000 0 0
COL3A1 -0.048 0.28 -10000 0 -0.67 59 59
EDNRB -0.03 0.13 -10000 0 -0.39 52 52
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.042 0.26 -10000 0 -0.62 58 58
CYSLTR1 -0.075 0.3 -10000 0 -0.64 86 86
SLC9A1 -0.01 0.15 0.2 55 -0.3 57 112
mol:GDP -0.12 0.26 -10000 0 -0.5 122 122
SLC9A3 -0.13 0.34 -10000 0 -0.66 127 127
RAF1 -0.13 0.25 -10000 0 -0.52 117 117
JUN -0.11 0.36 -10000 0 -0.92 69 69
JAK2 -0.043 0.26 0.28 60 -0.49 87 147
mol:IP3 -0.11 0.22 -10000 0 -0.46 111 111
ETA receptor/Endothelin-1 -0.019 0.32 0.42 77 -0.51 112 189
PLCB1 -0.086 0.18 -10000 0 -0.38 138 138
PLCB2 0.014 0.027 -10000 0 -0.39 2 2
ETA receptor/Endothelin-3 -0.074 0.19 -10000 0 -0.4 100 100
FOS -0.18 0.35 -10000 0 -0.93 82 82
Gai/GDP -0.007 0.14 -10000 0 -0.82 10 10
CRK 0.016 0.033 -10000 0 -0.52 2 2
mol:Ca ++ -0.14 0.32 -10000 0 -0.6 128 128
BCAR1 0.017 0.012 -10000 0 -0.25 1 1
PRKCB1 -0.13 0.24 -10000 0 -0.47 131 131
GNAQ -0.001 0.007 -10000 0 -10000 0 0
GNAZ 0.001 0.088 -10000 0 -0.44 19 19
GNAL 0.011 0.052 -10000 0 -0.33 11 11
Gs family/GDP -0.12 0.22 -10000 0 -0.46 115 115
ETA receptor/Endothelin-1/Gq/GTP -0.068 0.23 0.22 23 -0.42 114 137
MAPK14 -0.084 0.17 -10000 0 -0.39 88 88
TRPC6 -0.077 0.28 -10000 0 -0.72 54 54
GNAI2 0.006 0.075 -10000 0 -0.48 12 12
GNAI3 0.018 0 -10000 0 -10000 0 0
GNAI1 -0.017 0.12 -10000 0 -0.38 46 46
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.096 0.18 -10000 0 -0.38 109 109
ETB receptor/Endothelin-2 -0.11 0.18 -10000 0 -0.4 135 135
ETB receptor/Endothelin-3 -0.09 0.16 -10000 0 -0.38 92 92
ETB receptor/Endothelin-1 -0.068 0.21 -10000 0 -0.4 114 114
MAPK3 -0.17 0.34 -10000 0 -0.8 96 96
MAPK1 -0.17 0.34 -10000 0 -0.8 96 96
Rac1/GDP -0.1 0.24 -10000 0 -0.48 112 112
cAMP biosynthetic process -0.047 0.22 0.27 1 -0.48 75 76
MAPK8 -0.089 0.29 -10000 0 -0.62 89 89
SRC 0.015 0.035 -10000 0 -0.43 3 3
ETB receptor/Endothelin-1/Gi/GTP -0.037 0.15 -10000 0 -0.35 63 63
p130Cas/CRK/Src/PYK2 -0.1 0.25 -10000 0 -0.52 110 110
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.1 0.24 -10000 0 -0.48 112 112
COL1A2 -0.12 0.38 -10000 0 -0.81 99 99
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.095 0.22 -10000 0 -0.4 149 149
mol:DAG -0.11 0.22 -10000 0 -0.46 111 111
MAP2K2 -0.15 0.28 -10000 0 -0.61 111 111
MAP2K1 -0.15 0.28 -10000 0 -0.61 110 110
EDNRA -0.003 0.2 0.23 56 -0.56 50 106
positive regulation of muscle contraction -0.031 0.22 0.25 54 -0.51 62 116
Gq family/GDP -0.13 0.21 -10000 0 -0.5 100 100
HRAS/GTP -0.12 0.23 -10000 0 -0.48 115 115
PRKCH -0.099 0.22 -10000 0 -0.45 109 109
RAC1 0.018 0 -10000 0 -10000 0 0
PRKCA -0.098 0.22 -10000 0 -0.45 106 106
PRKCB -0.1 0.21 -10000 0 -0.44 113 113
PRKCE -0.099 0.22 -10000 0 -0.45 109 109
PRKCD -0.098 0.22 -10000 0 -0.45 106 106
PRKCG -0.097 0.22 -10000 0 -0.45 104 104
regulation of vascular smooth muscle contraction -0.21 0.41 -10000 0 -1.1 82 82
PRKCQ -0.11 0.23 -10000 0 -0.46 113 113
PLA2G4A -0.14 0.28 -10000 0 -0.56 126 126
GNA14 -0.081 0.18 -10000 0 -0.35 140 140
GNA15 0.001 0.077 -10000 0 -0.34 23 23
GNA12 0.018 0 -10000 0 -10000 0 0
GNA11 0.012 0.047 -10000 0 -0.52 4 4
Rac1/GTP -0.002 0.27 0.35 77 -0.51 67 144
MMP1 -0.25 0.4 0.32 2 -0.89 132 134
Wnt signaling

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.13 0.21 -9999 0 -0.46 102 102
FZD6 -0.077 0.2 -9999 0 -0.45 108 108
WNT6 -0.011 0.087 -9999 0 -0.26 54 54
WNT4 -0.062 0.18 -9999 0 -0.45 90 90
FZD3 -0.03 0.15 -9999 0 -0.48 51 51
WNT5A -0.084 0.2 -9999 0 -0.43 120 120
WNT11 -0.013 0.089 -9999 0 -0.26 57 57
HIF-1-alpha transcription factor network

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.15 0.47 -9999 0 -0.91 105 105
HDAC7 0.001 0.006 -9999 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.13 0.39 -9999 0 -0.77 90 90
SMAD4 0.01 0.067 -9999 0 -0.49 9 9
ID2 -0.16 0.48 -9999 0 -0.92 107 107
AP1 -0.1 0.19 -9999 0 -0.43 108 108
ABCG2 -0.16 0.48 -9999 0 -0.92 107 107
HIF1A -0.055 0.19 -9999 0 -0.53 59 59
TFF3 -0.23 0.52 -9999 0 -0.92 150 150
GATA2 -0.013 0.096 -9999 0 -0.33 40 40
AKT1 -0.006 0.1 -9999 0 -0.45 8 8
response to hypoxia -0.02 0.084 -9999 0 -0.17 14 14
MCL1 -0.16 0.47 -9999 0 -0.91 106 106
NDRG1 -0.17 0.49 -9999 0 -0.94 108 108
SERPINE1 -0.17 0.48 -9999 0 -0.93 109 109
FECH -0.16 0.48 -9999 0 -0.92 110 110
FURIN -0.16 0.48 -9999 0 -0.92 107 107
NCOA2 0.009 0.063 -9999 0 -0.4 11 11
EP300 0.009 0.12 -9999 0 -0.38 12 12
HMOX1 -0.17 0.49 -9999 0 -0.91 116 116
BHLHE40 -0.17 0.46 -9999 0 -0.88 117 117
BHLHE41 -0.17 0.46 -9999 0 -0.88 117 117
HIF1A/ARNT/SMAD3/SMAD4/SP1 -0.008 0.16 -9999 0 -0.37 49 49
ENG 0.007 0.15 -9999 0 -0.35 40 40
JUN -0.037 0.15 -9999 0 -0.47 57 57
RORA -0.17 0.49 -9999 0 -0.92 116 116
ABCB1 -0.1 0.25 -9999 0 -1.2 24 24
TFRC -0.18 0.49 -9999 0 -0.92 118 118
CXCR4 -0.18 0.49 -9999 0 -0.92 118 118
TF -0.16 0.48 -9999 0 -0.91 108 108
CITED2 -0.16 0.48 -9999 0 -0.92 107 107
HIF1A/ARNT -0.2 0.54 -9999 0 -1.1 99 99
LDHA -0.043 0.15 -9999 0 -1.2 8 8
ETS1 -0.16 0.48 -9999 0 -0.91 110 110
PGK1 -0.16 0.47 -9999 0 -0.91 105 105
NOS2 -0.17 0.46 -9999 0 -0.88 117 117
ITGB2 -0.17 0.49 -9999 0 -0.93 114 114
ALDOA -0.16 0.48 -9999 0 -0.91 110 110
Cbp/p300/CITED2 -0.16 0.48 -9999 0 -0.96 98 98
FOS -0.11 0.2 -9999 0 -0.38 171 171
HK2 -0.16 0.47 -9999 0 -0.91 106 106
SP1 0.022 0.031 -9999 0 -0.52 1 1
GCK 0.011 0.2 -9999 0 -1 6 6
HK1 -0.16 0.47 -9999 0 -0.89 111 111
NPM1 -0.16 0.47 -9999 0 -0.91 105 105
EGLN1 -0.16 0.48 -9999 0 -0.92 108 108
CREB1 0.025 0.024 -9999 0 -0.52 1 1
PGM1 -0.16 0.48 -9999 0 -0.92 108 108
SMAD3 0.005 0.079 -9999 0 -0.41 17 17
EDN1 -0.22 0.48 -9999 0 -1.2 98 98
IGFBP1 -0.16 0.47 -9999 0 -0.91 108 108
VEGFA -0.086 0.36 -9999 0 -0.69 89 89
HIF1A/JAB1 -0.038 0.14 -9999 0 -0.38 63 63
CP -0.25 0.51 -9999 0 -0.93 143 143
CXCL12 -0.18 0.51 -9999 0 -0.96 117 117
COPS5 0.01 0.056 -9999 0 -0.35 11 11
SMAD3/SMAD4 0.013 0.074 -9999 0 -0.36 18 18
BNIP3 -0.16 0.48 -9999 0 -0.92 109 109
EGLN3 -0.2 0.5 -9999 0 -0.96 118 118
CA9 -0.17 0.49 -9999 0 -0.93 111 111
TERT -0.16 0.48 -9999 0 -0.91 108 108
ENO1 -0.16 0.48 -9999 0 -0.92 106 106
PFKL -0.16 0.48 -9999 0 -0.92 105 105
NCOA1 0.011 0.057 -9999 0 -0.52 6 6
ADM -0.2 0.51 -9999 0 -0.94 125 125
ARNT 0.003 0.076 -9999 0 -10000 0 0
HNF4A 0.02 0.035 -9999 0 -0.52 2 2
ADFP -0.17 0.49 -9999 0 -0.93 115 115
SLC2A1 -0.085 0.36 -9999 0 -0.69 89 89
LEP -0.18 0.48 -9999 0 -0.89 121 121
HIF1A/ARNT/Cbp/p300 -0.13 0.4 -9999 0 -0.79 89 89
EPO -0.092 0.35 -9999 0 -0.77 54 54
CREBBP 0.01 0.12 -9999 0 -0.36 10 10
HIF1A/ARNT/Cbp/p300/HDAC7 -0.13 0.39 -9999 0 -0.79 88 88
PFKFB3 -0.16 0.48 -9999 0 -0.93 107 107
NT5E -0.16 0.48 -9999 0 -0.92 108 108
Syndecan-1-mediated signaling events

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.017 0.023 -9999 0 -0.52 1 1
CCL5 -0.051 0.18 -9999 0 -0.49 71 71
SDCBP 0.003 0.081 -9999 0 -0.4 19 19
FGFR/FGF2/Syndecan-1 -0.17 0.27 -9999 0 -0.57 123 123
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
Syndecan-1/Laminin-5 -0.16 0.26 -9999 0 -0.55 125 125
Syndecan-1/Syntenin -0.16 0.26 -9999 0 -0.55 122 122
MAPK3 -0.13 0.24 -9999 0 -0.53 104 104
HGF/MET 0.007 0.073 -9999 0 -0.38 13 13
TGFB1/TGF beta receptor Type II 0.017 0.023 -9999 0 -0.52 1 1
BSG 0.016 0.024 -9999 0 -0.25 4 4
keratinocyte migration -0.15 0.25 -9999 0 -0.53 125 125
Syndecan-1/RANTES -0.18 0.28 -9999 0 -0.59 131 131
Syndecan-1/CD147 -0.14 0.26 -9999 0 -0.56 109 109
Syndecan-1/Syntenin/PIP2 -0.15 0.25 -9999 0 -0.53 122 122
LAMA5 0.005 0.075 -9999 0 -0.41 15 15
positive regulation of cell-cell adhesion -0.15 0.24 -9999 0 -0.52 122 122
MMP7 -0.095 0.21 -9999 0 -0.44 129 129
HGF 0.008 0.069 -9999 0 -0.45 11 11
Syndecan-1/CASK -0.16 0.26 -9999 0 -0.54 123 123
Syndecan-1/HGF/MET -0.15 0.26 -9999 0 -0.56 112 112
regulation of cell adhesion -0.12 0.23 -9999 0 -0.53 98 98
HPSE -0.015 0.12 -9999 0 -0.39 43 43
positive regulation of cell migration -0.17 0.27 -9999 0 -0.57 123 123
SDC1 -0.17 0.27 -9999 0 -0.57 123 123
Syndecan-1/Collagen -0.17 0.27 -9999 0 -0.57 123 123
PPIB 0.014 0.044 -9999 0 -0.41 5 5
MET 0 0.075 -9999 0 -0.29 31 31
PRKACA 0.018 0 -9999 0 -10000 0 0
MMP9 -0.042 0.17 -9999 0 -0.51 60 60
MAPK1 -0.13 0.24 -9999 0 -0.53 106 106
homophilic cell adhesion -0.16 0.26 -9999 0 -0.45 180 180
MMP1 -0.19 0.22 -9999 0 -0.38 269 269
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.017 0.037 -10000 0 -0.36 3 3
NFATC2 -0.11 0.26 -10000 0 -0.59 82 82
NFATC3 -0.055 0.11 -10000 0 -0.26 30 30
CD40LG -0.32 0.43 -10000 0 -0.89 156 156
ITCH 0.006 0.085 -10000 0 -10000 0 0
CBLB 0.005 0.088 -10000 0 -0.59 1 1
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.23 0.38 -10000 0 -0.88 95 95
JUNB 0.011 0.055 -10000 0 -0.36 10 10
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.008 0.1 -10000 0 -0.27 48 48
T cell anergy -0.033 0.14 -10000 0 -0.39 48 48
TLE4 -0.071 0.23 -10000 0 -0.69 40 40
Jun/NFAT1-c-4/p21SNFT -0.3 0.45 -10000 0 -0.91 146 146
AP-1/NFAT1-c-4 -0.37 0.52 -10000 0 -1 157 157
IKZF1 -0.08 0.23 -10000 0 -0.58 60 60
T-helper 2 cell differentiation -0.22 0.35 -10000 0 -0.8 109 109
AP-1/NFAT1 -0.14 0.24 -10000 0 -0.51 119 119
CALM1 0.003 0.058 -10000 0 -10000 0 0
EGR2 -0.29 0.52 -10000 0 -1.2 101 101
EGR3 -0.37 0.58 -10000 0 -1.3 137 137
NFAT1/FOXP3 -0.064 0.2 -10000 0 -0.5 54 54
EGR1 -0.1 0.2 -10000 0 -0.39 156 156
JUN -0.035 0.15 -10000 0 -0.46 57 57
EGR4 0 0.007 -10000 0 -10000 0 0
mol:Ca2+ -0.016 0.06 -10000 0 -10000 0 0
GBP3 -0.14 0.31 -10000 0 -0.74 96 96
FOSL1 0.016 0.024 -10000 0 -0.25 4 4
NFAT1-c-4/MAF/IRF4 -0.28 0.44 -10000 0 -0.88 146 146
DGKA -0.066 0.21 -10000 0 -0.67 35 35
CREM 0.016 0.017 -10000 0 -0.26 2 2
NFAT1-c-4/PPARG -0.3 0.46 -10000 0 -0.9 160 160
CTLA4 -0.052 0.18 -10000 0 -0.51 45 45
NFAT1-c-4 (dimer)/EGR1 -0.33 0.48 -10000 0 -0.95 161 161
NFAT1-c-4 (dimer)/EGR4 -0.28 0.44 -10000 0 -0.88 157 157
FOS -0.11 0.2 -10000 0 -0.37 171 171
IFNG -0.3 0.47 -10000 0 -1 110 110
T cell activation -0.17 0.29 -10000 0 -0.79 53 53
MAF -0.012 0.12 -10000 0 -0.44 35 35
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.22 0.38 0.79 117 -10000 0 117
TNF -0.3 0.42 -10000 0 -0.86 153 153
FASLG -0.43 0.65 -10000 0 -1.3 170 170
TBX21 -0.11 0.21 -10000 0 -0.46 137 137
BATF3 0 0.001 -10000 0 -10000 0 0
PRKCQ -0.018 0.11 -10000 0 -0.32 51 51
PTPN1 -0.069 0.2 -10000 0 -0.58 44 44
NFAT1-c-4/ICER1 -0.28 0.44 -10000 0 -0.88 156 156
GATA3 -0.1 0.23 -10000 0 -0.51 124 124
T-helper 1 cell differentiation -0.28 0.44 -10000 0 -0.99 110 110
IL2RA -0.25 0.35 -10000 0 -0.83 103 103
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.058 0.19 -10000 0 -0.61 31 31
E2F1 0.013 0.071 -10000 0 -0.36 16 16
PPARG -0.036 0.14 -10000 0 -0.33 81 81
SLC3A2 -0.06 0.19 -10000 0 -0.53 45 45
IRF4 -0.01 0.085 -10000 0 -0.26 52 52
PTGS2 -0.33 0.44 -10000 0 -0.9 157 157
CSF2 -0.33 0.43 -10000 0 -0.89 157 157
JunB/Fra1/NFAT1-c-4 -0.26 0.43 -10000 0 -0.86 143 143
IL4 -0.24 0.37 -10000 0 -0.86 103 103
IL5 -0.32 0.43 -10000 0 -0.88 157 157
IL2 -0.18 0.29 -10000 0 -0.82 52 52
IL3 -0.04 0.052 -10000 0 -10000 0 0
RNF128 -0.053 0.2 -10000 0 -0.6 47 47
NFATC1 -0.22 0.39 -10000 0 -0.8 117 117
CDK4 0.14 0.22 0.58 48 -10000 0 48
PTPRK -0.12 0.3 -10000 0 -0.76 80 80
IL8 -0.36 0.44 -10000 0 -0.93 158 158
POU2F1 0.027 0 -10000 0 -10000 0 0
Plasma membrane estrogen receptor signaling

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 -0.058 0.14 -10000 0 -0.26 154 154
ER alpha/Gai/GDP/Gbeta gamma -0.089 0.19 -10000 0 -0.35 156 156
AKT1 -0.2 0.35 -10000 0 -0.74 152 152
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.2 0.35 -10000 0 -0.75 152 152
mol:Ca2+ -0.1 0.18 -10000 0 -0.44 88 88
IGF1R -0.083 0.2 -10000 0 -0.47 110 110
E2/ER alpha (dimer)/Striatin -0.09 0.15 -10000 0 -0.32 155 155
SHC1 0.017 0.023 -10000 0 -0.52 1 1
apoptosis 0.19 0.33 0.7 152 -10000 0 152
RhoA/GTP -0.086 0.12 -10000 0 -0.24 171 171
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.12 0.18 -10000 0 -0.38 155 155
regulation of stress fiber formation 0.041 0.12 0.29 41 -10000 0 41
E2/ERA-ERB (dimer) -0.086 0.15 -10000 0 -0.31 150 150
KRAS 0.009 0.065 -10000 0 -0.44 10 10
G13/GTP -0.08 0.14 -10000 0 -0.29 151 151
pseudopodium formation -0.041 0.12 -10000 0 -0.29 41 41
E2/ER alpha (dimer)/PELP1 -0.086 0.15 -10000 0 -0.31 150 150
GRB2 0.016 0.024 -10000 0 -0.25 4 4
GNG2 0.016 0.029 -10000 0 -0.34 3 3
GNAO1 0.016 0.024 -10000 0 -0.25 4 4
HRAS 0.012 0.051 -10000 0 -0.41 7 7
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.11 0.22 -10000 0 -0.44 152 152
E2/ER beta (dimer) 0.013 0.008 -10000 0 -0.17 1 1
mol:GDP -0.12 0.17 -10000 0 -0.38 152 152
mol:NADP -0.11 0.22 -10000 0 -0.44 152 152
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
mol:IP3 -0.11 0.19 -10000 0 -0.46 88 88
IGF-1R heterotetramer -0.083 0.2 -10000 0 -0.47 110 110
PLCB1 -0.12 0.19 -10000 0 -0.42 113 113
PLCB2 -0.074 0.17 -10000 0 -0.53 53 53
IGF1 -0.1 0.2 -10000 0 -0.41 146 146
mol:L-citrulline -0.11 0.22 -10000 0 -0.44 152 152
RHOA 0.005 0.08 -10000 0 -0.52 12 12
Gai/GDP -0.008 0.12 -10000 0 -0.75 10 10
JNK cascade 0.013 0.008 -10000 0 -0.17 1 1
BCAR1 0.017 0.012 -10000 0 -0.25 1 1
ESR2 0.017 0.012 -10000 0 -0.25 1 1
GNAQ 0 0 -10000 0 -10000 0 0
ESR1 -0.16 0.24 -10000 0 -0.46 199 199
Gq family/GDP/Gbeta gamma -0.024 0.12 -10000 0 -0.49 19 19
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 -0.044 0.13 -10000 0 -0.46 4 4
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.12 0.18 -10000 0 -0.38 156 156
GNAZ 0.001 0.088 -10000 0 -0.44 19 19
E2/ER alpha (dimer) -0.12 0.17 -10000 0 -0.33 199 199
STRN 0.011 0.056 -10000 0 -0.42 8 8
GNAL 0.011 0.052 -10000 0 -0.33 11 11
PELP1 0.018 0 -10000 0 -10000 0 0
MAPK11 0.021 0.007 -10000 0 -10000 0 0
GNAI2 0.006 0.075 -10000 0 -0.48 12 12
GNAI3 0.018 0 -10000 0 -10000 0 0
GNAI1 -0.017 0.12 -10000 0 -0.38 46 46
HBEGF -0.093 0.19 -10000 0 -0.42 66 66
cAMP biosynthetic process -0.081 0.11 -10000 0 -0.25 152 152
SRC -0.079 0.18 -10000 0 -0.33 156 156
PI3K 0.005 0.082 -10000 0 -0.37 21 21
GNB1 0.013 0.052 -10000 0 -0.52 5 5
G13/GDP/Gbeta gamma -0.1 0.15 -10000 0 -0.33 151 151
SOS1 0.017 0.023 -10000 0 -0.52 1 1
IGF-1R heterotetramer/IGF1 -0.16 0.21 -10000 0 -0.44 168 168
Gs family/GTP -0.066 0.13 -10000 0 -0.26 152 152
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.019 0.064 -10000 0 -0.28 20 20
vasodilation -0.1 0.22 -10000 0 -0.42 152 152
mol:DAG -0.11 0.19 -10000 0 -0.46 88 88
Gs family/GDP/Gbeta gamma -0.1 0.15 -10000 0 -0.32 152 152
MSN -0.045 0.13 -10000 0 -0.32 41 41
Gq family/GTP -0.084 0.18 -10000 0 -0.47 71 71
mol:PI-3-4-5-P3 -0.19 0.34 -10000 0 -0.72 152 152
NRAS 0.005 0.076 -10000 0 -0.4 16 16
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.1 0.22 0.42 152 -10000 0 152
GRB2/SOS1 0.024 0.023 -10000 0 -0.37 1 1
RhoA/GDP -0.093 0.18 -10000 0 -0.37 151 151
NOS3 -0.11 0.23 -10000 0 -0.46 152 152
GNA11 0.014 0.047 -10000 0 -0.52 4 4
MAPKKK cascade -0.12 0.26 -10000 0 -0.53 154 154
E2/ER alpha (dimer)/PELP1/Src -0.13 0.18 -10000 0 -0.4 155 155
ruffle organization -0.041 0.12 -10000 0 -0.29 41 41
ROCK2 -0.051 0.13 -10000 0 -0.37 29 29
GNA14 -0.079 0.18 -10000 0 -0.35 140 140
GNA15 0.002 0.076 -10000 0 -0.34 23 23
GNA13 0.011 0.055 -10000 0 -0.36 10 10
MMP9 -0.095 0.18 -10000 0 -0.44 48 48
MMP2 -0.09 0.2 -10000 0 -0.45 59 59
IL4-mediated signaling events

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.33 0.63 -10000 0 -1.3 118 118
STAT6 (cleaved dimer) -0.43 0.56 -10000 0 -1.2 148 148
IGHG1 -0.083 0.25 -10000 0 -0.42 90 90
IGHG3 -0.33 0.6 -10000 0 -1.2 141 141
AKT1 -0.11 0.31 -10000 0 -0.66 54 54
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.065 0.24 -10000 0 -0.6 28 28
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.14 0.34 -10000 0 -0.74 62 62
THY1 -0.35 0.65 -10000 0 -1.4 120 120
MYB -0.097 0.22 -10000 0 -0.49 119 119
HMGA1 0.014 0.039 -10000 0 -0.36 5 5
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.14 0.34 -10000 0 -0.64 98 98
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.12 0.31 -10000 0 -0.65 54 54
SP1 0.021 0.03 -10000 0 -0.53 1 1
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.016 0.055 -10000 0 -0.4 7 7
STAT6 (dimer)/ETS1 -0.34 0.63 -10000 0 -1.2 144 144
SOCS1 -0.18 0.4 -10000 0 -0.77 109 109
SOCS3 -0.12 0.33 -10000 0 -0.92 26 26
FCER2 -0.22 0.46 -10000 0 -0.91 103 103
PARP14 0.006 0.078 -10000 0 -0.43 15 15
CCL17 -0.42 0.71 -10000 0 -1.4 156 156
GRB2 0.016 0.024 -10000 0 -0.25 4 4
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.083 0.26 -10000 0 -0.61 29 29
T cell proliferation -0.35 0.65 -10000 0 -1.3 134 134
IL4R/JAK1 -0.35 0.64 -10000 0 -1.3 139 139
EGR2 -0.39 0.69 -10000 0 -1.4 137 137
JAK2 0.001 0.072 -10000 0 -0.36 11 11
JAK3 0.021 0.008 -10000 0 -10000 0 0
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
JAK1 0.012 0.061 -10000 0 -0.52 6 6
COL1A2 -0.22 0.54 -10000 0 -1.5 74 74
CCL26 -0.34 0.63 -10000 0 -1.3 133 133
IL4R -0.37 0.7 -10000 0 -1.4 137 137
PTPN6 0.021 0.038 -10000 0 -0.42 3 3
IL13RA2 -0.38 0.67 -10000 0 -1.4 127 127
IL13RA1 -0.002 0.089 -10000 0 -0.49 12 12
IRF4 -0.038 0.2 -10000 0 -0.83 9 9
ARG1 -0.064 0.27 -10000 0 -0.84 30 30
CBL -0.13 0.32 -10000 0 -0.61 91 91
GTF3A 0.02 0.032 -10000 0 -0.38 2 2
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
IL13RA1/JAK2 0.003 0.099 -10000 0 -0.36 17 17
IRF4/BCL6 -0.044 0.19 -10000 0 -0.74 10 10
CD40LG 0.012 0.07 -10000 0 -0.32 20 20
MAPK14 -0.13 0.33 -10000 0 -0.63 85 85
mitosis -0.1 0.3 -10000 0 -0.63 53 53
STAT6 -0.43 0.85 -10000 0 -1.6 140 140
SPI1 0.012 0.07 -10000 0 -0.43 11 11
RPS6KB1 -0.099 0.29 -10000 0 -0.62 47 47
STAT6 (dimer) -0.44 0.86 -10000 0 -1.6 140 140
STAT6 (dimer)/PARP14 -0.39 0.7 -10000 0 -1.4 140 140
mast cell activation 0.004 0.019 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.11 0.3 -10000 0 -0.66 53 53
FRAP1 -0.11 0.31 -10000 0 -0.66 54 54
LTA -0.33 0.63 -10000 0 -1.3 129 129
FES 0.01 0.058 -10000 0 -0.39 10 10
T-helper 1 cell differentiation 0.39 0.75 1.4 140 -10000 0 140
CCL11 -0.38 0.65 -10000 0 -1.3 141 141
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.1 0.3 -10000 0 -0.67 37 37
IL2RG 0.001 0.08 -10000 0 -0.29 35 35
IL10 -0.34 0.63 -10000 0 -1.3 120 120
IRS1 -0.048 0.17 -10000 0 -0.49 68 68
IRS2 -0.026 0.13 -10000 0 -0.39 57 57
IL4 -0.039 0.22 -10000 0 -1.4 6 6
IL5 -0.34 0.63 -10000 0 -1.3 130 130
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.24 0.5 -10000 0 -0.93 133 133
COL1A1 -0.23 0.56 -10000 0 -1.6 72 72
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.37 0.67 -10000 0 -1.4 124 124
IL2R gamma/JAK3 0.017 0.059 -10000 0 -0.33 5 5
TFF3 -0.52 0.77 -10000 0 -1.4 201 201
ALOX15 -0.35 0.64 -10000 0 -1.3 121 121
MYBL1 -0.066 0.17 -10000 0 -0.36 117 117
T-helper 2 cell differentiation -0.25 0.49 -10000 0 -0.93 136 136
SHC1 0.017 0.023 -10000 0 -0.52 1 1
CEBPB 0.008 0.075 -10000 0 -0.34 20 20
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.12 0.32 -10000 0 -0.71 48 48
mol:PI-3-4-5-P3 -0.11 0.31 -10000 0 -0.66 54 54
PI3K -0.12 0.33 -10000 0 -0.71 54 54
DOK2 -0.021 0.13 -10000 0 -0.4 48 48
ETS1 0.007 0.07 -10000 0 -0.28 24 24
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.073 0.25 -10000 0 -0.59 27 27
ITGB3 -0.34 0.63 -10000 0 -1.3 128 128
PIGR -0.5 0.76 -10000 0 -1.4 182 182
IGHE 0.022 0.086 0.2 48 -0.25 4 52
MAPKKK cascade -0.071 0.24 -10000 0 -0.58 27 27
BCL6 -0.004 0.1 -10000 0 -0.46 24 24
OPRM1 -0.34 0.63 -10000 0 -1.3 119 119
RETNLB -0.33 0.63 -10000 0 -1.3 129 129
SELP -0.46 0.75 -10000 0 -1.4 166 166
AICDA -0.35 0.61 -10000 0 -1.2 138 138
TCGA08_retinoblastoma

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B -0.017 0.12 -10000 0 -0.38 46 46
CDKN2C 0.005 0.085 -10000 0 -0.37 23 23
CDKN2A -0.052 0.15 -10000 0 -0.32 107 107
CCND2 0.019 0.085 0.2 74 -0.15 6 80
RB1 -0.022 0.092 0.15 3 -0.22 77 80
CDK4 0.026 0.096 0.23 77 -10000 0 77
CDK6 0.019 0.093 0.23 63 -0.2 6 69
G1/S progression 0.022 0.092 0.22 77 -0.15 3 80
FAS signaling pathway (CD95)

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.067 0.099 0.23 128 -10000 0 128
RFC1 0.067 0.099 0.23 128 -10000 0 128
PRKDC 0.064 0.1 0.23 126 -0.3 1 127
RIPK1 0.018 0.024 -10000 0 -0.52 1 1
CASP7 -0.013 0.12 0.24 2 -0.68 14 16
FASLG/FAS/FADD/FAF1 -0.012 0.13 0.22 54 -0.3 48 102
MAP2K4 -0.045 0.16 -10000 0 -0.41 46 46
mol:ceramide -0.044 0.15 -10000 0 -0.38 59 59
GSN 0.056 0.11 0.24 123 -0.3 11 134
FASLG/FAS/FADD/FAF1/Caspase 8 -0.013 0.13 -10000 0 -0.36 41 41
FAS -0.026 0.13 -10000 0 -0.42 51 51
BID 0.012 0.066 0.29 16 -0.32 8 24
MAP3K1 -0.016 0.13 0.26 2 -0.37 31 33
MAP3K7 0.015 0.021 -10000 0 -0.25 3 3
RB1 0.054 0.11 0.23 117 -0.29 9 126
CFLAR 0.01 0.065 -10000 0 -0.44 10 10
HGF/MET -0.036 0.14 -10000 0 -0.33 90 90
ARHGDIB 0.044 0.12 0.24 108 -0.29 20 128
FADD -0.003 0.068 -10000 0 -0.26 35 35
actin filament polymerization -0.056 0.11 0.3 11 -0.23 123 134
NFKB1 -0.042 0.08 -10000 0 -0.85 1 1
MAPK8 -0.06 0.19 -10000 0 -0.47 71 71
DFFA 0.066 0.099 0.24 123 -10000 0 123
DNA fragmentation during apoptosis 0.066 0.098 0.24 122 -10000 0 122
FAS/FADD/MET -0.014 0.1 -10000 0 -0.33 39 39
CFLAR/RIP1 0.02 0.05 -10000 0 -0.36 8 8
FAIM3 -0.001 0.099 -10000 0 -0.49 20 20
FAF1 0.013 0.025 -10000 0 -0.52 1 1
PARP1 0.064 0.1 0.23 128 -0.28 5 133
DFFB 0.066 0.099 0.24 122 -10000 0 122
CHUK -0.025 0.091 -10000 0 -0.43 6 6
FASLG -0.065 0.17 -10000 0 -0.38 106 106
FAS/FADD -0.02 0.11 -10000 0 -0.36 37 37
HGF 0.008 0.069 -10000 0 -0.45 11 11
LMNA 0.06 0.095 0.22 112 -0.26 7 119
CASP6 0.063 0.1 0.24 121 -0.27 4 125
CASP10 0.012 0.029 -10000 0 -0.25 6 6
CASP3 0.072 0.12 0.28 128 -10000 0 128
PTPN13 -0.071 0.2 -10000 0 -0.49 93 93
CASP8 0.013 0.068 0.37 18 -10000 0 18
IL6 -0.16 0.4 -10000 0 -1.3 58 58
MET 0 0.075 -10000 0 -0.29 31 31
ICAD/CAD 0.066 0.089 0.22 115 -10000 0 115
FASLG/FAS/FADD/FAF1/Caspase 10 -0.045 0.15 -10000 0 -0.38 59 59
activation of caspase activity by cytochrome c 0.012 0.066 0.29 16 -0.32 8 24
PAK2 0.067 0.099 0.24 126 -10000 0 126
BCL2 -0.11 0.22 -10000 0 -0.47 144 144
Glucocorticoid receptor regulatory network

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.018 0.15 0.35 14 -0.84 10 24
SMARCC2 0.018 0 -10000 0 -10000 0 0
SMARCC1 0.012 0.051 -10000 0 -0.41 7 7
TBX21 -0.2 0.33 -10000 0 -0.76 119 119
SUMO2 0.014 0.022 -10000 0 -0.26 3 3
STAT1 (dimer) -0.023 0.13 -10000 0 -0.34 67 67
FKBP4 0.012 0.055 -10000 0 -0.44 7 7
FKBP5 -0.045 0.16 -10000 0 -0.42 75 75
GR alpha/HSP90/FKBP51/HSP90 0.073 0.16 0.28 93 -0.29 38 131
PRL -0.057 0.14 -10000 0 -0.71 5 5
cortisol/GR alpha (dimer)/TIF2 0.23 0.26 0.53 183 -0.4 2 185
RELA -0.052 0.091 -10000 0 -0.26 22 22
FGG 0.2 0.22 0.48 141 -0.39 2 143
GR beta/TIF2 0.11 0.14 0.3 110 -0.32 14 124
IFNG -0.41 0.43 -10000 0 -0.85 197 197
apoptosis -0.004 0.18 0.49 7 -0.52 7 14
CREB1 0.007 0.056 -10000 0 -0.36 5 5
histone acetylation -0.045 0.14 0.3 2 -0.35 54 56
BGLAP -0.072 0.15 -10000 0 -0.52 18 18
GR/PKAc 0.092 0.14 0.29 65 -0.33 14 79
NF kappa B1 p50/RelA -0.091 0.17 -10000 0 -0.41 60 60
SMARCD1 0.018 0 -10000 0 -10000 0 0
MDM2 0.099 0.1 0.24 134 -10000 0 134
GATA3 -0.093 0.23 -10000 0 -0.5 124 124
AKT1 0.006 0.059 0.21 5 -0.38 9 14
CSF2 -0.073 0.15 -10000 0 -0.61 16 16
GSK3B 0.016 0.008 -10000 0 -10000 0 0
NR1I3 0.009 0.18 0.48 6 -0.91 3 9
CSN2 0.17 0.18 0.41 123 -0.38 6 129
BRG1/BAF155/BAF170/BAF60A 0.041 0.034 -10000 0 -0.27 5 5
NFATC1 -0.004 0.12 -10000 0 -0.48 28 28
POU2F1 0.025 0.012 -10000 0 -0.22 1 1
CDKN1A -0.035 0.28 -10000 0 -1.5 16 16
response to stress 0 0 -10000 0 -10000 0 0
response to UV -0.002 0.007 -10000 0 -10000 0 0
SFN -0.015 0.12 -10000 0 -0.45 37 37
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.064 0.16 0.29 73 -0.3 35 108
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.086 0.33 0.47 5 -0.8 80 85
JUN -0.21 0.24 -10000 0 -0.51 156 156
IL4 -0.1 0.2 -10000 0 -0.64 32 32
CDK5R1 0.013 0.031 -10000 0 -0.25 7 7
PRKACA 0.018 0 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.22 0.28 0.21 47 -0.49 222 269
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.081 0.15 0.29 70 -0.29 25 95
cortisol/GR alpha (monomer) 0.28 0.32 0.62 189 -0.46 3 192
NCOA2 0.009 0.063 -10000 0 -0.4 11 11
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.18 0.21 -10000 0 -0.47 155 155
AP-1/NFAT1-c-4 -0.44 0.4 -10000 0 -0.79 244 244
AFP -0.16 0.2 -10000 0 -0.65 30 30
SUV420H1 0.014 0.037 -10000 0 -0.29 7 7
IRF1 0.11 0.25 0.46 46 -0.81 19 65
TP53 -0.015 0.17 -10000 0 -0.53 47 47
PPP5C 0.012 0.052 -10000 0 -0.39 8 8
KRT17 -0.53 0.58 -10000 0 -1.2 180 180
KRT14 -0.32 0.51 -10000 0 -1.3 102 102
TBP 0.028 0.012 -10000 0 -0.24 1 1
CREBBP 0.061 0.1 0.26 78 -0.53 2 80
HDAC1 0.011 0.025 -10000 0 -0.53 1 1
HDAC2 0.008 0.053 -10000 0 -0.29 15 15
AP-1 -0.44 0.4 -10000 0 -0.8 246 246
MAPK14 0.015 0.013 -10000 0 -0.25 1 1
MAPK10 -0.026 0.12 -10000 0 -0.36 58 58
MAPK11 0.016 0.008 -10000 0 -10000 0 0
KRT5 -0.54 0.58 -10000 0 -1.1 225 225
interleukin-1 receptor activity -0.001 0.009 -10000 0 -10000 0 0
NCOA1 0.013 0.059 -10000 0 -0.52 6 6
STAT1 -0.023 0.13 -10000 0 -0.34 67 67
CGA -0.12 0.2 -10000 0 -0.63 33 33
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.12 0.16 0.37 113 -0.35 4 117
MAPK3 0.014 0.027 -10000 0 -0.39 2 2
MAPK1 0.014 0.034 -10000 0 -0.52 2 2
ICAM1 -0.22 0.34 -10000 0 -0.84 84 84
NFKB1 -0.053 0.093 -10000 0 -0.3 13 13
MAPK8 -0.15 0.19 -10000 0 -0.41 133 133
MAPK9 -0.008 0.11 -10000 0 -0.51 24 24
cortisol/GR alpha (dimer) -0.014 0.18 0.49 7 -0.55 7 14
BAX 0.001 0.11 -10000 0 -10000 0 0
POMC -0.13 0.2 -10000 0 -0.9 10 10
EP300 0.059 0.11 0.26 78 -0.53 4 82
cortisol/GR alpha (dimer)/p53 0.21 0.28 0.54 174 -0.42 9 183
proteasomal ubiquitin-dependent protein catabolic process 0.07 0.08 0.21 71 -10000 0 71
SGK1 0.11 0.13 0.34 102 -0.26 4 106
IL13 -0.31 0.29 -10000 0 -0.71 131 131
IL6 -0.28 0.41 -10000 0 -0.94 113 113
PRKACG 0.016 0.033 -10000 0 -0.52 2 2
IL5 -0.26 0.24 -10000 0 -0.62 109 109
IL2 -0.32 0.33 -10000 0 -0.75 136 136
CDK5 0.015 0.027 -10000 0 -0.39 2 2
PRKACB -0.036 0.14 -10000 0 -0.34 79 79
HSP90AA1 0.013 0.045 -10000 0 -0.39 6 6
IL8 -0.27 0.37 -10000 0 -0.87 109 109
CDK5R1/CDK5 0.02 0.03 -10000 0 -0.22 4 4
NF kappa B1 p50/RelA/PKAc -0.063 0.15 -10000 0 -0.38 45 45
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.23 0.24 0.51 183 -0.36 2 185
SMARCA4 0.015 0.031 -10000 0 -0.32 4 4
chromatin remodeling 0.16 0.16 0.36 153 -0.3 2 155
NF kappa B1 p50/RelA/Cbp -0.018 0.16 0.31 24 -0.41 22 46
JUN (dimer) -0.21 0.24 -10000 0 -0.51 156 156
YWHAH 0.013 0.048 -10000 0 -0.47 5 5
VIPR1 -0.11 0.24 -10000 0 -0.59 74 74
NR3C1 0.16 0.21 0.42 144 -0.46 11 155
NR4A1 0.01 0.063 -10000 0 -0.29 18 18
TIF2/SUV420H1 0.017 0.055 -10000 0 -0.42 6 6
MAPKKK cascade -0.004 0.18 0.49 7 -0.52 7 14
cortisol/GR alpha (dimer)/Src-1 0.24 0.26 0.53 183 -0.43 3 186
PBX1 0.004 0.1 -10000 0 -0.48 23 23
POU1F1 0.023 0.033 -10000 0 -0.3 5 5
SELE -0.35 0.47 -10000 0 -1 154 154
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.16 0.16 0.36 153 -0.3 2 155
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.23 0.24 0.51 183 -0.36 2 185
mol:cortisol 0.16 0.19 0.37 188 -10000 0 188
MMP1 -0.44 0.52 -10000 0 -1.1 164 164
IL6-mediated signaling events

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.11 0.3 -10000 0 -0.72 54 54
CRP -0.11 0.3 -10000 0 -0.71 59 59
cell cycle arrest -0.14 0.34 -10000 0 -0.73 95 95
TIMP1 -0.11 0.3 -10000 0 -0.75 62 62
IL6ST -0.11 0.22 -10000 0 -0.46 143 143
Rac1/GDP -0.1 0.22 0.28 2 -0.44 117 119
AP1 -0.05 0.16 -10000 0 -0.46 30 30
GAB2 0.011 0.048 -10000 0 -0.25 17 17
TNFSF11 -0.18 0.41 -10000 0 -0.93 97 97
HSP90B1 0.008 0.11 -10000 0 -0.8 6 6
GAB1 0.007 0.074 -10000 0 -0.42 14 14
MAPK14 -0.11 0.22 -10000 0 -0.51 77 77
AKT1 0.038 0.073 -10000 0 -0.47 3 3
FOXO1 0.036 0.086 -10000 0 -0.45 5 5
MAP2K6 -0.12 0.22 0.27 2 -0.43 132 134
mol:GTP 0 0.002 -10000 0 -10000 0 0
MAP2K4 -0.1 0.25 -10000 0 -0.48 116 116
MITF -0.11 0.22 0.29 2 -0.41 140 142
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.018 0 -10000 0 -10000 0 0
A2M -0.042 0.28 -10000 0 -1.4 22 22
CEBPB 0.013 0.073 -10000 0 -0.33 20 20
GRB2/SOS1/GAB family/SHP2 -0.017 0.1 -10000 0 -0.41 9 9
STAT3 -0.15 0.37 -10000 0 -0.78 96 96
STAT1 -0.042 0.17 -10000 0 -0.95 16 16
CEBPD -0.16 0.38 -10000 0 -0.9 84 84
PIK3CA 0.017 0.029 -10000 0 -0.34 3 3
PI3K 0.008 0.083 -10000 0 -0.37 21 21
JUN -0.034 0.15 -10000 0 -0.46 57 57
PIAS3/MITF -0.095 0.21 0.27 2 -0.41 115 117
MAPK11 -0.11 0.22 -10000 0 -0.51 77 77
STAT3 (dimer)/FOXO1 -0.082 0.29 -10000 0 -0.62 76 76
GRB2/SOS1/GAB family -0.11 0.18 -10000 0 -0.47 71 71
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.12 0.22 -10000 0 -0.4 153 153
GRB2 0.017 0.024 -10000 0 -0.25 4 4
JAK2 0.01 0.053 -10000 0 -0.32 12 12
LBP -0.097 0.26 -10000 0 -0.59 59 59
PIK3R1 -0.008 0.11 -10000 0 -0.42 33 33
JAK1 0.013 0.059 -10000 0 -0.53 6 6
MYC -0.14 0.37 -10000 0 -0.85 84 84
FGG -0.11 0.3 -10000 0 -0.7 64 64
macrophage differentiation -0.14 0.34 -10000 0 -0.73 95 95
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.13 0.2 -10000 0 -0.37 178 178
JUNB -0.11 0.29 -10000 0 -0.7 59 59
FOS -0.11 0.2 -10000 0 -0.37 171 171
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.12 0.22 0.31 2 -0.42 145 147
STAT1/PIAS1 -0.11 0.22 0.32 2 -0.43 125 127
GRB2/SOS1/GAB family/SHP2/PI3K 0.03 0.067 -10000 0 -0.38 4 4
STAT3 (dimer) -0.14 0.36 -10000 0 -0.78 95 95
PRKCD -0.1 0.27 -10000 0 -0.57 90 90
IL6R 0.002 0.085 -10000 0 -0.37 23 23
SOCS3 -0.1 0.23 -10000 0 -0.69 39 39
gp130 (dimer)/JAK1/JAK1/LMO4 -0.096 0.19 -10000 0 -0.35 170 170
Rac1/GTP -0.11 0.24 0.28 2 -0.46 115 117
HCK -0.005 0.11 -10000 0 -0.47 25 25
MAPKKK cascade 0.008 0.093 -10000 0 -0.55 4 4
bone resorption -0.16 0.38 -10000 0 -0.86 97 97
IRF1 -0.12 0.33 -10000 0 -0.81 64 64
mol:GDP -0.12 0.23 0.29 2 -0.42 147 149
SOS1 0.018 0.024 -10000 0 -0.52 1 1
VAV1 -0.12 0.23 0.29 2 -0.42 147 149
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.11 0.22 -10000 0 -0.48 90 90
PTPN11 0.004 0.058 -10000 0 -1.2 1 1
IL6/IL6RA -0.056 0.14 -10000 0 -0.37 72 72
gp130 (dimer)/TYK2/TYK2/LMO4 -0.095 0.18 -10000 0 -0.34 169 169
gp130 (dimer)/JAK2/JAK2/LMO4 -0.099 0.18 -10000 0 -0.35 174 174
IL6 -0.084 0.18 -10000 0 -0.36 146 146
PIAS3 0.018 0 -10000 0 -10000 0 0
PTPRE -0.002 0.088 -10000 0 -0.47 17 17
PIAS1 0.017 0.012 -10000 0 -0.25 1 1
RAC1 0.018 0.001 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.11 0.18 0.27 2 -0.35 159 161
LMO4 -0.073 0.18 -10000 0 -0.38 123 123
STAT3 (dimer)/PIAS3 -0.14 0.34 -10000 0 -0.72 97 97
MCL1 0.043 0.083 -10000 0 -0.82 2 2
TCR signaling in naïve CD8+ T cells

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC -0.058 0.21 -10000 0 -0.44 103 103
FYN -0.085 0.26 -10000 0 -0.54 107 107
LAT/GRAP2/SLP76 -0.098 0.21 -10000 0 -0.46 114 114
IKBKB 0.012 0.047 -10000 0 -0.31 10 10
AKT1 -0.048 0.19 -10000 0 -0.37 112 112
B2M -0.005 0.1 -10000 0 -0.45 25 25
IKBKG 0.003 0.061 -10000 0 -0.13 54 54
MAP3K8 -0.036 0.15 -10000 0 -0.39 70 70
mol:Ca2+ -0.022 0.031 -10000 0 -0.072 105 105
integrin-mediated signaling pathway 0.007 0.068 -10000 0 -0.31 20 20
LAT/GRAP2/SLP76/VAV1/PI3K Class IA -0.083 0.26 -10000 0 -0.54 112 112
TRPV6 -0.11 0.19 -10000 0 -0.38 159 159
CD28 -0.044 0.16 -10000 0 -0.4 78 78
SHC1 -0.09 0.26 -10000 0 -0.56 104 104
receptor internalization -0.12 0.3 -10000 0 -0.59 123 123
PRF1 -0.079 0.24 -10000 0 -0.65 53 53
KRAS 0.009 0.065 -10000 0 -0.44 10 10
GRB2 0.016 0.024 -10000 0 -0.25 4 4
COT/AKT1 -0.047 0.16 -10000 0 -0.31 112 112
LAT -0.095 0.27 -10000 0 -0.56 112 112
EntrezGene:6955 0 0.004 -10000 0 -10000 0 0
CD3D -0.029 0.13 -10000 0 -0.35 68 68
CD3E 0.016 0.018 -10000 0 -0.26 2 2
CD3G -0.092 0.2 -10000 0 -0.41 136 136
RASGRP2 -0.002 0.036 -10000 0 -0.17 13 13
RASGRP1 -0.061 0.2 -10000 0 -0.37 128 128
HLA-A -0.012 0.12 -10000 0 -0.43 34 34
RASSF5 -0.004 0.096 -10000 0 -0.38 29 29
RAP1A/GTP/RAPL 0.007 0.068 -10000 0 -0.31 20 20
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.004 0.064 -10000 0 -0.11 70 70
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.045 0.078 -10000 0 -0.2 88 88
PRKCA -0.043 0.1 -10000 0 -0.24 100 100
GRAP2 0.012 0.042 -10000 0 -0.28 10 10
mol:IP3 -0.051 0.18 0.18 85 -0.37 106 191
EntrezGene:6957 -0.001 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.08 0.22 -10000 0 -0.46 99 99
ORAI1 0.07 0.11 0.3 66 -0.38 1 67
CSK -0.088 0.26 -10000 0 -0.55 104 104
B7 family/CD28 -0.11 0.3 -10000 0 -0.6 118 118
CHUK 0.005 0.081 -10000 0 -0.5 13 13
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.11 0.3 -10000 0 -0.63 108 108
PTPN6 -0.094 0.26 -10000 0 -0.56 106 106
VAV1 -0.1 0.28 -10000 0 -0.59 108 108
Monovalent TCR/CD3 -0.096 0.22 -10000 0 -0.4 146 146
CBL 0.017 0.012 -10000 0 -0.25 1 1
LCK -0.097 0.28 -10000 0 -0.58 107 107
PAG1 -0.092 0.26 -10000 0 -0.56 104 104
RAP1A 0.012 0.057 -10000 0 -0.52 6 6
TCR/CD3/MHC I/CD8/LCK -0.12 0.3 -10000 0 -0.6 118 118
CD80 0.009 0.048 -10000 0 -0.27 14 14
CD86 -0.008 0.11 -10000 0 -0.5 26 26
PDK1/CARD11/BCL10/MALT1 -0.054 0.094 -10000 0 -0.24 92 92
HRAS 0.012 0.051 -10000 0 -0.41 7 7
GO:0035030 -0.091 0.24 -10000 0 -0.49 118 118
CD8A 0 0.005 -10000 0 -10000 0 0
CD8B 0.001 0.069 -10000 0 -0.28 29 29
PTPRC -0.041 0.16 -10000 0 -0.42 71 71
PDK1/PKC theta -0.06 0.23 -10000 0 -0.46 109 109
CSK/PAG1 -0.08 0.25 -10000 0 -0.53 100 100
SOS1 0.017 0.023 -10000 0 -0.52 1 1
peptide-MHC class I -0.01 0.13 -10000 0 -0.48 31 31
GRAP2/SLP76 -0.085 0.26 -10000 0 -0.55 107 107
STIM1 0.034 0.059 -10000 0 -0.36 2 2
RAS family/GTP -0.002 0.088 -10000 0 -0.16 75 75
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.13 0.33 -10000 0 -0.64 123 123
mol:DAG -0.072 0.14 0.1 33 -0.33 109 142
RAP1A/GDP 0.003 0.031 -10000 0 -0.081 18 18
PLCG1 0.016 0.026 -10000 0 -0.39 2 2
CD247 -0.11 0.21 -10000 0 -0.41 153 153
cytotoxic T cell degranulation -0.076 0.23 -10000 0 -0.62 54 54
RAP1A/GTP -0.005 0.014 -10000 0 -0.075 17 17
mol:PI-3-4-5-P3 -0.063 0.22 -10000 0 -0.44 111 111
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.076 0.23 0.21 77 -0.47 107 184
NRAS 0.005 0.076 -10000 0 -0.4 16 16
ZAP70 0.005 0.06 -10000 0 -0.27 24 24
GRB2/SOS1 0.024 0.023 -10000 0 -0.37 1 1
LAT/GRAP2/SLP76/VAV1 -0.1 0.21 0.16 1 -0.47 113 114
MALT1 0.011 0.053 -10000 0 -0.37 9 9
TRAF6 0.017 0.023 -10000 0 -0.52 1 1
CD8 heterodimer 0.002 0.049 -10000 0 -0.19 29 29
CARD11 0.002 0.077 -10000 0 -0.33 24 24
PRKCB -0.048 0.1 -10000 0 -0.23 109 109
PRKCE -0.045 0.11 -10000 0 -0.24 101 101
PRKCQ -0.078 0.26 -10000 0 -0.52 112 112
LCP2 -0.004 0.097 -10000 0 -0.4 27 27
BCL10 0.017 0.012 -10000 0 -0.25 1 1
regulation of survival gene product expression -0.037 0.16 -10000 0 -0.32 112 112
IKK complex 0.012 0.059 -10000 0 -0.1 57 57
RAS family/GDP -0.008 0.015 -10000 0 -0.064 20 20
MAP3K14 -0.029 0.12 -10000 0 -0.25 91 91
PDPK1 -0.042 0.18 -10000 0 -0.36 106 106
TCR/CD3/MHC I/CD8/Fyn -0.091 0.26 -10000 0 -0.58 94 94
IL27-mediated signaling events

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.026 0.03 -10000 0 -0.46 2 2
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response 0.17 0.26 0.61 101 -10000 0 101
IL27/IL27R/JAK1 -0.2 0.35 -10000 0 -0.88 81 81
TBX21 -0.22 0.3 -10000 0 -0.61 152 152
IL12B 0.001 0.075 -10000 0 -0.35 21 21
IL12A -0.01 0.064 -10000 0 -0.19 55 55
IL6ST -0.12 0.22 -10000 0 -0.47 143 143
IL27RA/JAK1 -0.11 0.33 -10000 0 -1.2 39 39
IL27 -0.082 0.2 -10000 0 -0.5 98 98
TYK2 0.011 0.011 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.006 0.11 -10000 0 -1.4 1 1
T-helper 2 cell differentiation 0.17 0.26 0.61 101 -10000 0 101
T cell proliferation during immune response 0.17 0.26 0.61 101 -10000 0 101
MAPKKK cascade -0.17 0.26 -10000 0 -0.61 101 101
STAT3 0.015 0.04 -10000 0 -0.52 3 3
STAT2 0.018 0 -10000 0 -10000 0 0
STAT1 -0.021 0.12 -10000 0 -0.33 58 58
IL12RB1 0.017 0.003 -10000 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 -0.21 0.28 -10000 0 -0.59 150 150
IL27/IL27R/JAK2/TYK2 -0.17 0.27 -10000 0 -0.62 101 101
positive regulation of T cell mediated cytotoxicity -0.17 0.26 -10000 0 -0.61 101 101
STAT1 (dimer) -0.27 0.4 0.46 9 -0.91 104 113
JAK2 0.004 0.055 -10000 0 -0.33 12 12
JAK1 0.011 0.057 -10000 0 -0.52 6 6
STAT2 (dimer) -0.16 0.25 -10000 0 -0.61 93 93
T cell proliferation -0.2 0.27 -10000 0 -0.62 116 116
IL12/IL12R/TYK2/JAK2 -0.033 0.15 -10000 0 -0.9 8 8
IL17A -0.006 0.11 -10000 0 -1.4 1 1
mast cell activation 0.17 0.26 0.61 101 -10000 0 101
IFNG -0.031 0.047 -10000 0 -0.11 99 99
T cell differentiation -0.01 0.009 0.024 1 -0.021 176 177
STAT3 (dimer) -0.16 0.25 -10000 0 -0.61 95 95
STAT5A (dimer) -0.16 0.26 -10000 0 -0.61 96 96
STAT4 (dimer) -0.17 0.27 -10000 0 -0.61 112 112
STAT4 -0.024 0.13 -10000 0 -0.42 50 50
T cell activation 0.002 0.038 0.08 82 -10000 0 82
IL27R/JAK2/TYK2 -0.16 0.33 -10000 0 -0.93 63 63
GATA3 -0.25 0.55 -10000 0 -1.3 119 119
IL18 -0.035 0.12 -10000 0 -0.32 76 76
positive regulation of mast cell cytokine production -0.15 0.25 -10000 0 -0.59 95 95
IL27/EBI3 -0.06 0.16 -10000 0 -0.38 93 93
IL27RA -0.12 0.34 -10000 0 -1.3 38 38
IL6 -0.077 0.18 -10000 0 -0.51 59 59
STAT5A 0.011 0.056 -10000 0 -0.42 8 8
monocyte differentiation -0.001 0.002 -10000 0 -10000 0 0
IL2 0.054 0.16 0.49 38 -1.2 3 41
IL1B -0.033 0.12 -10000 0 -0.29 81 81
EBI3 0.002 0.071 -10000 0 -0.44 12 12
TNF -0.003 0.067 -10000 0 -0.25 31 31
Noncanonical Wnt signaling pathway

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0.013 0.048 -9999 0 -0.47 5 5
GNB1/GNG2 -0.11 0.19 -9999 0 -0.42 103 103
mol:DAG -0.093 0.18 -9999 0 -0.44 72 72
PLCG1 -0.096 0.18 -9999 0 -0.46 72 72
YES1 -0.12 0.2 -9999 0 -0.45 104 104
FZD3 -0.03 0.15 -9999 0 -0.48 51 51
FZD6 -0.077 0.2 -9999 0 -0.45 108 108
G protein -0.099 0.19 -9999 0 -0.46 76 76
MAP3K7 -0.068 0.15 -9999 0 -0.39 61 61
mol:Ca2+ -0.09 0.17 -9999 0 -0.43 72 72
mol:IP3 -0.093 0.18 -9999 0 -0.44 72 72
NLK 0.016 0.044 -9999 0 -0.9 1 1
GNB1 0.013 0.052 -9999 0 -0.52 5 5
CAMK2A -0.079 0.16 -9999 0 -0.42 61 61
MAP3K7IP1 0.018 0 -9999 0 -10000 0 0
Noncanonical Wnts/FZD -0.13 0.21 -9999 0 -0.46 102 102
CSNK1A1 0.017 0.023 -9999 0 -0.52 1 1
GNAS -0.12 0.2 -9999 0 -0.44 104 104
GO:0007205 -0.092 0.17 -9999 0 -0.46 62 62
WNT6 -0.011 0.087 -9999 0 -0.26 54 54
WNT4 -0.062 0.18 -9999 0 -0.45 90 90
NFAT1/CK1 alpha -0.091 0.19 -9999 0 -0.48 65 65
GNG2 0.016 0.029 -9999 0 -0.34 3 3
WNT5A -0.084 0.2 -9999 0 -0.43 120 120
WNT11 -0.013 0.089 -9999 0 -0.26 57 57
CDC42 -0.11 0.2 -9999 0 -0.42 104 104
Fc-epsilon receptor I signaling in mast cells

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.007 0.074 -9999 0 -0.5 11 11
LAT2 -0.089 0.18 -9999 0 -0.41 88 88
AP1 -0.14 0.22 -9999 0 -0.5 117 117
mol:PIP3 -0.099 0.22 -9999 0 -0.48 95 95
IKBKB -0.043 0.12 -9999 0 -0.26 87 87
AKT1 -0.068 0.16 -9999 0 -0.4 75 75
IKBKG -0.041 0.12 -9999 0 -0.25 89 89
MS4A2 -0.15 0.23 -9999 0 -0.43 203 203
mol:Sphingosine-1-phosphate 0 0 -9999 0 -10000 0 0
PIK3CA 0.015 0.029 -9999 0 -0.34 3 3
MAP3K1 -0.086 0.19 -9999 0 -0.43 96 96
mol:Ca2+ -0.071 0.16 -9999 0 -0.36 95 95
LYN 0.012 0.032 -9999 0 -0.26 7 7
CBLB -0.086 0.18 -9999 0 -0.45 71 71
SHC1 0.017 0.023 -9999 0 -0.52 1 1
RasGAP/p62DOK -0.013 0.11 -9999 0 -0.3 58 58
positive regulation of cell migration -0.013 0.089 -9999 0 -0.28 46 46
INPP5D 0 0 -9999 0 -10000 0 0
PLD2 -0.088 0.18 -9999 0 -0.39 99 99
PTPN13 -0.12 0.22 -9999 0 -0.55 78 78
PTPN11 0.012 0.027 -9999 0 -0.56 1 1
GO:0007205 0 0 -9999 0 -10000 0 0
regulation of mast cell degranulation -0.046 0.14 -9999 0 -0.32 74 74
SYK -0.025 0.14 -9999 0 -0.49 43 43
GRB2 0.015 0.024 -9999 0 -0.26 4 4
LAT/PLCgamma1/GRB2/SLP76/GADs -0.14 0.2 -9999 0 -0.49 100 100
LAT -0.092 0.18 -9999 0 -0.44 79 79
PAK2 -0.081 0.2 -9999 0 -0.44 88 88
NFATC2 -0.042 0.082 -9999 0 -0.62 5 5
HRAS -0.096 0.21 -9999 0 -0.48 93 93
GAB2 0.009 0.048 -9999 0 -0.25 17 17
PLA2G1B 0.038 0.026 -9999 0 -10000 0 0
Fc epsilon R1 -0.12 0.2 -9999 0 -0.39 168 168
Antigen/IgE/Fc epsilon R1 -0.11 0.19 -9999 0 -0.35 168 168
mol:GDP -0.11 0.22 -9999 0 -0.51 94 94
JUN -0.034 0.15 -9999 0 -0.46 57 57
mol:Ca++ 0 0 -9999 0 -10000 0 0
PIK3R1 -0.01 0.11 -9999 0 -0.42 33 33
FOS -0.11 0.2 -9999 0 -0.37 171 171
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.097 0.18 -9999 0 -0.36 139 139
CHUK -0.046 0.12 -9999 0 -0.26 93 93
KLRG1 -0.084 0.17 -9999 0 -0.42 74 74
VAV1 -0.1 0.2 -9999 0 -0.45 93 93
calcium-dependent protein kinase C activity 0 0 -9999 0 -10000 0 0
CBL -0.086 0.18 -9999 0 -0.43 76 76
negative regulation of mast cell degranulation -0.079 0.16 -9999 0 -0.39 74 74
BTK -0.11 0.23 -9999 0 -0.54 87 87
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.13 0.25 -9999 0 -0.64 82 82
GAB2/PI3K/SHP2 -0.1 0.15 -9999 0 -0.43 76 76
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.097 0.2 -9999 0 -0.44 96 96
RAF1 0.029 0.026 -9999 0 -10000 0 0
Fc epsilon R1/FcgammaRIIB/SHIP -0.12 0.21 -9999 0 -0.36 181 181
FCER1G 0.02 0.026 -9999 0 -0.26 4 4
FCER1A -0.074 0.2 -9999 0 -0.51 91 91
Antigen/IgE/Fc epsilon R1/Fyn -0.095 0.18 -9999 0 -0.33 170 170
MAPK3 0.037 0.026 -9999 0 -10000 0 0
MAPK1 0.037 0.026 -9999 0 -10000 0 0
NFKB1 0.017 0.023 -9999 0 -0.52 1 1
MAPK8 -0.02 0.11 -9999 0 -0.48 19 19
DUSP1 -0.038 0.15 -9999 0 -0.41 69 69
NF-kappa-B/RelA -0.039 0.061 -9999 0 -0.2 17 17
actin cytoskeleton reorganization -0.088 0.18 -9999 0 -0.48 65 65
mol:Glucocorticoid Dexamethasone 0 0 -9999 0 -10000 0 0
PI3K -0.091 0.2 -9999 0 -0.45 97 97
FER -0.086 0.18 -9999 0 -0.43 76 76
RELA 0.018 0 -9999 0 -10000 0 0
ITK -0.053 0.13 -9999 0 -0.42 48 48
SOS1 0.017 0.023 -9999 0 -0.52 1 1
PLCG1 -0.1 0.22 -9999 0 -0.51 92 92
cytokine secretion -0.029 0.044 -9999 0 -0.19 1 1
SPHK1 -0.11 0.2 -9999 0 -0.42 107 107
PTK2 -0.092 0.19 -9999 0 -0.5 65 65
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.14 0.21 -9999 0 -0.42 149 149
EDG1 -0.013 0.089 -9999 0 -0.28 46 46
mol:DAG -0.095 0.22 -9999 0 -0.47 99 99
MAP2K2 0.032 0.031 -9999 0 -0.28 1 1
MAP2K1 0.033 0.024 -9999 0 -10000 0 0
MAP2K7 0.017 0.023 -9999 0 -0.52 1 1
KLRG1/SHP2 -0.073 0.15 -9999 0 -0.39 71 71
MAP2K4 -0.011 0.16 -9999 0 -0.91 16 16
Fc epsilon R1/FcgammaRIIB -0.12 0.22 -9999 0 -0.39 181 181
mol:Choline -0.087 0.17 -9999 0 -0.38 99 99
SHC/Grb2/SOS1 -0.066 0.17 -9999 0 -0.41 72 72
FYN 0.008 0.067 -9999 0 -0.41 12 12
DOK1 0.002 0.083 -9999 0 -0.41 19 19
PXN -0.079 0.18 -9999 0 -0.46 65 65
HCLS1 -0.096 0.19 -9999 0 -0.36 145 145
PRKCB -0.069 0.16 -9999 0 -0.35 100 100
FCGR2B -0.031 0.15 -9999 0 -0.5 50 50
IGHE -0.003 0.006 -9999 0 -10000 0 0
KLRG1/SHIP -0.08 0.16 -9999 0 -0.4 74 74
LCP2 -0.004 0.098 -9999 0 -0.4 27 27
PLA2G4A -0.11 0.21 -9999 0 -0.45 109 109
RASA1 0.004 0.078 -9999 0 -0.42 16 16
mol:Phosphatidic acid -0.087 0.17 -9999 0 -0.38 99 99
IKK complex -0.023 0.098 -9999 0 -0.2 76 76
WIPF1 0.005 0.076 -9999 0 -0.4 16 16
IL12-mediated signaling events

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 -0.029 0.12 -10000 0 -0.36 29 29
TBX21 -0.3 0.59 -10000 0 -1.3 118 118
B2M -0.005 0.1 -10000 0 -0.45 25 25
TYK2 0.012 0.022 -10000 0 -10000 0 0
IL12RB1 0.012 0.022 -10000 0 -10000 0 0
GADD45B -0.18 0.44 -10000 0 -1.1 86 86
IL12RB2 -0.076 0.16 -10000 0 -0.32 142 142
GADD45G -0.18 0.43 -10000 0 -1 94 94
natural killer cell activation -0.005 0.024 -10000 0 -10000 0 0
RELB 0.003 0.078 -10000 0 -0.38 19 19
RELA 0.018 0 -10000 0 -10000 0 0
IL18 -0.046 0.17 -10000 0 -0.44 76 76
IL2RA -0.03 0.14 -10000 0 -0.4 60 60
IFNG -0.088 0.17 -10000 0 -0.33 161 161
STAT3 (dimer) -0.14 0.37 -10000 0 -0.77 110 110
HLA-DRB5 -0.002 0.093 -10000 0 -0.51 17 17
FASLG -0.24 0.52 -10000 0 -1.1 117 117
NF kappa B2 p52/RelB -0.24 0.41 -10000 0 -0.86 130 130
CD4 0.015 0.007 -10000 0 -10000 0 0
SOCS1 0.015 0.031 -10000 0 -0.32 4 4
EntrezGene:6955 -0.005 0.012 -10000 0 -10000 0 0
CD3D -0.033 0.13 -10000 0 -0.35 68 68
CD3E 0.013 0.021 -10000 0 -0.28 2 2
CD3G -0.097 0.2 -10000 0 -0.42 136 136
IL12Rbeta2/JAK2 -0.048 0.13 -10000 0 -0.34 57 57
CCL3 -0.2 0.44 -10000 0 -0.98 100 100
CCL4 -0.2 0.46 -10000 0 -1 104 104
HLA-A -0.012 0.11 -10000 0 -0.43 34 34
IL18/IL18R -0.056 0.21 -10000 0 -0.41 117 117
NOS2 -0.19 0.44 -10000 0 -0.84 130 130
IL12/IL12R/TYK2/JAK2/SPHK2 -0.029 0.12 -10000 0 -0.37 28 28
IL1R1 -0.25 0.51 -10000 0 -1.1 118 118
IL4 0.016 0.063 -10000 0 -0.48 7 7
JAK2 0.004 0.06 -10000 0 -0.34 12 12
EntrezGene:6957 -0.004 0.011 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.13 0.33 -10000 0 -0.66 103 103
RAB7A -0.12 0.34 -10000 0 -0.81 80 80
lysosomal transport -0.12 0.33 -10000 0 -0.75 82 82
FOS -0.29 0.5 -10000 0 -1.1 122 122
STAT4 (dimer) -0.18 0.43 -10000 0 -0.88 117 117
STAT5A (dimer) -0.27 0.42 -10000 0 -0.88 137 137
GZMA -0.2 0.43 -10000 0 -0.86 127 127
GZMB -0.28 0.57 -10000 0 -1.2 119 119
HLX 0.005 0.079 -10000 0 -0.48 13 13
LCK -0.25 0.52 -10000 0 -1 138 138
TCR/CD3/MHC II/CD4 -0.11 0.23 -10000 0 -0.49 107 107
IL2/IL2R -0.014 0.14 -10000 0 -0.35 61 61
MAPK14 -0.18 0.44 -10000 0 -0.95 103 103
CCR5 -0.19 0.46 -10000 0 -1.1 90 90
IL1B -0.053 0.17 -10000 0 -0.42 81 81
STAT6 -0.066 0.18 -10000 0 -0.35 93 93
STAT4 -0.024 0.13 -10000 0 -0.42 50 50
STAT3 0.015 0.04 -10000 0 -0.52 3 3
STAT1 -0.02 0.12 -10000 0 -0.33 58 58
NFKB1 0.017 0.023 -10000 0 -0.52 1 1
NFKB2 0.015 0.031 -10000 0 -0.32 4 4
IL12B 0 0.077 -10000 0 -0.34 21 21
CD8A -0.001 0.008 -10000 0 -10000 0 0
CD8B 0.001 0.07 -10000 0 -0.28 29 29
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity 0.029 0.12 0.35 29 -10000 0 29
IL2RB -0.016 0.12 -10000 0 -0.43 40 40
proteasomal ubiquitin-dependent protein catabolic process -0.16 0.38 -10000 0 -0.79 117 117
IL2RG -0.002 0.078 -10000 0 -0.28 35 35
IL12 -0.011 0.089 -10000 0 -0.27 30 30
STAT5A 0.011 0.056 -10000 0 -0.42 8 8
CD247 -0.11 0.21 -10000 0 -0.42 153 153
IL2 0.011 0.051 -10000 0 -0.33 10 10
SPHK2 0.017 0.023 -10000 0 -0.52 1 1
FRAP1 0.018 0 -10000 0 -10000 0 0
IL12A -0.019 0.095 -10000 0 -0.28 55 55
IL12/IL12R/TYK2/JAK2 -0.25 0.54 -10000 0 -1 128 128
MAP2K3 -0.18 0.44 -10000 0 -0.94 106 106
RIPK2 0.013 0.04 -10000 0 -0.28 9 9
MAP2K6 -0.19 0.45 -10000 0 -0.95 109 109
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA 0.002 0.08 -10000 0 -0.52 12 12
IL18RAP -0.071 0.19 -10000 0 -0.4 114 114
IL12Rbeta1/TYK2 0.018 0.032 -10000 0 -10000 0 0
EOMES -0.059 0.26 -10000 0 -1.3 21 21
STAT1 (dimer) -0.2 0.39 -10000 0 -0.79 127 127
T cell proliferation -0.12 0.31 -10000 0 -0.64 115 115
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 -0.01 0.12 -10000 0 -0.41 37 37
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.2 0.3 -10000 0 -0.7 114 114
ATF2 -0.15 0.4 -10000 0 -0.85 102 102
Osteopontin-mediated events

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.062 0.17 -9999 0 -0.43 52 52
NF kappa B1 p50/RelA/I kappa B alpha -0.043 0.18 -9999 0 -0.5 41 41
alphaV/beta3 Integrin/Osteopontin/Src -0.098 0.18 -9999 0 -0.39 131 131
AP1 -0.15 0.26 -9999 0 -0.6 96 96
ILK -0.064 0.16 -9999 0 -0.42 44 44
bone resorption -0.055 0.17 -9999 0 -0.4 59 59
PTK2B 0.017 0.017 -9999 0 -0.25 2 2
PYK2/p130Cas -0.059 0.17 -9999 0 -0.39 59 59
ITGAV -0.001 0.1 -9999 0 -0.49 21 21
mol:GTP 0 0 -9999 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.007 0.081 -9999 0 -0.37 21 21
alphaV/beta3 Integrin/Osteopontin -0.076 0.18 -9999 0 -0.34 142 142
MAP3K1 -0.09 0.18 -9999 0 -0.32 166 166
JUN -0.034 0.15 -9999 0 -0.46 57 57
MAPK3 -0.064 0.17 -9999 0 -0.47 46 46
MAPK1 -0.064 0.17 -9999 0 -0.47 47 47
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
NFKB1 0.017 0.023 -9999 0 -0.52 1 1
MAPK8 -0.08 0.17 -9999 0 -0.41 67 67
ITGB3 0.003 0.077 -9999 0 -0.32 25 25
NFKBIA -0.063 0.19 -9999 0 -0.52 48 48
FOS -0.11 0.2 -9999 0 -0.37 171 171
CD44 -0.004 0.1 -9999 0 -0.43 26 26
CHUK 0.005 0.081 -9999 0 -0.5 13 13
PLAU -0.14 0.38 -9999 0 -1.2 54 54
NF kappa B1 p50/RelA -0.047 0.19 -9999 0 -0.52 45 45
BCAR1 0.017 0.012 -9999 0 -0.25 1 1
RELA 0.018 0 -9999 0 -10000 0 0
alphaV beta3 Integrin 0.003 0.1 -9999 0 -0.42 22 22
mol:GDP 0 0 -9999 0 -10000 0 0
SYK -0.085 0.18 -9999 0 -0.32 162 162
VAV3 -0.12 0.2 -9999 0 -0.39 125 125
MAP3K14 -0.069 0.17 -9999 0 -0.31 137 137
ROCK2 0.013 0.048 -9999 0 -0.47 5 5
SPP1 -0.14 0.23 -9999 0 -0.42 188 188
RAC1 0.018 0 -9999 0 -10000 0 0
Rac1/GTP -0.11 0.18 -9999 0 -0.41 92 92
MMP2 -0.13 0.24 -9999 0 -0.56 98 98
Arf6 signaling events

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0 0.058 -9999 0 -0.26 23 23
ARNO/beta Arrestin1-2 -0.013 0.089 -9999 0 -0.24 59 59
EGFR -0.079 0.18 -9999 0 -0.35 139 139
EPHA2 0.008 0.059 -9999 0 -0.33 14 14
USP6 0.012 0.04 -9999 0 -0.25 12 12
IQSEC1 0.016 0.026 -9999 0 -0.39 2 2
EGFR/EGFR/EGF/EGF -0.15 0.2 -9999 0 -0.42 173 173
ARRB2 0.011 0.052 -9999 0 -0.32 12 12
mol:GTP 0.006 0.015 -9999 0 -0.13 2 2
ARRB1 0.004 0.075 -9999 0 -0.37 18 18
FBXO8 0.015 0.04 -9999 0 -0.52 3 3
TSHR 0.008 0.071 -9999 0 -0.5 10 10
EGF -0.14 0.23 -9999 0 -0.42 193 193
somatostatin receptor activity 0 0 -9999 0 -0.001 99 99
ARAP2 0 0 -9999 0 0 112 112
mol:GDP -0.054 0.11 -9999 0 -0.25 90 90
mol:PI-3-4-5-P3 0 0 -9999 0 -0.001 103 103
ITGA2B 0.016 0.02 -9999 0 -0.25 3 3
ARF6 0.016 0.033 -9999 0 -0.52 2 2
Ephrin A1/EPHA2/NCK1/GIT1 0.025 0.071 -9999 0 -0.27 24 24
ADAP1 0 0 -9999 0 0 88 88
KIF13B -0.002 0.095 -9999 0 -0.43 23 23
HGF/MET 0.007 0.073 -9999 0 -0.38 13 13
PXN 0.018 0 -9999 0 -10000 0 0
ARF6/GTP -0.067 0.11 -9999 0 -0.26 97 97
EGFR/EGFR/EGF/EGF/ARFGEP100 -0.12 0.18 -9999 0 -0.35 173 173
ADRB2 -0.045 0.16 -9999 0 -0.4 80 80
receptor agonist activity 0 0 -9999 0 0 101 101
actin filament binding 0 0 -9999 0 0 99 99
SRC 0.015 0.035 -9999 0 -0.43 3 3
ITGB3 0.002 0.075 -9999 0 -0.32 25 25
GNAQ 0 0 -9999 0 -0.001 95 95
EFA6/PI-4-5-P2 0 0 -9999 0 -0.001 93 93
ARF6/GDP -0.003 0.059 -9999 0 -0.24 10 10
ARF6/GDP/GULP/ACAP1 -0.058 0.13 -9999 0 -0.3 93 93
alphaIIb/beta3 Integrin/paxillin/GIT1 0.034 0.048 -9999 0 -0.26 8 8
ACAP1 0 0 -9999 0 0 21 21
ACAP2 0 0 -9999 0 0 105 105
LHCGR/beta Arrestin2 0.009 0.07 -9999 0 -0.44 12 12
EFNA1 0 0.094 -9999 0 -0.49 18 18
HGF 0.008 0.069 -9999 0 -0.45 11 11
CYTH3 0 0 -9999 0 -0.001 101 101
CYTH2 -0.001 0.002 -9999 0 -0.004 103 103
NCK1 0.011 0.045 -9999 0 -0.28 12 12
fibronectin binding 0 0 -9999 0 0 84 84
endosomal lumen acidification 0 0 -9999 0 0 91 91
microtubule-based process 0 0 -9999 0 -10000 0 0
GULP1 -0.035 0.15 -9999 0 -0.44 61 61
GNAQ/ARNO -0.001 0.003 -9999 0 -0.006 92 92
mol:Phosphatidic acid 0 0 -9999 0 0 105 105
PIP3-E 0.004 0.068 -9999 0 -0.3 23 23
MET 0 0.075 -9999 0 -0.29 31 31
GNA14 -0.08 0.18 -9999 0 -0.35 140 140
GNA15 0.002 0.076 -9999 0 -0.34 23 23
GIT1 0.014 0.035 -9999 0 -0.3 6 6
mol:PI-4-5-P2 0 0 -9999 0 -0.001 95 95
GNA11 0.013 0.047 -9999 0 -0.52 4 4
LHCGR 0.003 0.083 -9999 0 -0.46 16 16
AGTR1 -0.15 0.21 -9999 0 -0.36 231 231
desensitization of G-protein coupled receptor protein signaling pathway 0.009 0.07 -9999 0 -0.44 12 12
IPCEF1/ARNO -0.095 0.14 -9999 0 -0.28 179 179
alphaIIb/beta3 Integrin 0.014 0.056 -9999 0 -0.36 7 7
IL23-mediated signaling events

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.23 0.53 -10000 0 -1.3 86 86
IL23A -0.21 0.49 -10000 0 -1.2 78 78
NF kappa B1 p50/RelA/I kappa B alpha -0.22 0.42 -10000 0 -1 90 90
positive regulation of T cell mediated cytotoxicity -0.21 0.51 -10000 0 -1.1 91 91
ITGA3 -0.2 0.48 -10000 0 -1.1 82 82
IL17F -0.097 0.32 -10000 0 -0.66 83 83
IL12B 0.004 0.084 -10000 0 -0.35 21 21
STAT1 (dimer) -0.21 0.49 -10000 0 -1.1 93 93
CD4 -0.17 0.44 -10000 0 -1 68 68
IL23 -0.2 0.47 -10000 0 -1.1 81 81
IL23R -0.011 0.18 -10000 0 -1.4 7 7
IL1B -0.23 0.53 -10000 0 -1.3 82 82
T-helper cell lineage commitment 0 0 -10000 0 -10000 0 0
IL24 -0.18 0.44 -10000 0 -1.1 70 70
TYK2 0.013 0.024 -10000 0 -10000 0 0
STAT4 -0.024 0.13 -10000 0 -0.42 50 50
STAT3 0.015 0.041 -10000 0 -0.52 3 3
IL18RAP -0.075 0.18 -10000 0 -0.41 114 114
IL12RB1 0.013 0.024 -10000 0 -10000 0 0
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
IL12Rbeta1/TYK2 0.017 0.031 -10000 0 -10000 0 0
IL23R/JAK2 -0.013 0.19 -10000 0 -1.3 7 7
positive regulation of chronic inflammatory response -0.21 0.51 -10000 0 -1.1 91 91
natural killer cell activation 0.001 0.012 0.073 8 -10000 0 8
JAK2 0.011 0.065 -10000 0 -0.34 12 12
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
NFKB1 0.016 0.024 -10000 0 -0.52 1 1
RELA 0.017 0.004 -10000 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.19 0.45 -10000 0 -1 83 83
ALOX12B -0.17 0.44 -10000 0 -1 74 74
CXCL1 -0.27 0.54 -10000 0 -1.1 114 114
T cell proliferation -0.21 0.51 -10000 0 -1.1 91 91
NFKBIA 0.014 0.043 -10000 0 -0.46 4 4
IL17A -0.052 0.26 -10000 0 -0.54 61 61
PI3K -0.19 0.47 -10000 0 -1.1 88 88
IFNG -0.027 0.05 0.12 2 -0.12 64 66
STAT3 (dimer) -0.21 0.41 -10000 0 -0.98 90 90
IL18R1 -0.014 0.11 -10000 0 -0.41 37 37
IL23/IL23R/JAK2/TYK2/SOCS3 -0.08 0.28 -10000 0 -0.63 49 49
IL18/IL18R -0.082 0.2 -10000 0 -0.41 117 117
macrophage activation -0.015 0.017 -10000 0 -0.044 71 71
TNF -0.2 0.49 -10000 0 -1.1 78 78
STAT3/STAT4 -0.24 0.45 -10000 0 -1 96 96
STAT4 (dimer) -0.21 0.5 -10000 0 -1.1 95 95
IL18 -0.05 0.17 -10000 0 -0.44 76 76
IL19 -0.19 0.44 -10000 0 -1.1 69 69
STAT5A (dimer) -0.2 0.49 -10000 0 -1.1 91 91
STAT1 -0.02 0.12 -10000 0 -0.33 58 58
SOCS3 0.005 0.074 -10000 0 -0.38 17 17
CXCL9 -0.27 0.57 -10000 0 -1.2 123 123
MPO -0.17 0.44 -10000 0 -1 75 75
positive regulation of humoral immune response -0.21 0.51 -10000 0 -1.1 91 91
IL23/IL23R/JAK2/TYK2 -0.22 0.54 -10000 0 -1.2 90 90
IL6 -0.26 0.55 -10000 0 -1.2 100 100
STAT5A 0.011 0.056 -10000 0 -0.42 8 8
IL2 0.008 0.053 -10000 0 -0.34 10 10
positive regulation of tyrosine phosphorylation of STAT protein 0.001 0.012 0.073 8 -10000 0 8
CD3E -0.17 0.44 -10000 0 -1 70 70
keratinocyte proliferation -0.21 0.51 -10000 0 -1.1 91 91
NOS2 -0.18 0.44 -10000 0 -0.96 92 92
Thromboxane A2 receptor signaling

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 -0.015 0.12 -10000 0 -0.38 44 44
GNB1/GNG2 -0.058 0.078 -10000 0 -0.18 138 138
AKT1 -0.023 0.12 -10000 0 -0.21 74 74
EGF -0.14 0.23 -10000 0 -0.42 193 193
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR 0.03 0.061 -10000 0 -0.29 5 5
mol:Ca2+ -0.048 0.17 -10000 0 -0.3 138 138
LYN 0.029 0.062 -10000 0 -0.29 5 5
RhoA/GTP -0.041 0.056 -10000 0 -0.14 64 64
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK -0.066 0.19 -10000 0 -0.35 139 139
GNG2 0.016 0.029 -10000 0 -0.34 3 3
ARRB2 0.018 0 -10000 0 -10000 0 0
TP alpha/Gq family/GDP/G beta5/gamma2 -0.004 0.1 -10000 0 -0.39 22 22
G beta5/gamma2 -0.075 0.1 -10000 0 -0.24 137 137
PRKCH -0.062 0.19 -10000 0 -0.35 137 137
DNM1 0.013 0.047 -10000 0 -0.37 7 7
TXA2/TP beta/beta Arrestin3 0.006 0.019 -10000 0 -0.21 2 2
mol:GTP 0 0.002 -10000 0 -10000 0 0
PTGDR -0.002 0.088 -10000 0 -0.35 29 29
G12 family/GTP -0.096 0.13 -10000 0 -0.3 138 138
ADRBK1 0.018 0 -10000 0 -10000 0 0
ADRBK2 0.002 0.088 -10000 0 -0.49 16 16
RhoA/GTP/ROCK1 0.016 0.05 -10000 0 -0.31 12 12
mol:GDP 0.019 0.12 0.34 20 -10000 0 20
mol:NADP 0.017 0.012 -10000 0 -0.25 1 1
RAB11A 0.016 0.029 -10000 0 -0.34 3 3
PRKG1 0.017 0.012 -10000 0 -0.25 1 1
mol:IP3 -0.067 0.2 -10000 0 -0.37 138 138
cell morphogenesis 0.016 0.05 -10000 0 -0.31 12 12
PLCB2 -0.1 0.26 -10000 0 -0.5 138 138
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK 0.016 0.073 -10000 0 -0.31 6 6
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK 0.02 0.085 -10000 0 -0.38 12 12
RHOA 0.005 0.08 -10000 0 -0.52 12 12
PTGIR 0.016 0.033 -10000 0 -0.52 2 2
PRKCB1 -0.081 0.22 -10000 0 -0.4 141 141
GNAQ 0 0 -10000 0 -10000 0 0
mol:L-citrulline 0.017 0.012 -10000 0 -0.25 1 1
TXA2/TXA2-R family -0.11 0.27 -10000 0 -0.52 139 139
LCK -0.008 0.11 -10000 0 -0.37 16 16
TXA2/TP beta/beta Arrestin3/RAB11/GDP 0.034 0.044 -10000 0 -0.36 2 2
TXA2-R family/G12 family/GDP/G beta/gamma 0.029 0.059 -10000 0 -0.53 5 5
TXA2/TP beta/beta Arrestin2/RAB11/GDP 0.034 0.044 -10000 0 -0.36 2 2
MAPK14 -0.033 0.13 -10000 0 -0.23 137 137
TGM2/GTP -0.079 0.23 -10000 0 -0.41 147 147
MAPK11 -0.033 0.13 -10000 0 -0.23 137 137
ARHGEF1 -0.021 0.1 -10000 0 -0.18 73 73
GNAI2 0.006 0.075 -10000 0 -0.48 12 12
JNK cascade -0.069 0.21 -10000 0 -0.38 140 140
RAB11/GDP 0.016 0.028 -10000 0 -0.34 3 3
ICAM1 -0.052 0.17 -10000 0 -0.3 139 139
cAMP biosynthetic process -0.063 0.19 -10000 0 -0.34 139 139
Gq family/GTP/EBP50 -0.038 0.11 -10000 0 -0.25 94 94
actin cytoskeleton reorganization 0.016 0.05 -10000 0 -0.31 12 12
SRC 0.029 0.062 -10000 0 -0.29 5 5
GNB5 0.005 0.081 -10000 0 -0.5 13 13
GNB1 0.013 0.052 -10000 0 -0.52 5 5
EGF/EGFR -0.028 0.11 -10000 0 -0.28 49 49
VCAM1 -0.054 0.17 -10000 0 -0.31 141 141
TP beta/Gq family/GDP/G beta5/gamma2 -0.004 0.1 -10000 0 -0.39 22 22
platelet activation -0.042 0.17 -10000 0 -0.3 137 137
PGI2/IP 0.012 0.024 -10000 0 -0.38 2 2
PRKACA 0.015 0.046 -10000 0 -0.26 12 12
Gq family/GDP/G beta5/gamma2 -0.005 0.096 -10000 0 -0.36 22 22
TXA2/TP beta/beta Arrestin2 -0.005 0.044 -10000 0 -0.56 3 3
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R 0.021 0.044 -10000 0 -0.24 12 12
mol:DAG -0.079 0.22 -10000 0 -0.42 137 137
EGFR -0.079 0.18 -10000 0 -0.35 139 139
TXA2/TP alpha -0.09 0.25 -10000 0 -0.46 139 139
Gq family/GTP -0.038 0.078 -10000 0 -0.24 59 59
YES1 0.026 0.07 -10000 0 -0.34 6 6
GNAI2/GTP -0.015 0.055 -10000 0 -0.27 10 10
PGD2/DP -0.001 0.062 -10000 0 -0.24 29 29
SLC9A3R1 -0.043 0.16 -10000 0 -0.44 70 70
FYN 0.026 0.073 -10000 0 -0.31 12 12
mol:NO 0.017 0.012 -10000 0 -0.25 1 1
GNA15 0.002 0.076 -10000 0 -0.34 23 23
PGK/cGMP 0.023 0.01 -10000 0 -10000 0 0
RhoA/GDP 0.006 0.079 -10000 0 -0.51 12 12
TP alpha/TGM2/GDP/G beta/gamma 0.028 0.078 -10000 0 -0.37 7 7
NOS3 0.017 0.012 -10000 0 -0.26 1 1
RAC1 0.018 0 -10000 0 -10000 0 0
PRKCA -0.061 0.19 -10000 0 -0.35 137 137
PRKCB -0.064 0.19 -10000 0 -0.35 139 139
PRKCE -0.062 0.19 -10000 0 -0.35 136 136
PRKCD -0.068 0.2 -10000 0 -0.37 136 136
PRKCG -0.069 0.2 -10000 0 -0.38 136 136
muscle contraction -0.095 0.25 -10000 0 -0.48 138 138
PRKCZ -0.06 0.18 -10000 0 -0.34 140 140
ARR3 0.017 0.012 -10000 0 -0.25 1 1
TXA2/TP beta 0.028 0.059 -10000 0 -0.23 16 16
PRKCQ -0.068 0.2 -10000 0 -0.36 140 140
MAPKKK cascade -0.086 0.23 -10000 0 -0.44 138 138
SELE -0.077 0.2 -10000 0 -0.38 141 141
TP beta/GNAI2/GDP/G beta/gamma 0.038 0.068 -10000 0 -0.37 7 7
ROCK1 0.018 0 -10000 0 -10000 0 0
GNA14 -0.079 0.18 -10000 0 -0.35 140 140
chemotaxis -0.13 0.31 -10000 0 -0.61 137 137
GNA12 0.018 0 -10000 0 -10000 0 0
GNA13 0.011 0.055 -10000 0 -0.36 10 10
GNA11 0.014 0.047 -10000 0 -0.52 4 4
Rac1/GTP 0.013 0.002 -10000 0 -10000 0 0
Nongenotropic Androgen signaling

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.011 0.02 -10000 0 -0.24 3 3
GNB1/GNG2 -0.031 0.13 -10000 0 -0.28 107 107
regulation of S phase of mitotic cell cycle -0.031 0.12 -10000 0 -0.24 120 120
GNAO1 0.016 0.024 -10000 0 -0.25 4 4
HRAS 0.011 0.051 -10000 0 -0.41 7 7
SHBG/T-DHT 0.012 0 -10000 0 -10000 0 0
PELP1 0.017 0.001 -10000 0 -10000 0 0
AKT1 0.008 0.038 -10000 0 -0.26 9 9
MAP2K1 -0.032 0.12 -10000 0 -0.24 107 107
T-DHT/AR -0.064 0.16 -10000 0 -0.38 104 104
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.001 0.003 -10000 0 -0.005 164 164
GNAI2 0.006 0.075 -10000 0 -0.48 12 12
GNAI3 0.018 0 -10000 0 -10000 0 0
GNAI1 -0.017 0.12 -10000 0 -0.38 46 46
mol:GDP -0.089 0.17 -10000 0 -0.43 103 103
cell proliferation -0.066 0.18 -10000 0 -0.4 83 83
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
FOS -0.13 0.3 -10000 0 -0.81 76 76
mol:Ca2+ -0.014 0.022 -10000 0 -0.067 41 41
MAPK3 -0.05 0.14 -10000 0 -0.41 34 34
MAPK1 -0.029 0.092 -10000 0 -0.27 26 26
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
mol:IP3 -0.001 0.002 -10000 0 -0.003 166 166
cAMP biosynthetic process 0.013 0.021 -10000 0 -10000 0 0
GNG2 0.016 0.029 -10000 0 -0.34 3 3
potassium channel inhibitor activity -0.001 0.002 -10000 0 -0.003 166 166
HRAS/GTP -0.036 0.12 -10000 0 -0.26 107 107
actin cytoskeleton reorganization -0.01 0.049 -10000 0 -0.24 21 21
SRC 0.015 0.035 -10000 0 -0.43 3 3
voltage-gated calcium channel activity -0.001 0.002 -10000 0 -0.003 166 166
PI3K 0.006 0.07 -10000 0 -0.31 21 21
apoptosis 0.064 0.17 0.41 82 -10000 0 82
T-DHT/AR/PELP1 -0.044 0.13 -10000 0 -0.32 103 103
HRAS/GDP -0.063 0.18 -10000 0 -0.4 105 105
CREB1 -0.069 0.18 -10000 0 -0.44 82 82
RAC1-CDC42/GTP 0.02 0.057 -10000 0 -0.24 21 21
AR -0.089 0.21 -10000 0 -0.52 104 104
GNB1 0.013 0.052 -10000 0 -0.52 5 5
RAF1 -0.033 0.12 -10000 0 -0.25 107 107
RAC1-CDC42/GDP -0.047 0.17 -10000 0 -0.38 103 103
T-DHT/AR/PELP1/Src -0.032 0.12 -10000 0 -0.28 105 105
MAP2K2 -0.033 0.12 -10000 0 -0.32 34 34
T-DHT/AR/PELP1/Src/PI3K -0.032 0.12 -10000 0 -0.24 120 120
GNAZ 0.001 0.088 -10000 0 -0.44 19 19
SHBG 0.018 0 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP 0.002 0.1 -10000 0 -0.44 15 15
mol:T-DHT 0 0.001 -10000 0 -0.003 52 52
RAC1 0.018 0 -10000 0 -10000 0 0
GNRH1 0 0.057 -10000 0 -0.23 26 26
Gi family/GTP -0.022 0.092 -10000 0 -0.28 21 21
CDC42 0.018 0 -10000 0 -10000 0 0
Signaling events mediated by the Hedgehog family

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 -0.1 0.26 -10000 0 -0.62 82 82
IHH -0.014 0.093 -10000 0 -0.48 14 14
SHH Np/Cholesterol/GAS1 -0.057 0.14 -10000 0 -0.29 133 133
LRPAP1 0.016 0.026 -10000 0 -0.39 2 2
dorsoventral neural tube patterning 0.056 0.14 0.29 133 -10000 0 133
SMO/beta Arrestin2 -0.055 0.17 -10000 0 -0.47 49 49
SMO -0.066 0.18 -10000 0 -0.47 60 60
AKT1 -0.027 0.13 -10000 0 -0.5 22 22
ARRB2 0.018 0 -10000 0 -10000 0 0
BOC -0.02 0.12 -10000 0 -0.38 50 50
ADRBK1 0.018 0 -10000 0 -10000 0 0
heart looping -0.065 0.18 -10000 0 -0.46 60 60
STIL -0.052 0.15 -10000 0 -0.37 52 52
DHH N/PTCH2 0.026 0 -10000 0 -10000 0 0
DHH N/PTCH1 -0.028 0.13 -10000 0 -0.37 24 24
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
DHH 0.018 0 -10000 0 -10000 0 0
PTHLH -0.12 0.31 -10000 0 -0.83 66 66
determination of left/right symmetry -0.065 0.18 -10000 0 -0.46 60 60
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
skeletal system development -0.12 0.31 -10000 0 -0.82 66 66
IHH N/Hhip 0.004 0.068 -10000 0 -0.29 22 22
DHH N/Hhip 0.021 0.037 -10000 0 -0.37 3 3
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.065 0.18 -10000 0 -0.46 60 60
pancreas development 0.011 0.052 -10000 0 -0.33 11 11
HHAT -0.045 0.17 -10000 0 -0.51 63 63
PI3K 0.005 0.082 -10000 0 -0.37 21 21
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.072 0.19 -10000 0 -0.47 98 98
somite specification -0.065 0.18 -10000 0 -0.46 60 60
SHH Np/Cholesterol/PTCH1 -0.049 0.14 -10000 0 -0.36 49 49
SHH Np/Cholesterol/PTCH2 -0.007 0.098 -10000 0 -0.28 61 61
SHH Np/Cholesterol/Megalin -0.1 0.18 -10000 0 -0.33 181 181
SHH -0.021 0.13 -10000 0 -0.37 61 61
catabolic process -0.042 0.14 -10000 0 -0.33 76 76
SMO/Vitamin D3 -0.061 0.17 -10000 0 -0.4 63 63
SHH Np/Cholesterol/Hhip -0.01 0.1 -10000 0 -0.28 64 64
LRP2 -0.16 0.24 -10000 0 -0.48 183 183
receptor-mediated endocytosis -0.12 0.2 -10000 0 -0.47 84 84
SHH Np/Cholesterol/BOC -0.027 0.12 -10000 0 -0.28 85 85
SHH Np/Cholesterol/CDO -0.019 0.11 -10000 0 -0.29 74 74
mesenchymal cell differentiation 0.011 0.1 0.28 64 -10000 0 64
mol:Vitamin D3 -0.047 0.14 -10000 0 -0.36 49 49
IHH N/PTCH2 0.01 0.055 -10000 0 -0.32 11 11
CDON -0.004 0.099 -10000 0 -0.41 27 27
IHH N/PTCH1 -0.04 0.14 -10000 0 -0.33 76 76
Megalin/LRPAP1 -0.1 0.18 -10000 0 -0.37 158 158
PTCH2 0.018 0 -10000 0 -10000 0 0
SHH Np/Cholesterol -0.017 0.097 -10000 0 -0.28 61 61
PTCH1 -0.043 0.14 -10000 0 -0.33 76 76
HHIP 0.011 0.052 -10000 0 -0.33 11 11
Stabilization and expansion of the E-cadherin adherens junction

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization -0.027 0.13 -10000 0 -0.26 110 110
epithelial cell differentiation -0.007 0.1 -10000 0 -0.26 76 76
CYFIP2 -0.042 0.16 -10000 0 -0.47 65 65
ENAH 0.012 0.096 -10000 0 -0.31 14 14
EGFR -0.079 0.18 -10000 0 -0.35 139 139
EPHA2 0.008 0.059 -10000 0 -0.33 14 14
MYO6 -0.012 0.11 -10000 0 -0.25 90 90
CTNNB1 0.001 0.09 -10000 0 -0.45 19 19
ABI1/Sra1/Nap1 -0.004 0.11 -10000 0 -0.31 53 53
AQP5 -0.086 0.19 -10000 0 -0.44 97 97
CTNND1 0.016 0.029 -10000 0 -0.34 3 3
mol:PI-4-5-P2 -0.004 0.1 -10000 0 -0.24 78 78
regulation of calcium-dependent cell-cell adhesion -0.014 0.1 -10000 0 -0.24 82 82
EGF -0.14 0.23 -10000 0 -0.42 193 193
NCKAP1 0.015 0.031 -10000 0 -0.32 4 4
AQP3 -0.088 0.2 -10000 0 -0.47 96 96
cortical microtubule organization -0.007 0.1 -10000 0 -0.26 76 76
GO:0000145 -0.006 0.095 -10000 0 -0.23 78 78
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.004 0.11 -10000 0 -0.26 76 76
MLLT4 -0.006 0.11 -10000 0 -0.46 26 26
ARF6/GDP -0.04 0.086 -10000 0 -0.39 12 12
ARF6 0.016 0.033 -10000 0 -0.52 2 2
Ephrin A1/EPHA2/NCK1/GIT1 0.025 0.071 -10000 0 -0.27 24 24
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP -0.006 0.12 -10000 0 -0.45 14 14
PVRL2 0.002 0.089 -10000 0 -0.52 15 15
ZYX -0.009 0.11 -10000 0 -0.24 84 84
ARF6/GTP 0.03 0.072 -10000 0 -0.27 22 22
CDH1 -0.049 0.17 -10000 0 -0.48 70 70
EGFR/EGFR/EGF/EGF -0.14 0.14 -10000 0 -0.28 224 224
RhoA/GDP -0.01 0.11 -10000 0 -0.25 85 85
actin cytoskeleton organization -0.007 0.11 -10000 0 -0.38 8 8
IGF-1R heterotetramer -0.083 0.2 -10000 0 -0.47 110 110
GIT1 0.014 0.035 -10000 0 -0.3 6 6
IGF1R -0.083 0.2 -10000 0 -0.47 110 110
IGF1 -0.1 0.2 -10000 0 -0.41 146 146
DIAPH1 -0.055 0.18 -10000 0 -0.58 53 53
Wnt receptor signaling pathway 0.007 0.1 0.26 76 -10000 0 76
RHOA 0.005 0.08 -10000 0 -0.52 12 12
RhoA/GTP -0.044 0.089 -10000 0 -0.37 16 16
CTNNA1 0.017 0.023 -10000 0 -0.52 1 1
VCL -0.007 0.11 -10000 0 -0.39 8 8
EFNA1 0 0.094 -10000 0 -0.49 18 18
LPP -0.003 0.1 -10000 0 -0.4 7 7
Ephrin A1/EPHA2 -0.044 0.094 -10000 0 -0.24 91 91
SEC6/SEC8 -0.045 0.092 -10000 0 -0.41 10 10
MGAT3 -0.014 0.11 -10000 0 -0.25 82 82
HGF/MET -0.044 0.089 -10000 0 -0.34 10 10
HGF 0.008 0.069 -10000 0 -0.45 11 11
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN -0.027 0.13 -10000 0 -0.26 110 110
actin cable formation 0.017 0.1 -10000 0 -0.28 21 21
KIAA1543 0.001 0.1 -10000 0 -0.42 7 7
KIFC3 -0.005 0.1 -10000 0 -0.24 77 77
NCK1 0.011 0.045 -10000 0 -0.28 12 12
EXOC3 0.017 0.012 -10000 0 -0.25 1 1
ACTN1 -0.009 0.11 -10000 0 -0.24 85 85
NCK1/GIT1 0.019 0.042 -10000 0 -0.44 2 2
mol:GDP -0.007 0.1 -10000 0 -0.26 76 76
EXOC4 0.016 0.033 -10000 0 -0.52 2 2
STX4 -0.003 0.1 -10000 0 -0.24 76 76
PIP5K1C -0.004 0.1 -10000 0 -0.24 78 78
LIMA1 -0.024 0.14 -10000 0 -0.52 41 41
ABI1 0.016 0.02 -10000 0 -0.25 3 3
ROCK1 0.009 0.1 -10000 0 -0.34 12 12
adherens junction assembly 0.012 0.11 -10000 0 -0.41 10 10
IGF-1R heterotetramer/IGF1 -0.12 0.16 -10000 0 -0.43 72 72
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin -0.002 0.1 -10000 0 -0.39 33 33
MET 0 0.075 -10000 0 -0.29 31 31
PLEKHA7 -0.003 0.099 -10000 0 -0.24 77 77
mol:GTP 0.024 0.07 -10000 0 -0.27 24 24
establishment of epithelial cell apical/basal polarity 0.006 0.11 -10000 0 -0.41 10 10
cortical actin cytoskeleton stabilization -0.027 0.13 -10000 0 -0.26 110 110
regulation of cell-cell adhesion -0.007 0.11 -10000 0 -0.38 8 8
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton -0.027 0.13 -10000 0 -0.26 110 110
PLK2 and PLK4 events

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 -0.049 0.17 -9999 0 -0.44 77 77
PLK4 0.008 0.065 -9999 0 -0.38 13 13
regulation of centriole replication -0.029 0.13 -9999 0 -0.37 59 59
E-cadherin signaling events

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
E-cadherin/beta catenin-gamma catenin -0.02 0.13 -9999 0 -0.32 78 78
E-cadherin/beta catenin -0.034 0.14 -9999 0 -0.38 74 74
CTNNB1 0.001 0.09 -9999 0 -0.45 19 19
JUP 0.011 0.056 -9999 0 -0.42 8 8
CDH1 -0.049 0.17 -9999 0 -0.48 70 70
Syndecan-4-mediated signaling events

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.042 0.19 -9999 0 -0.51 66 66
Syndecan-4/Syndesmos -0.044 0.21 -9999 0 -0.51 71 71
positive regulation of JNK cascade -0.072 0.22 -9999 0 -0.51 88 88
Syndecan-4/ADAM12 -0.071 0.24 -9999 0 -0.54 94 94
CCL5 -0.051 0.18 -9999 0 -0.49 71 71
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
DNM2 0.017 0.012 -9999 0 -0.25 1 1
ITGA5 0.015 0.035 -9999 0 -0.43 3 3
SDCBP 0.003 0.081 -9999 0 -0.4 19 19
PLG 0.016 0.033 -9999 0 -0.51 2 2
ADAM12 -0.051 0.17 -9999 0 -0.47 74 74
mol:GTP 0 0 -9999 0 -10000 0 0
NUDT16L1 0.01 0.063 -9999 0 -0.49 8 8
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
Syndecan-4/PKC alpha -0.006 0.012 -9999 0 -10000 0 0
Syndecan-4/Laminin alpha1 -0.041 0.21 -9999 0 -0.51 71 71
Syndecan-4/CXCL12/CXCR4 -0.077 0.24 -9999 0 -0.54 88 88
Syndecan-4/Laminin alpha3 -0.08 0.23 -9999 0 -0.55 77 77
MDK -0.016 0.12 -9999 0 -0.37 46 46
Syndecan-4/FZD7 -0.07 0.23 -9999 0 -0.53 85 85
Syndecan-4/Midkine -0.055 0.21 -9999 0 -0.52 76 76
FZD7 -0.049 0.16 -9999 0 -0.4 85 85
Syndecan-4/FGFR1/FGF -0.074 0.22 -9999 0 -0.49 87 87
THBS1 -0.025 0.14 -9999 0 -0.52 42 42
integrin-mediated signaling pathway -0.062 0.22 -9999 0 -0.51 84 84
positive regulation of MAPKKK cascade -0.072 0.22 -9999 0 -0.51 88 88
Syndecan-4/TACI -0.042 0.2 -9999 0 -0.51 72 72
CXCR4 -0.028 0.14 -9999 0 -0.42 55 55
cell adhesion -0.008 0.1 -9999 0 -0.29 56 56
Syndecan-4/Dynamin -0.04 0.2 -9999 0 -0.51 71 71
Syndecan-4/TSP1 -0.06 0.22 -9999 0 -0.52 81 81
Syndecan-4/GIPC -0.042 0.2 -9999 0 -0.51 71 71
Syndecan-4/RANTES -0.072 0.23 -9999 0 -0.55 78 78
ITGB1 0.014 0.044 -9999 0 -0.41 5 5
LAMA1 0.015 0.026 -9999 0 -0.25 5 5
LAMA3 -0.07 0.19 -9999 0 -0.43 103 103
RAC1 0.018 0 -9999 0 -10000 0 0
PRKCA 0.018 0.05 -9999 0 -0.24 6 6
Syndecan-4/alpha-Actinin -0.045 0.21 -9999 0 -0.52 73 73
TFPI 0.004 0.061 -9999 0 -0.26 25 25
F2 0.017 0.007 -9999 0 -10000 0 0
alpha5/beta1 Integrin 0.022 0.041 -9999 0 -0.37 5 5
positive regulation of cell adhesion -0.072 0.22 -9999 0 -0.52 77 77
ACTN1 0.005 0.079 -9999 0 -0.48 13 13
TNC -0.039 0.14 -9999 0 -0.36 79 79
Syndecan-4/CXCL12 -0.067 0.23 -9999 0 -0.54 82 82
FGF6 0.009 0.066 -9999 0 -0.52 8 8
RHOA 0.005 0.08 -9999 0 -0.52 12 12
CXCL12 -0.041 0.16 -9999 0 -0.47 64 64
TNFRSF13B 0.013 0.035 -9999 0 -0.25 9 9
FGF2 -0.064 0.16 -9999 0 -0.34 122 122
FGFR1 -0.013 0.11 -9999 0 -0.35 44 44
Syndecan-4/PI-4-5-P2 -0.05 0.2 -9999 0 -0.52 71 71
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.047 0.16 -9999 0 -0.45 73 73
cell migration 0.002 0.008 -9999 0 -10000 0 0
PRKCD 0.015 0.041 -9999 0 -0.44 4 4
vasculogenesis -0.057 0.21 -9999 0 -0.5 81 81
SDC4 -0.053 0.22 -9999 0 -0.55 71 71
Syndecan-4/Tenascin C -0.065 0.22 -9999 0 -0.53 84 84
Syndecan-4/PI-4-5-P2/PKC alpha -0.005 0.009 -9999 0 -10000 0 0
Syndecan-4/Syntenin -0.047 0.21 -9999 0 -0.52 73 73
MMP9 -0.04 0.17 -9999 0 -0.5 60 60
Rac1/GTP -0.008 0.1 -9999 0 -0.3 56 56
cytoskeleton organization -0.041 0.2 -9999 0 -0.49 71 71
GIPC1 0.014 0.042 -9999 0 -0.45 4 4
Syndecan-4/TFPI -0.046 0.21 -9999 0 -0.51 73 73
ErbB4 signaling events

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF -0.1 0.3 -10000 0 -0.9 54 54
epithelial cell differentiation -0.1 0.23 -10000 0 -0.7 59 59
ITCH 0.019 0.028 -10000 0 -10000 0 0
WWP1 -0.13 0.4 -10000 0 -1.4 44 44
FYN 0.008 0.067 -10000 0 -0.41 12 12
EGFR -0.079 0.18 -10000 0 -0.35 139 139
PRL 0.015 0.031 -10000 0 -0.32 4 4
neuron projection morphogenesis -0.032 0.22 -10000 0 -0.71 45 45
PTPRZ1 -0.028 0.11 -10000 0 -0.29 79 79
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC -0.047 0.25 -10000 0 -0.81 46 46
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta -0.08 0.27 -10000 0 -0.9 47 47
ADAM17 0.017 0.037 -10000 0 -0.26 4 4
ErbB4/ErbB4 -0.11 0.32 -10000 0 -0.99 52 52
ErbB4/ErbB4/neuregulin 3/neuregulin 3 -0.1 0.3 -10000 0 -0.82 62 62
NCOR1 0.016 0.033 -10000 0 -0.52 2 2
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn -0.073 0.26 -10000 0 -0.84 49 49
GRIN2B -0.074 0.25 -10000 0 -0.8 49 49
ErbB4/ErbB2/betacellulin -0.12 0.28 -10000 0 -0.72 73 73
STAT1 -0.02 0.12 -10000 0 -0.33 58 58
HBEGF 0.005 0.072 -10000 0 -0.36 18 18
PRLR -0.03 0.15 -10000 0 -0.49 50 50
E4ICDs/ETO2 -0.17 0.34 -10000 0 -0.6 143 143
axon guidance -0.079 0.28 -10000 0 -0.88 50 50
NEDD4 0.003 0.095 -10000 0 -0.53 15 15
Prolactin receptor/Prolactin receptor/Prolactin -0.01 0.11 -10000 0 -0.37 45 45
CBFA2T3 -0.13 0.23 -10000 0 -0.45 162 162
ErbB4/ErbB2/HBEGF -0.091 0.27 -10000 0 -0.8 55 55
MAPK3 -0.04 0.23 -10000 0 -0.75 45 45
STAT1 (dimer) -0.11 0.3 -10000 0 -0.9 56 56
MAPK1 -0.04 0.23 -10000 0 -0.75 45 45
JAK2 0.01 0.053 -10000 0 -0.32 12 12
ErbB4/ErbB2/neuregulin 1 beta -0.09 0.27 -10000 0 -0.82 53 53
NRG1 0.018 0.047 -10000 0 -0.28 6 6
NRG3 0 0.081 -10000 0 -0.34 26 26
NRG2 -0.017 0.1 -10000 0 -0.3 57 57
NRG4 0.009 0.051 -10000 0 -0.27 16 16
heart development -0.079 0.28 -10000 0 -0.88 50 50
neural crest cell migration -0.088 0.26 -10000 0 -0.8 53 53
ERBB2 -0.007 0.088 -10000 0 -0.35 18 18
WWOX/E4ICDs -0.1 0.29 -10000 0 -0.91 52 52
SHC1 0.017 0.023 -10000 0 -0.52 1 1
ErbB4/EGFR/neuregulin 4 -0.13 0.31 -10000 0 -0.78 71 71
apoptosis 0.097 0.28 0.79 60 -10000 0 60
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta -0.11 0.31 -10000 0 -0.92 55 55
ErbB4/ErbB2/epiregulin -0.1 0.27 -10000 0 -0.77 60 60
ErbB4/ErbB4/betacellulin/betacellulin -0.13 0.3 -10000 0 -0.86 62 62
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 -0.088 0.29 -10000 0 -0.72 74 74
MDM2 -0.096 0.3 -10000 0 -0.92 52 52
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta -0.062 0.25 -10000 0 -0.83 45 45
STAT5A -0.072 0.27 -10000 0 -0.84 50 50
ErbB4/EGFR/neuregulin 1 beta -0.11 0.28 -10000 0 -0.77 64 64
DLG4 0.018 0 -10000 0 -10000 0 0
GRB2/SHC 0.024 0.023 -10000 0 -0.37 1 1
E4ICDs/TAB2/NCoR1 -0.081 0.28 -10000 0 -0.84 54 54
STAT5A (dimer) -0.11 0.26 -10000 0 -0.79 59 59
MAP3K7IP2 0.014 0.047 -10000 0 -0.52 4 4
STAT5B (dimer) -0.068 0.27 -10000 0 -0.83 51 51
LRIG1 -0.032 0.15 -10000 0 -0.48 53 53
EREG -0.024 0.11 -10000 0 -0.28 74 74
BTC -0.05 0.17 -10000 0 -0.42 82 82
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta -0.081 0.28 -10000 0 -0.89 50 50
ERBB4 -0.11 0.32 -10000 0 -1 52 52
STAT5B 0.016 0.026 -10000 0 -0.39 2 2
YAP1 -0.014 0.1 -10000 0 -0.71 6 6
GRB2 0.016 0.024 -10000 0 -0.25 4 4
ErbB4/ErbB2/neuregulin 4 -0.088 0.27 -10000 0 -0.82 53 53
glial cell differentiation 0.079 0.28 0.83 54 -10000 0 54
WWOX -0.003 0.072 -10000 0 -0.25 40 40
cell proliferation -0.1 0.27 -10000 0 -0.71 69 69
BMP receptor signaling

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS -0.065 0.13 -9999 0 -0.32 63 63
SMAD6-7/SMURF1 0.034 0.021 -9999 0 -0.3 1 1
NOG 0.009 0.056 -9999 0 -0.31 14 14
SMAD9 -0.023 0.12 -9999 0 -0.65 12 12
SMAD4 0.009 0.067 -9999 0 -0.49 9 9
SMAD5 -0.062 0.14 -9999 0 -0.4 48 48
BMP7/USAG1 -0.18 0.18 -9999 0 -0.39 202 202
SMAD5/SKI -0.051 0.14 -9999 0 -0.39 43 43
SMAD1 0.024 0.061 -9999 0 -0.37 7 7
BMP2 -0.019 0.11 -9999 0 -0.32 58 58
SMAD1/SMAD1/SMAD4 -0.01 0.044 -9999 0 -0.33 3 3
BMPR1A 0.009 0.068 -9999 0 -0.47 10 10
BMPR1B -0.11 0.16 -9999 0 -0.29 216 216
BMPR1A-1B/BAMBI -0.13 0.17 -9999 0 -0.36 157 157
AHSG 0.016 0.024 -9999 0 -0.25 4 4
CER1 0.017 0.012 -9999 0 -0.25 1 1
BMP2-4/CER1 -0.052 0.14 -9999 0 -0.35 84 84
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.053 0.14 -9999 0 -0.38 43 43
BMP2-4 (homodimer) -0.075 0.16 -9999 0 -0.42 83 83
RGMB 0.009 0.07 -9999 0 -0.52 9 9
BMP6/BMPR2/BMPR1A-1B -0.042 0.11 -9999 0 -0.3 53 53
RGMA -0.027 0.12 -9999 0 -0.3 75 75
SMURF1 0.018 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.072 0.14 -9999 0 -0.32 96 96
BMP2-4/USAG1 -0.2 0.2 -9999 0 -0.38 245 245
SMAD6/SMURF1/SMAD5 -0.051 0.14 -9999 0 -0.39 43 43
SOSTDC1 -0.23 0.23 -9999 0 -0.39 314 314
BMP7/BMPR2/BMPR1A-1B -0.06 0.12 -9999 0 -0.3 68 68
SKI 0.017 0.017 -9999 0 -0.25 2 2
BMP6 (homodimer) -0.006 0.089 -9999 0 -0.3 40 40
HFE2 0.004 0.08 -9999 0 -0.45 15 15
ZFYVE16 0.016 0.033 -9999 0 -0.52 2 2
MAP3K7 0.016 0.02 -9999 0 -0.25 3 3
BMP2-4/CHRD -0.059 0.16 -9999 0 -0.37 84 84
SMAD5/SMAD5/SMAD4 -0.055 0.14 -9999 0 -0.39 45 45
MAPK1 0.016 0.033 -9999 0 -0.52 2 2
TAK1/TAB family -0.032 0.13 -9999 0 -0.43 25 25
BMP7 (homodimer) -0.041 0.13 -9999 0 -0.29 101 101
NUP214 0.016 0.026 -9999 0 -0.39 2 2
BMP6/FETUA 0.008 0.065 -9999 0 -0.36 8 8
SMAD1/SKI 0.032 0.06 -9999 0 -0.34 7 7
SMAD6 0.016 0.024 -9999 0 -0.25 4 4
CTDSP2 0.014 0.044 -9999 0 -0.41 5 5
BMP2-4/FETUA -0.053 0.14 -9999 0 -0.35 84 84
MAP3K7IP1 0.018 0 -9999 0 -10000 0 0
GREM1 -0.038 0.16 -9999 0 -0.45 63 63
BMPR2 (homodimer) 0.016 0.033 -9999 0 -0.52 2 2
GADD34/PP1CA 0.03 0.04 -9999 0 -0.3 5 5
BMPR1A-1B (homodimer) -0.068 0.12 -9999 0 -0.38 39 39
CHRDL1 -0.013 0.09 -9999 0 -0.27 56 56
ENDOFIN/SMAD1 0.032 0.063 -9999 0 -0.41 4 4
SMAD6-7/SMURF1/SMAD1 0.046 0.058 -9999 0 -0.37 3 3
SMAD6/SMURF1 0.018 0 -9999 0 -10000 0 0
BAMBI -0.13 0.22 -9999 0 -0.41 182 182
SMURF2 0.009 0.058 -9999 0 -0.34 13 13
BMP2-4/CHRDL1 -0.068 0.16 -9999 0 -0.36 97 97
BMP2-4/GREM1 -0.085 0.18 -9999 0 -0.37 119 119
SMAD7 0.016 0.026 -9999 0 -0.39 2 2
SMAD8A/SMAD8A/SMAD4 -0.016 0.11 -9999 0 -0.53 16 16
SMAD1/SMAD6 0.033 0.06 -9999 0 -0.34 7 7
TAK1/SMAD6 0.025 0.014 -9999 0 -10000 0 0
BMP7 -0.041 0.13 -9999 0 -0.29 101 101
BMP6 -0.006 0.089 -9999 0 -0.3 40 40
MAP3K7IP2 0.014 0.047 -9999 0 -0.52 4 4
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.052 0.13 -9999 0 -0.37 40 40
PPM1A 0.016 0.026 -9999 0 -0.39 2 2
SMAD1/SMURF2 0.029 0.067 -9999 0 -0.36 7 7
SMAD7/SMURF1 0.025 0.019 -9999 0 -0.37 1 1
CTDSPL 0.011 0.062 -9999 0 -0.52 7 7
PPP1CA 0.011 0.048 -9999 0 -0.3 11 11
XIAP 0 0 -9999 0 -10000 0 0
CTDSP1 0.016 0.033 -9999 0 -0.52 2 2
PPP1R15A 0.016 0.029 -9999 0 -0.34 3 3
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.081 0.16 -9999 0 -0.36 89 89
CHRD 0.003 0.073 -9999 0 -0.33 22 22
BMPR2 0.016 0.033 -9999 0 -0.52 2 2
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.074 0.15 -9999 0 -0.33 96 96
BMP4 -0.092 0.19 -9999 0 -0.39 143 143
FST -0.017 0.11 -9999 0 -0.32 54 54
BMP2-4/NOG -0.056 0.15 -9999 0 -0.35 88 88
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 -0.048 0.11 -9999 0 -0.3 53 53
Caspase cascade in apoptosis

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 -0.002 0.11 0.2 9 -0.25 59 68
ACTA1 -0.03 0.14 0.21 23 -0.33 64 87
NUMA1 -0.005 0.11 0.2 9 -0.25 67 76
SPTAN1 -0.01 0.13 0.23 14 -0.32 55 69
LIMK1 -0.029 0.15 0.23 9 -0.33 78 87
BIRC3 -0.085 0.19 -10000 0 -0.41 128 128
BIRC2 0.016 0.02 -10000 0 -0.25 3 3
BAX 0.016 0.02 -10000 0 -0.25 3 3
CASP10 -0.042 0.13 -10000 0 -0.31 100 100
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
PTK2 -0.003 0.12 0.22 4 -0.27 53 57
DIABLO 0.018 0 -10000 0 -10000 0 0
apoptotic nuclear changes -0.009 0.13 0.23 14 -0.32 55 69
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.01 0.063 -10000 0 -0.49 8 8
GSN -0.019 0.14 0.23 10 -0.33 65 75
MADD 0.018 0 -10000 0 -10000 0 0
TFAP2A -0.009 0.14 -10000 0 -0.56 27 27
BID -0.022 0.089 -10000 0 -0.2 96 96
MAP3K1 -0.029 0.13 -10000 0 -0.42 42 42
TRADD 0.016 0.026 -10000 0 -0.39 2 2
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.022 0.041 -10000 0 -0.37 5 5
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB -0.029 0.14 0.23 5 -0.33 69 74
CASP9 0.017 0.023 -10000 0 -0.52 1 1
DNA repair -0.02 0.075 0.28 9 -0.19 37 46
neuron apoptosis -0.026 0.17 -10000 0 -0.64 36 36
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis -0.005 0.13 0.23 11 -0.3 56 67
APAF1 0.012 0.051 -10000 0 -0.41 7 7
CASP6 0.003 0.11 -10000 0 -0.7 7 7
TRAF2 0.014 0.042 -10000 0 -0.45 4 4
ICAD/CAD -0.003 0.13 0.23 11 -0.31 55 66
CASP7 0.044 0.12 0.29 68 -0.45 9 77
KRT18 -0.071 0.21 -10000 0 -0.57 76 76
apoptosis -0.005 0.13 0.22 31 -0.3 56 87
DFFA -0.01 0.13 0.24 11 -0.32 55 66
DFFB -0.01 0.13 0.24 11 -0.32 55 66
PARP1 0.02 0.075 0.19 37 -0.28 9 46
actin filament polymerization 0.026 0.14 0.3 87 -0.22 9 96
TNF -0.004 0.094 -10000 0 -0.36 31 31
CYCS -0.012 0.062 -10000 0 -0.16 24 24
SATB1 -0.019 0.13 -10000 0 -0.46 23 23
SLK -0.01 0.13 0.23 12 -0.32 56 68
p15 BID/BAX -0.011 0.081 -10000 0 -0.28 11 11
CASP2 0.011 0.089 -10000 0 -0.38 11 11
JNK cascade 0.029 0.13 0.41 42 -10000 0 42
CASP3 -0.017 0.14 0.21 39 -0.34 61 100
LMNB2 0.018 0.068 -10000 0 -0.29 7 7
RIPK1 0.017 0.023 -10000 0 -0.52 1 1
CASP4 -0.005 0.11 -10000 0 -0.49 24 24
Mammalian IAPs/DIABLO -0.024 0.11 -10000 0 -0.28 76 76
negative regulation of DNA binding -0.009 0.14 -10000 0 -0.56 27 27
stress fiber formation -0.01 0.13 0.23 13 -0.32 56 69
GZMB -0.058 0.16 -10000 0 -0.37 98 98
CASP1 -0.038 0.16 -10000 0 -0.42 60 60
LMNB1 -0.032 0.12 -10000 0 -0.29 38 38
APP -0.027 0.17 -10000 0 -0.65 36 36
TNFRSF1A 0.016 0.033 -10000 0 -0.52 2 2
response to stress 0 0 -10000 0 -10000 0 0
CASP8 0.013 0 -10000 0 -10000 0 0
VIM -0.009 0.13 0.22 34 -0.3 57 91
LMNA 0.014 0.076 -10000 0 -0.3 11 11
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD 0.004 0.094 -10000 0 -0.38 13 13
LRDD 0.018 0 -10000 0 -10000 0 0
SREBF1 -0.036 0.15 0.24 10 -0.32 85 95
APAF-1/Caspase 9 0.014 0.068 -10000 0 -0.57 2 2
nuclear fragmentation during apoptosis -0.005 0.11 0.2 9 -0.24 67 76
CFL2 -0.027 0.15 0.22 9 -0.31 86 95
GAS2 -0.035 0.15 0.23 11 -0.32 83 94
positive regulation of apoptosis -0.002 0.08 -10000 0 -0.26 21 21
PRF1 -0.008 0.091 -10000 0 -0.3 43 43
Ephrin B reverse signaling

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 -0.008 0.11 -10000 0 -0.4 33 33
EPHB2 0.008 0.062 -10000 0 -0.32 16 16
EFNB1 0.017 0.051 -10000 0 -0.4 5 5
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP 0.021 0.082 -10000 0 -0.34 9 9
Ephrin B2/EPHB1-2 -0.006 0.089 -10000 0 -0.28 34 34
neuron projection morphogenesis -0.023 0.061 -10000 0 -0.31 11 11
Ephrin B1/EPHB1-2/Tiam1 0.015 0.087 -10000 0 -0.29 22 22
DNM1 0.013 0.047 -10000 0 -0.37 7 7
cell-cell signaling 0 0.002 -10000 0 -10000 0 0
MAP2K4 -0.084 0.23 -10000 0 -0.55 95 95
YES1 -0.13 0.3 -10000 0 -0.84 81 81
Ephrin B1/EPHB1-2/NCK2 0.019 0.078 -10000 0 -0.28 17 17
PI3K -0.081 0.24 -10000 0 -0.56 97 97
mol:GDP 0.013 0.086 -10000 0 -0.29 22 22
ITGA2B 0.016 0.02 -10000 0 -0.25 3 3
endothelial cell proliferation -0.01 0.1 -10000 0 -0.33 40 40
FYN -0.13 0.3 -10000 0 -0.83 81 81
MAP3K7 -0.084 0.23 -10000 0 -0.63 81 81
FGR -0.11 0.3 -10000 0 -0.82 81 81
TIAM1 0.006 0.073 -10000 0 -0.44 13 13
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
RGS3 0.017 0.012 -10000 0 -0.25 1 1
cell adhesion -0.069 0.22 -10000 0 -0.56 82 82
LYN -0.12 0.3 -10000 0 -0.83 81 81
Ephrin B1/EPHB1-2/Src Family Kinases -0.12 0.28 -10000 0 -0.77 81 81
Ephrin B1/EPHB1-2 -0.11 0.25 -10000 0 -0.68 81 81
SRC -0.11 0.3 -10000 0 -0.82 81 81
ITGB3 0.002 0.075 -10000 0 -0.32 25 25
EPHB1 -0.022 0.1 -10000 0 -0.28 72 72
EPHB4 -0.013 0.12 -10000 0 -0.43 36 36
RAC1 0.018 0 -10000 0 -10000 0 0
Ephrin B2/EPHB4 -0.01 0.1 -10000 0 -0.34 40 40
alphaIIb/beta3 Integrin 0.014 0.056 -10000 0 -0.36 7 7
BLK -0.13 0.3 -10000 0 -0.83 81 81
HCK -0.13 0.3 -10000 0 -0.83 81 81
regulation of stress fiber formation -0.018 0.076 0.28 17 -10000 0 17
MAPK8 -0.074 0.22 -10000 0 -0.56 82 82
Ephrin B1/EPHB1-2/RGS3 0.02 0.075 -10000 0 -0.27 15 15
endothelial cell migration -0.09 0.22 -10000 0 -0.48 113 113
NCK2 0.015 0.026 -10000 0 -0.25 5 5
PTPN13 -0.089 0.24 -10000 0 -0.59 93 93
regulation of focal adhesion formation -0.018 0.076 0.28 17 -10000 0 17
chemotaxis -0.019 0.074 0.27 15 -10000 0 15
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
Rac1/GTP 0.015 0.078 -10000 0 -0.32 10 10
angiogenesis -0.11 0.24 -10000 0 -0.68 81 81
LCK -0.14 0.31 -10000 0 -0.84 81 81
IL2 signaling events mediated by PI3K

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.005 0.13 -10000 0 -0.58 4 4
UGCG -0.11 0.27 -10000 0 -0.77 74 74
AKT1/mTOR/p70S6K/Hsp90/TERT -0.07 0.19 -10000 0 -0.38 108 108
mol:GTP 0 0.001 -10000 0 -10000 0 0
mol:glucosylceramide -0.11 0.27 -10000 0 -0.76 74 74
mol:DAG -0.014 0.12 -10000 0 -0.95 8 8
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.14 0.2 -10000 0 -0.42 146 146
FRAP1 -0.12 0.26 -10000 0 -0.48 149 149
FOXO3 -0.064 0.19 -10000 0 -0.41 85 85
AKT1 -0.073 0.21 -10000 0 -0.43 91 91
GAB2 0.007 0.048 -10000 0 -0.25 17 17
SMPD1 -0.004 0.079 -10000 0 -0.8 4 4
SGMS1 -0.01 0.099 -10000 0 -0.73 8 8
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP 0 0.069 -10000 0 -0.26 30 30
CALM1 0.018 0 -10000 0 -10000 0 0
cell proliferation -0.088 0.2 -10000 0 -0.42 116 116
EIF3A 0.017 0.012 -10000 0 -0.25 1 1
PI3K 0.006 0.083 -10000 0 -0.31 30 30
RPS6KB1 -0.034 0.1 -10000 0 -0.29 3 3
mol:sphingomyelin -0.014 0.12 -10000 0 -0.95 8 8
natural killer cell activation -0.002 0.004 -10000 0 -0.012 33 33
JAK3 0.018 0.004 -10000 0 -10000 0 0
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
JAK1 0.012 0.057 -10000 0 -0.52 6 6
NFKB1 0.017 0.023 -10000 0 -0.52 1 1
MYC -0.091 0.28 -10000 0 -0.79 53 53
MYB -0.23 0.5 -10000 0 -1.2 108 108
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K -0.043 0.16 -10000 0 -0.4 49 49
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 -0.014 0.099 -10000 0 -0.38 4 4
mol:PI-3-4-5-P3 -0.042 0.16 -10000 0 -0.38 51 51
Rac1/GDP 0.011 0.064 -10000 0 -0.28 21 21
T cell proliferation -0.038 0.15 -10000 0 -0.36 51 51
SHC1 0.015 0.024 -10000 0 -0.52 1 1
RAC1 0.017 0.001 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity -0.009 0.029 -10000 0 -0.061 118 118
PRKCZ -0.04 0.15 -10000 0 -0.37 51 51
NF kappa B1 p50/RelA -0.085 0.23 -10000 0 -0.46 106 106
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K -0.016 0.14 -10000 0 -0.49 28 28
HSP90AA1 0.013 0.045 -10000 0 -0.39 6 6
RELA 0.018 0 -10000 0 -10000 0 0
IL2RA -0.032 0.14 -10000 0 -0.41 60 60
IL2RB -0.016 0.12 -10000 0 -0.43 40 40
TERT 0.013 0.042 -10000 0 -0.33 7 7
E2F1 -0.076 0.19 -10000 0 -0.44 113 113
SOS1 0.015 0.024 -10000 0 -0.53 1 1
RPS6 0.015 0.037 -10000 0 -0.39 4 4
mol:cAMP 0.004 0.014 0.029 119 -10000 0 119
PTPN11 0.015 0.024 -10000 0 -0.52 1 1
IL2RG -0.002 0.078 -10000 0 -0.28 35 35
actin cytoskeleton organization -0.038 0.15 -10000 0 -0.36 51 51
GRB2 0.014 0.024 -10000 0 -0.25 4 4
IL2 0.011 0.051 -10000 0 -0.33 10 10
PIK3CA 0.016 0.03 -10000 0 -0.35 3 3
Rac1/GTP 0.013 0.064 -10000 0 -0.26 21 21
LCK -0.073 0.18 -10000 0 -0.4 117 117
BCL2 -0.19 0.39 -10000 0 -0.86 121 121
LPA receptor mediated events

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.005 0.08 -9999 0 -0.24 48 48
NF kappa B1 p50/RelA/I kappa B alpha 0.003 0.086 -9999 0 -0.3 16 16
AP1 -0.092 0.14 -9999 0 -0.3 133 133
mol:PIP3 -0.067 0.11 -9999 0 -0.28 90 90
AKT1 0.007 0.11 -9999 0 -0.34 29 29
PTK2B -0.009 0.064 -9999 0 -0.2 47 47
RHOA -0.007 0.093 -9999 0 -0.42 16 16
PIK3CB 0.012 0.055 -9999 0 -0.44 7 7
mol:Ca2+ -0.025 0.094 -9999 0 -0.26 61 61
MAGI3 -0.014 0.12 -9999 0 -0.46 35 35
RELA 0.018 0 -9999 0 -10000 0 0
apoptosis -0.004 0.067 -9999 0 -0.22 44 44
HRAS/GDP 0.009 0.036 -9999 0 -0.29 7 7
positive regulation of microtubule depolymerization -0.045 0.12 -9999 0 -0.26 117 117
NF kappa B1 p50/RelA -0.04 0.092 -9999 0 -0.32 30 30
endothelial cell migration -0.036 0.18 -9999 0 -0.55 54 54
ADCY4 -0.005 0.11 -9999 0 -0.3 48 48
ADCY5 -0.014 0.11 -9999 0 -0.31 48 48
ADCY6 -0.004 0.1 -9999 0 -0.29 47 47
ADCY7 -0.007 0.11 -9999 0 -0.32 47 47
ADCY1 -0.003 0.1 -9999 0 -0.29 47 47
ADCY2 -0.025 0.12 -9999 0 -0.35 51 51
ADCY3 -0.006 0.1 -9999 0 -0.29 49 49
ADCY8 -0.005 0.1 -9999 0 -0.29 47 47
ADCY9 -0.01 0.11 -9999 0 -0.29 48 48
GSK3B -0.002 0.061 -9999 0 -0.18 45 45
arachidonic acid secretion 0.001 0.1 -9999 0 -0.28 47 47
GNG2 0.016 0.029 -9999 0 -0.34 3 3
TRIP6 0 0.088 -9999 0 -0.4 23 23
GNAO1 -0.004 0.078 -9999 0 -0.25 44 44
HRAS 0.012 0.051 -9999 0 -0.41 7 7
NFKBIA -0.014 0.091 -9999 0 -0.28 31 31
GAB1 0.006 0.074 -9999 0 -0.43 14 14
mol:GTP 0 0 -9999 0 -10000 0 0
lamellipodium assembly 0.006 0.15 -9999 0 -0.89 15 15
JUN -0.034 0.15 -9999 0 -0.46 57 57
LPA/LPA2/NHERF2 -0.024 0.1 -9999 0 -0.31 52 52
TIAM1 -0.025 0.18 -9999 0 -1 15 15
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
mol:IP3 -0.025 0.095 -9999 0 -0.26 61 61
PLCB3 -0.016 0.094 -9999 0 -0.29 50 50
FOS -0.11 0.2 -9999 0 -0.37 171 171
positive regulation of mitosis 0.001 0.1 -9999 0 -0.28 47 47
LPA/LPA1-2-3 -0.015 0.068 -9999 0 -0.21 54 54
mol:Ca ++ 0 0 -9999 0 -10000 0 0
JNK cascade 0 0 -9999 0 -10000 0 0
BCAR1 0.017 0.012 -9999 0 -0.25 1 1
stress fiber formation 0.001 0.063 -9999 0 -0.19 45 45
GNAZ -0.013 0.096 -9999 0 -0.28 55 55
EGFR/PI3K-beta/Gab1 -0.069 0.12 -9999 0 -0.29 90 90
positive regulation of dendritic cell cytokine production -0.015 0.068 -9999 0 -0.21 54 54
LPA/LPA2/MAGI-3 -0.013 0.08 -9999 0 -0.28 35 35
ARHGEF1 0.009 0.074 -9999 0 -0.21 46 46
GNAI2 -0.01 0.095 -9999 0 -0.29 49 49
GNAI3 -0.003 0.077 -9999 0 -0.25 44 44
GNAI1 -0.023 0.11 -9999 0 -0.31 58 58
LPA/LPA3 -0.011 0.033 -9999 0 -0.11 54 54
LPA/LPA2 -0.011 0.033 -9999 0 -0.1 54 54
LPA/LPA1 -0.019 0.09 -9999 0 -0.28 54 54
HB-EGF/EGFR -0.069 0.16 -9999 0 -0.35 104 104
HBEGF -0.027 0.13 -9999 0 -0.38 64 64
mol:DAG -0.025 0.095 -9999 0 -0.26 61 61
cAMP biosynthetic process -0.007 0.11 -9999 0 -0.3 51 51
NFKB1 0.017 0.023 -9999 0 -0.52 1 1
SRC 0.015 0.035 -9999 0 -0.43 3 3
GNB1 0.013 0.052 -9999 0 -0.52 5 5
LYN -0.013 0.088 -9999 0 -0.27 29 29
GNAQ -0.005 0.027 -9999 0 -0.082 54 54
LPAR2 0 0.001 -9999 0 -10000 0 0
LPAR3 0 0.001 -9999 0 -10000 0 0
LPAR1 -0.012 0.052 -9999 0 -0.16 54 54
IL8 -0.13 0.19 -9999 0 -0.42 119 119
PTK2 -0.003 0.067 -9999 0 -0.21 45 45
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
CASP3 -0.004 0.068 -9999 0 -0.22 44 44
EGFR -0.079 0.18 -9999 0 -0.35 139 139
PLCG1 -0.014 0.056 -9999 0 -0.14 66 66
PLD2 -0.004 0.071 -9999 0 -0.22 47 47
G12/G13 0.005 0.08 -9999 0 -0.24 46 46
PI3K-beta -0.039 0.098 -9999 0 -0.36 30 30
cell migration 0.016 0.062 -9999 0 -0.25 17 17
SLC9A3R2 -0.032 0.15 -9999 0 -0.49 52 52
PXN 0.001 0.064 -9999 0 -0.2 45 45
HRAS/GTP 0.001 0.1 -9999 0 -0.29 47 47
RAC1 0.018 0 -9999 0 -10000 0 0
MMP9 -0.042 0.17 -9999 0 -0.51 60 60
PRKCE 0.01 0.061 -9999 0 -0.43 9 9
PRKCD -0.019 0.094 -9999 0 -0.26 56 56
Gi(beta/gamma) 0 0.11 -9999 0 -0.31 38 38
mol:LPA -0.012 0.052 -9999 0 -0.16 54 54
TRIP6/p130 Cas/FAK1/Paxillin 0.012 0.086 -9999 0 -0.31 17 17
MAPKKK cascade 0.001 0.1 -9999 0 -0.28 47 47
contractile ring contraction involved in cytokinesis -0.007 0.092 -9999 0 -0.42 16 16
mol:GDP 0 0 -9999 0 -10000 0 0
GNA14 -0.043 0.096 -9999 0 -0.29 56 56
GNA15 -0.003 0.051 -9999 0 -0.29 10 10
GNA12 0.018 0 -9999 0 -10000 0 0
GNA13 0.011 0.055 -9999 0 -0.36 10 10
MAPT -0.047 0.13 -9999 0 -0.27 116 116
GNA11 0.002 0.038 -9999 0 -0.23 6 6
Rac1/GTP 0.005 0.16 -9999 0 -0.94 15 15
MMP2 -0.036 0.18 -9999 0 -0.55 54 54
Syndecan-2-mediated signaling events

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.042 0.15 -9999 0 -0.38 76 76
EPHB2 0.007 0.061 -9999 0 -0.32 16 16
Syndecan-2/TACI -0.006 0.092 -9999 0 -0.3 38 38
LAMA1 0.015 0.026 -9999 0 -0.25 5 5
Syndecan-2/alpha2 ITGB1 -0.062 0.17 -9999 0 -0.31 143 143
HRAS 0.012 0.051 -9999 0 -0.41 7 7
Syndecan-2/CASK -0.016 0.089 -9999 0 -0.31 38 38
ITGA5 0.015 0.035 -9999 0 -0.43 3 3
BAX 0.01 0.085 -9999 0 -10000 0 0
EPB41 0.016 0.026 -9999 0 -0.39 2 2
positive regulation of cell-cell adhesion -0.011 0.094 -9999 0 -0.28 49 49
LAMA3 -0.07 0.19 -9999 0 -0.43 103 103
EZR 0 0 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
CAV2 -0.019 0.12 -9999 0 -0.39 48 48
Syndecan-2/MMP2 -0.033 0.14 -9999 0 -0.38 65 65
RP11-540L11.1 0 0 -9999 0 -10000 0 0
alpha2 ITGB1 -0.024 0.13 -9999 0 -0.37 58 58
dendrite morphogenesis -0.009 0.095 -9999 0 -0.3 42 42
Syndecan-2/GM-CSF -0.014 0.099 -9999 0 -0.31 43 43
determination of left/right symmetry -0.017 0.11 -9999 0 -0.27 70 70
Syndecan-2/PKC delta -0.006 0.094 -9999 0 -0.3 41 41
GNB2L1 0.015 0.04 -9999 0 -0.52 3 3
MAPK3 -0.005 0.09 -9999 0 -0.27 44 44
MAPK1 -0.005 0.092 -9999 0 -0.28 44 44
Syndecan-2/RACK1 0.004 0.087 -9999 0 -0.26 44 44
NF1 0.015 0.035 -9999 0 -0.43 3 3
FGFR/FGF/Syndecan-2 -0.017 0.11 -9999 0 -0.27 70 70
ITGA2 -0.048 0.17 -9999 0 -0.46 73 73
MAPK8 0.001 0.094 -9999 0 -0.3 41 41
Syndecan-2/alpha2/beta1 Integrin -0.018 0.13 -9999 0 -0.3 84 84
Syndecan-2/Kininogen -0.004 0.091 -9999 0 -0.3 38 38
ITGB1 0.014 0.044 -9999 0 -0.41 5 5
SRC 0.007 0.085 -9999 0 -0.25 45 45
Syndecan-2/CASK/Protein 4.1 -0.004 0.083 -9999 0 -0.27 39 39
extracellular matrix organization -0.004 0.091 -9999 0 -0.3 39 39
actin cytoskeleton reorganization -0.042 0.15 -9999 0 -0.38 76 76
Syndecan-2/Caveolin-2/Ras -0.014 0.12 -9999 0 -0.33 55 55
Syndecan-2/Laminin alpha3 -0.055 0.15 -9999 0 -0.34 99 99
Syndecan-2/RasGAP 0.006 0.094 -9999 0 -0.25 52 52
alpha5/beta1 Integrin 0.022 0.041 -9999 0 -0.37 5 5
PRKCD 0.014 0.042 -9999 0 -0.45 4 4
Syndecan-2 dimer -0.009 0.096 -9999 0 -0.3 42 42
GO:0007205 0.004 0.005 -9999 0 -10000 0 0
DNA mediated transformation 0 0 -9999 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.012 0.094 -9999 0 -0.24 53 53
RHOA 0.005 0.08 -9999 0 -0.52 12 12
SDCBP 0.003 0.081 -9999 0 -0.4 19 19
TNFRSF13B 0.013 0.035 -9999 0 -0.25 9 9
RASA1 0.004 0.078 -9999 0 -0.42 16 16
alpha2/beta1 Integrin -0.024 0.13 -9999 0 -0.37 58 58
Syndecan-2/Synbindin -0.003 0.091 -9999 0 -0.3 38 38
TGFB1 0.017 0.023 -9999 0 -0.52 1 1
CASP3 0.003 0.085 -9999 0 -0.27 41 41
FN1 -0.048 0.17 -9999 0 -0.46 73 73
Syndecan-2/IL8 -0.055 0.14 -9999 0 -0.33 87 87
SDC2 -0.017 0.11 -9999 0 -0.27 70 70
KNG1 0.017 0.017 -9999 0 -0.25 2 2
Syndecan-2/Neurofibromin -0.005 0.093 -9999 0 -0.3 40 40
TRAPPC4 0.018 0 -9999 0 -10000 0 0
CSF2 -0.001 0.074 -9999 0 -0.28 33 33
Syndecan-2/TGFB1 -0.004 0.092 -9999 0 -0.3 39 39
Syndecan-2/Syntenin/PI-4-5-P2 -0.011 0.094 -9999 0 -0.28 49 49
Syndecan-2/Ezrin -0.01 0.092 -9999 0 -0.28 50 50
PRKACA 0.004 0.084 -9999 0 -0.27 40 40
angiogenesis -0.055 0.14 -9999 0 -0.33 87 87
MMP2 -0.032 0.15 -9999 0 -0.47 54 54
IL8 -0.072 0.17 -9999 0 -0.34 135 135
calcineurin-NFAT signaling pathway -0.006 0.092 -9999 0 -0.3 38 38
amb2 Integrin signaling

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.029 0.15 -9999 0 -0.4 63 63
alphaM/beta2 Integrin/GPIbA -0.011 0.11 -9999 0 -0.34 40 40
alphaM/beta2 Integrin/proMMP-9 -0.036 0.15 -9999 0 -0.36 80 80
PLAUR -0.016 0.13 -9999 0 -0.47 37 37
HMGB1 0.011 0.021 -9999 0 -0.27 1 1
alphaM/beta2 Integrin/Talin 0 0.1 -9999 0 -0.36 31 31
AGER 0.01 0.031 -9999 0 -0.39 2 2
RAP1A 0.012 0.057 -9999 0 -0.52 6 6
SELPLG -0.003 0.097 -9999 0 -0.43 24 24
mol:LDL 0 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.012 0.13 -9999 0 -0.36 39 39
mol:GTP 0 0 -9999 0 -10000 0 0
MMP9 -0.042 0.17 -9999 0 -0.51 60 60
CYR61 -0.042 0.16 -9999 0 -0.42 72 72
TLN1 0.017 0.023 -9999 0 -0.52 1 1
Rap1/GTP -0.036 0.1 -9999 0 -0.42 25 25
RHOA 0.005 0.08 -9999 0 -0.52 12 12
P-selectin oligomer -0.12 0.22 -9999 0 -0.44 156 156
MYH2 -0.003 0.13 -9999 0 -0.41 30 30
MST1R -0.039 0.16 -9999 0 -0.51 57 57
leukocyte activation during inflammatory response 0.008 0.086 -9999 0 -0.31 30 30
APOB 0.018 0 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
complement component iC3b receptor activity 0 0 -9999 0 -10000 0 0
MMP2 -0.032 0.15 -9999 0 -0.47 54 54
JAM3 -0.006 0.11 -9999 0 -0.5 24 24
GP1BA -0.002 0.071 -9999 0 -0.25 39 39
alphaM/beta2 Integrin/CTGF -0.031 0.14 -9999 0 -0.39 59 59
alphaM/beta2 Integrin -0.008 0.13 -9999 0 -0.43 29 29
JAM3 homodimer -0.006 0.11 -9999 0 -0.5 24 24
ICAM2 0.007 0.068 -9999 0 -0.4 13 13
ICAM1 -0.019 0.12 -9999 0 -0.39 47 47
phagocytosis triggered by activation of immune response cell surface activating receptor -0.008 0.13 -9999 0 -0.43 29 29
cell adhesion -0.011 0.11 -9999 0 -0.34 40 40
NFKB1 -0.032 0.17 -9999 0 -0.38 76 76
THY1 -0.007 0.11 -9999 0 -0.5 25 25
RhoA/GDP 0.004 0.058 -9999 0 -0.38 12 12
Lipoprotein(a) 0.023 0.016 -9999 0 -0.31 1 1
alphaM/beta2 Integrin/LRP/tPA -0.049 0.14 -9999 0 -0.32 93 93
IL6 -0.087 0.27 -9999 0 -0.71 71 71
ITGB2 -0.022 0.12 -9999 0 -0.43 40 40
elevation of cytosolic calcium ion concentration -0.044 0.18 -9999 0 -0.41 79 79
alphaM/beta2 Integrin/JAM2/JAM3 -0.02 0.15 -9999 0 -0.38 64 64
JAM2 -0.019 0.13 -9999 0 -0.43 43 43
alphaM/beta2 Integrin/ICAM1 -0.028 0.16 -9999 0 -0.43 44 44
alphaM/beta2 Integrin/uPA/Plg -0.027 0.14 -9999 0 -0.34 73 73
RhoA/GTP -0.008 0.14 -9999 0 -0.44 30 30
positive regulation of phagocytosis -0.007 0.16 -9999 0 -0.5 35 35
Ron/MSP -0.017 0.12 -9999 0 -0.37 55 55
alphaM/beta2 Integrin/uPAR/uPA -0.044 0.18 -9999 0 -0.42 79 79
alphaM/beta2 Integrin/uPAR -0.019 0.14 -9999 0 -0.4 52 52
PLAU -0.052 0.17 -9999 0 -0.43 83 83
PLAT -0.093 0.19 -9999 0 -0.37 150 150
actin filament polymerization -0.001 0.13 -9999 0 -0.39 30 30
MST1 0.016 0.02 -9999 0 -0.25 3 3
alphaM/beta2 Integrin/lipoprotein(a) 0.011 0.088 -9999 0 -0.31 30 30
TNF -0.035 0.19 -9999 0 -0.61 32 32
RAP1B 0.013 0.044 -9999 0 -0.32 8 8
alphaM/beta2 Integrin/uPA -0.041 0.15 -9999 0 -0.38 74 74
fibrinolysis -0.028 0.14 -9999 0 -0.34 73 73
HCK -0.005 0.11 -9999 0 -0.47 25 25
dendritic cell antigen processing and presentation -0.008 0.13 -9999 0 -0.43 29 29
VTN 0.016 0.02 -9999 0 -0.25 3 3
alphaM/beta2 Integrin/CYR61 -0.035 0.14 -9999 0 -0.36 70 70
LPA 0.016 0.026 -9999 0 -0.39 2 2
LRP1 0.017 0.023 -9999 0 -0.52 1 1
cell migration -0.051 0.18 -9999 0 -0.36 106 106
FN1 -0.048 0.17 -9999 0 -0.46 73 73
alphaM/beta2 Integrin/Thy1 -0.014 0.12 -9999 0 -0.37 49 49
MPO 0.008 0.05 -9999 0 -0.25 19 19
KNG1 0.017 0.017 -9999 0 -0.25 2 2
RAP1/GDP 0.017 0.044 -9999 0 -0.31 8 8
ROCK1 0 0.13 -9999 0 -0.43 26 26
ELA2 0.017 0.017 -9999 0 -0.25 2 2
PLG 0.016 0.033 -9999 0 -0.52 2 2
CTGF -0.035 0.15 -9999 0 -0.42 63 63
alphaM/beta2 Integrin/Hck -0.012 0.14 -9999 0 -0.43 41 41
ITGAM 0.002 0.071 -9999 0 -0.48 10 10
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.072 0.18 -9999 0 -0.35 131 131
HP 0.013 0.049 -9999 0 -0.43 6 6
leukocyte adhesion -0.034 0.18 -9999 0 -0.54 43 43
SELP -0.12 0.22 -9999 0 -0.44 156 156
Visual signal transduction: Rods

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.011 0.056 -9999 0 -0.42 8 8
GNAT1/GTP 0.01 0.035 -9999 0 -0.34 5 5
Metarhodopsin II/Arrestin -0.045 0.12 -9999 0 -0.31 64 64
PDE6G/GNAT1/GTP 0.02 0.033 -9999 0 -0.31 4 4
mol:GTP 0 0 -9999 0 -10000 0 0
absorption of light 0 0 -9999 0 -10000 0 0
GNAT1 0.013 0.048 -9999 0 -0.47 5 5
GRK1 0 0 -9999 0 -10000 0 0
CNG Channel -0.082 0.12 -9999 0 -0.27 140 140
mol:Na + -0.04 0.088 -9999 0 -0.43 14 14
mol:ADP 0 0 -9999 0 -10000 0 0
RGS9-1/Gbeta5/R9AP -0.056 0.15 -9999 0 -0.34 96 96
mol:GDP 0 0 -9999 0 -10000 0 0
cGMP/CNG Channel -0.002 0.11 -9999 0 -0.44 14 14
CNGB1 0.018 0 -9999 0 -10000 0 0
RDH5 -0.003 0.072 -9999 0 -0.25 40 40
SAG -0.098 0.19 -9999 0 -0.36 162 162
mol:Ca2+ 0.001 0.11 -9999 0 -0.39 17 17
Na + (4 Units) -0.039 0.085 -9999 0 -0.38 17 17
RGS9 -0.033 0.13 -9999 0 -0.31 81 81
GNB1/GNGT1 -0.033 0.1 -9999 0 -0.37 18 18
GNAT1/GDP -0.04 0.13 -9999 0 -0.29 99 99
GUCY2D 0.018 0 -9999 0 -10000 0 0
GNGT1 -0.063 0.14 -9999 0 -0.28 144 144
GUCY2F 0.006 0.076 -9999 0 -0.46 13 13
GNB5 0.005 0.081 -9999 0 -0.5 13 13
mol:GMP (4 units) -0.034 0.12 -9999 0 -0.26 118 118
mol:11-cis-retinal -0.003 0.072 -9999 0 -0.25 40 40
mol:cGMP 0.026 0.087 -9999 0 -0.3 30 30
GNB1 0.013 0.052 -9999 0 -0.52 5 5
Rhodopsin 0.012 0.049 -9999 0 -10000 0 0
SLC24A1 0.011 0.056 -9999 0 -0.42 8 8
CNGA1 -0.061 0.15 -9999 0 -0.32 123 123
Metarhodopsin II 0.011 0 -9999 0 -10000 0 0
mol:Ca ++ 0 0 -9999 0 -10000 0 0
GC1/GCAP Family 0.027 0.075 -9999 0 -0.29 24 24
RGS9BP -0.072 0.18 -9999 0 -0.41 111 111
Metarhodopsin II/Transducin -0.005 0.064 -9999 0 -0.25 22 22
GCAP Family/Ca ++ 0.016 0.074 -9999 0 -0.3 24 24
PDE6A/B -0.066 0.17 -9999 0 -0.37 115 115
mol:Pi -0.056 0.15 -9999 0 -0.34 96 96
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
Transducin -0.014 0.083 -9999 0 -0.29 22 22
PDE6B -0.1 0.22 -9999 0 -0.5 123 123
PDE6A 0.011 0.048 -9999 0 -0.3 11 11
PDE6G 0.016 0.024 -9999 0 -0.25 4 4
RHO 0.018 0 -9999 0 -10000 0 0
PDE6 -0.088 0.17 -9999 0 -0.29 188 188
GUCA1A 0.001 0.092 -9999 0 -0.48 18 18
GC2/GCAP Family 0.02 0.092 -9999 0 -0.32 30 30
GUCA1C 0.005 0.078 -9999 0 -0.43 15 15
GUCA1B 0.014 0.035 -9999 0 -0.3 6 6
TCGA08_p53

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A -0.037 0.11 -10000 0 -0.23 108 108
TP53 -0.036 0.1 0.28 2 -0.36 37 39
Senescence -0.036 0.1 0.28 2 -0.36 37 39
Apoptosis -0.036 0.1 0.28 2 -0.36 37 39
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 0.028 0.072 0.24 31 -0.18 13 44
MDM4 0.013 0.044 -10000 0 -0.32 8 8
Integrins in angiogenesis

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.01 0.064 -9999 0 -0.37 9 9
alphaV beta3 Integrin -0.034 0.13 -9999 0 -0.33 62 62
PTK2 -0.008 0.14 -9999 0 -0.47 26 26
IGF1R -0.083 0.2 -9999 0 -0.47 110 110
PI4KB 0.016 0.033 -9999 0 -0.52 2 2
MFGE8 -0.018 0.12 -9999 0 -0.36 50 50
SRC 0.015 0.035 -9999 0 -0.43 3 3
CDKN1B -0.022 0.13 -9999 0 -0.48 30 30
VEGFA 0 0.075 -9999 0 -0.29 31 31
ILK 0.002 0.072 -9999 0 -0.75 2 2
ROCK1 0.018 0 -9999 0 -10000 0 0
AKT1 0.007 0.075 -9999 0 -0.49 5 5
PTK2B 0.012 0.091 -9999 0 -0.32 27 27
alphaV/beta3 Integrin/JAM-A -0.014 0.12 -9999 0 -0.28 60 60
CBL 0.017 0.012 -9999 0 -0.25 1 1
mol:GTP 0 0 -9999 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.01 0.087 -9999 0 -0.33 27 27
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.11 0.22 -9999 0 -0.39 169 169
VEGF/Rho/ROCK/alphaV/beta3 Integrin 0.021 0.086 -9999 0 -0.44 9 9
alphaV/beta3 Integrin/Syndecan-1 -0.02 0.13 -9999 0 -0.33 67 67
PI4KA 0.018 0 -9999 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.18 0.24 -9999 0 -0.53 131 131
PI4 Kinase 0.025 0.024 -9999 0 -0.37 2 2
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
alphaV/beta3 Integrin/Osteopontin -0.082 0.16 -9999 0 -0.33 141 141
RPS6KB1 -0.15 0.23 -9999 0 -0.49 135 135
TLN1 0.017 0.023 -9999 0 -0.52 1 1
MAPK3 -0.092 0.22 -9999 0 -0.64 58 58
GPR124 0 0.095 -9999 0 -0.52 17 17
MAPK1 -0.092 0.22 -9999 0 -0.64 58 58
PXN 0.018 0 -9999 0 -10000 0 0
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
alphaV/beta3 Integrin/Tumstatin 0.011 0.087 -9999 0 -0.35 24 24
cell adhesion -0.008 0.12 -9999 0 -0.32 57 57
ANGPTL3 0.011 0.056 -9999 0 -0.42 8 8
VEGFR2 homodimer/VEGFA homodimer/Src 0.021 0.059 -9999 0 -0.3 11 11
IGF-1R heterotetramer -0.083 0.2 -9999 0 -0.47 110 110
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
TGFBR2 0.013 0.049 -9999 0 -0.43 6 6
ITGB3 0.002 0.075 -9999 0 -0.32 25 25
IGF1 -0.1 0.2 -9999 0 -0.41 146 146
RAC1 0.018 0 -9999 0 -10000 0 0
regulation of cell-matrix adhesion 0.004 0.11 -9999 0 -0.38 33 33
apoptosis -0.002 0.099 -9999 0 -0.48 21 21
CD47 -0.005 0.11 -9999 0 -0.47 25 25
alphaV/beta3 Integrin/CD47 0 0.1 -9999 0 -0.32 42 42
VCL 0.016 0.029 -9999 0 -0.34 3 3
alphaV/beta3 Integrin/Del1 -0.066 0.17 -9999 0 -0.35 115 115
CSF1 0.014 0.037 -9999 0 -0.29 7 7
PIK3C2A -0.003 0.096 -9999 0 -0.74 6 6
PI4 Kinase/Pyk2 -0.042 0.092 -9999 0 -0.4 18 18
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.013 0.099 -9999 0 -0.35 27 27
FAK1/Vinculin 0.004 0.11 -9999 0 -0.37 26 26
alphaV beta3/Integrin/ppsTEM5 0.004 0.11 -9999 0 -0.38 33 33
RHOA 0.005 0.08 -9999 0 -0.52 12 12
VTN 0.016 0.02 -9999 0 -0.25 3 3
BCAR1 0.017 0.012 -9999 0 -0.25 1 1
FGF2 -0.064 0.16 -9999 0 -0.34 122 122
F11R -0.037 0.12 -9999 0 -0.37 41 41
alphaV/beta3 Integrin/Lactadherin -0.006 0.12 -9999 0 -0.39 38 38
alphaV/beta3 Integrin/TGFBR2 0.011 0.089 -9999 0 -0.35 26 26
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.031 0.062 -9999 0 -0.27 19 19
HSP90AA1 0.013 0.045 -9999 0 -0.39 6 6
alphaV/beta3 Integrin/Talin 0.014 0.075 -9999 0 -0.31 23 23
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.048 0.17 -9999 0 -0.46 73 73
alphaV/beta3 Integrin/Pyk2 0.018 0.094 -9999 0 -0.32 27 27
SDC1 -0.038 0.16 -9999 0 -0.46 62 62
VAV3 -0.024 0.13 -9999 0 -0.27 102 102
PTPN11 0.017 0.023 -9999 0 -0.52 1 1
IRS1 -0.048 0.17 -9999 0 -0.49 68 68
FAK1/Paxillin 0.004 0.11 -9999 0 -0.37 25 25
cell migration 0.011 0.1 -9999 0 -0.34 23 23
ITGAV -0.002 0.1 -9999 0 -0.48 21 21
PI3K -0.016 0.12 -9999 0 -0.41 22 22
SPP1 -0.14 0.23 -9999 0 -0.43 188 188
KDR 0.013 0.052 -9999 0 -0.52 5 5
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 -0.002 0.099 -9999 0 -0.48 21 21
COL4A3 0.013 0.047 -9999 0 -0.37 7 7
angiogenesis -0.081 0.22 -9999 0 -0.65 56 56
Rac1/GTP -0.013 0.12 -9999 0 -0.24 102 102
EDIL3 -0.11 0.22 -9999 0 -0.44 152 152
cell proliferation 0.011 0.089 -9999 0 -0.34 26 26
Signaling events mediated by PTP1B

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.01 0.066 -10000 0 -0.52 8 8
Jak2/Leptin Receptor -0.039 0.12 -10000 0 -0.35 43 43
PTP1B/AKT1 -0.043 0.12 0.29 2 -0.3 61 63
FYN 0.008 0.067 -10000 0 -0.41 12 12
p210 bcr-abl/PTP1B -0.055 0.12 0.32 2 -0.32 65 67
EGFR -0.085 0.18 -10000 0 -0.36 139 139
EGF/EGFR -0.14 0.2 -10000 0 -0.37 193 193
CSF1 0.014 0.037 -10000 0 -0.29 7 7
AKT1 0.011 0.054 -10000 0 -0.38 9 9
INSR 0.015 0.037 -10000 0 -0.39 4 4
PTP1B/N-cadherin -0.065 0.15 0.28 2 -0.35 74 76
Insulin Receptor/Insulin -0.02 0.1 -10000 0 -0.32 29 29
HCK -0.005 0.11 -10000 0 -0.47 25 25
CRK 0.016 0.033 -10000 0 -0.52 2 2
TYK2 -0.046 0.12 0.3 2 -0.32 55 57
EGF -0.15 0.23 -10000 0 -0.43 193 193
YES1 0.007 0.07 -10000 0 -0.43 12 12
CAV1 -0.074 0.14 0.29 2 -0.36 66 68
TXN 0.013 0.017 -10000 0 -0.26 2 2
PTP1B/IRS1/GRB2 -0.067 0.15 -10000 0 -0.36 87 87
cell migration 0.055 0.12 0.32 65 -0.32 2 67
STAT3 0.014 0.041 -10000 0 -0.52 3 3
PRLR -0.027 0.15 -10000 0 -0.49 50 50
ITGA2B 0.015 0.02 -10000 0 -0.25 3 3
CSF1R 0.017 0.017 -10000 0 -0.25 2 2
Prolactin Receptor/Prolactin -0.002 0.12 -10000 0 -0.36 47 47
FGR 0.017 0.017 -10000 0 -0.25 2 2
PTP1B/p130 Cas -0.044 0.12 0.28 2 -0.31 60 62
Crk/p130 Cas -0.036 0.12 -10000 0 -0.3 56 56
DOK1 -0.039 0.13 0.3 2 -0.37 44 46
JAK2 -0.037 0.12 -10000 0 -0.36 39 39
Jak2/Leptin Receptor/Leptin -0.069 0.13 -10000 0 -0.39 42 42
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
PTPN1 -0.056 0.12 0.32 2 -0.32 65 67
LYN 0.014 0.031 -10000 0 -0.25 7 7
CDH2 -0.027 0.13 -10000 0 -0.34 66 66
SRC -0.005 0.07 -10000 0 -0.68 3 3
ITGB3 0.001 0.076 -10000 0 -0.32 25 25
CAT1/PTP1B -0.085 0.17 0.25 2 -0.41 78 80
CAPN1 0.003 0.078 -10000 0 -0.44 15 15
CSK 0.015 0.031 -10000 0 -0.32 4 4
PI3K -0.036 0.1 -10000 0 -0.32 41 41
mol:H2O2 -0.003 0.005 -10000 0 -10000 0 0
STAT3 (dimer) -0.062 0.12 -10000 0 -0.39 37 37
negative regulation of transcription -0.037 0.11 -10000 0 -0.35 40 40
FCGR2A -0.003 0.099 -10000 0 -0.45 23 23
FER 0.013 0.027 -10000 0 -0.4 2 2
alphaIIb/beta3 Integrin 0.011 0.056 -10000 0 -0.37 7 7
BLK -0.019 0.1 -10000 0 -0.29 63 63
Insulin Receptor/Insulin/Shc 0.032 0.032 -10000 0 -0.31 4 4
RHOA 0.004 0.081 -10000 0 -0.53 12 12
LEPR -0.005 0.093 -10000 0 -0.34 34 34
BCAR1 0.017 0.012 -10000 0 -0.25 1 1
p210 bcr-abl/Grb2 0.016 0.023 -10000 0 -0.25 4 4
mol:NADPH -0.003 0.004 -10000 0 -10000 0 0
TRPV6 -0.06 0.16 -10000 0 -0.44 55 55
PRL 0.018 0.033 -10000 0 -0.32 4 4
SOCS3 -0.005 0.17 -10000 0 -1.3 8 8
SPRY2 -0.036 0.15 -10000 0 -0.43 60 60
Insulin Receptor/Insulin/IRS1 -0.008 0.12 -10000 0 -0.32 62 62
CSF1/CSF1R -0.037 0.12 -10000 0 -0.3 56 56
Ras protein signal transduction 0.029 0.039 0.17 1 -0.19 3 4
IRS1 -0.048 0.17 -10000 0 -0.49 68 68
INS 0.017 0.024 -10000 0 -0.53 1 1
LEP -0.051 0.15 -10000 0 -0.34 101 101
STAT5B -0.043 0.11 0.25 2 -0.28 64 66
STAT5A -0.044 0.11 0.25 2 -0.28 65 67
GRB2 0.016 0.024 -10000 0 -0.25 4 4
PDGFB-D/PDGFRB -0.048 0.13 0.28 2 -0.35 56 58
CSN2 0.02 0.1 -10000 0 -1.4 2 2
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
LAT -0.025 0.12 -10000 0 -0.55 19 19
YBX1 0.007 0.072 -10000 0 -0.33 16 16
LCK -0.074 0.18 -10000 0 -0.4 117 117
SHC1 0.017 0.023 -10000 0 -0.52 1 1
NOX4 -0.059 0.18 -10000 0 -0.49 78 78
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.002 0.07 -9999 0 -0.28 28 28
Caspase 8 (4 units) -0.034 0.14 -9999 0 -0.37 42 42
NEF -0.014 0.042 -9999 0 -0.18 10 10
NFKBIA -0.004 0.061 -9999 0 -0.52 4 4
BIRC3 -0.064 0.21 -9999 0 -0.55 74 74
CYCS -0.04 0.14 -9999 0 -0.39 41 41
RIPK1 0.017 0.023 -9999 0 -0.52 1 1
CD247 -0.13 0.24 -9999 0 -0.47 153 153
MAP2K7 -0.023 0.13 -9999 0 -0.4 30 30
protein ubiquitination 0.018 0.095 -9999 0 -0.33 13 13
CRADD 0.01 0.063 -9999 0 -0.49 8 8
DAXX 0.017 0.012 -9999 0 -0.25 1 1
FAS -0.024 0.13 -9999 0 -0.42 51 51
BID -0.048 0.14 -9999 0 -0.33 77 77
NF-kappa-B/RelA/I kappa B alpha -0.014 0.12 -9999 0 -0.27 76 76
TRADD 0.016 0.026 -9999 0 -0.39 2 2
MAP3K5 -0.022 0.13 -9999 0 -0.42 47 47
CFLAR 0.009 0.065 -9999 0 -0.44 10 10
FADD 0 0.067 -9999 0 -0.25 35 35
NF-kappa-B/RelA/I kappa B alpha/ubiquitin -0.014 0.12 -9999 0 -0.27 76 76
MAPK8 -0.016 0.12 -9999 0 -0.42 22 22
APAF1 0.012 0.051 -9999 0 -0.41 7 7
TRAF1 0.013 0.04 -9999 0 -0.28 9 9
TRAF2 0.014 0.042 -9999 0 -0.45 4 4
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG -0.052 0.15 -9999 0 -0.3 101 101
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD 0.01 0.1 -9999 0 -0.41 11 11
CHUK 0.017 0.1 -9999 0 -0.36 13 13
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0 0.11 -9999 0 -0.29 55 55
TCRz/NEF -0.11 0.21 -9999 0 -0.43 133 133
TNF -0.004 0.094 -9999 0 -0.36 31 31
FASLG -0.12 0.26 -9999 0 -0.46 157 157
NFKB1 -0.001 0.046 -9999 0 -0.52 1 1
TNFR1A/BAG4/TNF-alpha 0.012 0.074 -9999 0 -0.31 18 18
CASP6 -0.02 0.14 -9999 0 -0.53 19 19
CASP7 -0.072 0.23 -9999 0 -0.54 80 80
RELA 0 0.04 -9999 0 -10000 0 0
CASP2 0.018 0 -9999 0 -10000 0 0
CASP3 -0.066 0.22 -9999 0 -0.54 78 78
TNFRSF1A 0.016 0.033 -9999 0 -0.52 2 2
TNFR1A/BAG4 0.014 0.054 -9999 0 -0.37 5 5
CASP8 0.018 0 -9999 0 -10000 0 0
CASP9 0.017 0.023 -9999 0 -0.52 1 1
MAP3K14 0.015 0.1 -9999 0 -0.41 11 11
APAF-1/Caspase 9 -0.097 0.15 -9999 0 -0.39 94 94
BCL2 -0.066 0.15 -9999 0 -0.39 51 51
Canonical Wnt signaling pathway

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.035 0.05 0.2 17 -0.53 1 18
AES 0.033 0.037 0.2 3 -10000 0 3
FBXW11 0.015 0.035 -10000 0 -0.43 3 3
mol:GTP 0.001 0.001 -10000 0 -10000 0 0
LRP6/FZD1 0.009 0.076 -10000 0 -0.36 19 19
SMAD4 0.009 0.067 -10000 0 -0.49 9 9
DKK2 -0.026 0.14 -10000 0 -0.42 52 52
TLE1 -0.017 0.16 0.2 2 -0.45 55 57
MACF1 0.016 0.026 -10000 0 -0.39 2 2
CTNNB1 -0.006 0.098 0.28 2 -0.36 13 15
WIF1 -0.024 0.098 -10000 0 -0.25 81 81
beta catenin/RanBP3 0.069 0.19 0.37 120 -0.46 2 122
KREMEN2 -0.19 0.23 -10000 0 -0.41 257 257
DKK1 -0.12 0.19 -10000 0 -0.34 199 199
beta catenin/beta TrCP1 0.005 0.096 0.3 1 -0.37 11 12
FZD1 0.003 0.082 -10000 0 -0.43 17 17
AXIN2 -0.097 0.33 -10000 0 -1.3 31 31
AXIN1 0.017 0.012 -10000 0 -0.25 1 1
RAN 0.018 0.012 -10000 0 -0.25 1 1
Axin1/APC/GSK3/beta catenin 0.034 0.036 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.017 0.16 0.27 3 -0.43 34 37
Axin1/APC/GSK3 0.049 0.042 0.24 4 -10000 0 4
Axin1/APC/GSK3/beta catenin/Macf1 0.037 0.067 -10000 0 -0.31 1 1
HNF1A 0.031 0.044 -10000 0 -0.26 2 2
CTBP1 0.033 0.041 0.21 2 -0.26 1 3
MYC -0.12 0.36 -10000 0 -1.1 49 49
RANBP3 0.018 0.001 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 -0.12 0.16 -10000 0 -0.33 186 186
NKD1 0.009 0.059 -10000 0 -0.38 11 11
TCF4 0.008 0.12 0.18 15 -0.49 26 41
TCF3 0.029 0.057 0.21 2 -0.36 5 7
WNT1/LRP6/FZD1/Axin1 0.031 0.062 -10000 0 -0.27 20 20
Ran/GTP 0.014 0.009 -10000 0 -0.17 1 1
CtBP/CBP/TCF/TLE1/AES 0.098 0.25 0.49 122 -0.48 8 130
LEF1 -0.007 0.13 0.2 3 -0.33 56 59
DVL1 0.045 0.042 -10000 0 -0.31 3 3
CSNK2A1 0.017 0.023 -10000 0 -0.52 1 1
beta catenin/TCF/CtBP/CBP/TLE1/AES -0.038 0.17 -10000 0 -0.49 34 34
DKK1/LRP6/Kremen 2 -0.17 0.17 -10000 0 -0.33 249 249
LRP6 0.008 0.065 -10000 0 -0.38 13 13
CSNK1A1 0.035 0.048 0.19 17 -0.46 1 18
NLK 0.008 0.044 -10000 0 -0.28 11 11
CCND1 -0.25 0.54 -10000 0 -1.4 87 87
WNT1 0.016 0.023 -10000 0 -0.52 1 1
GSK3A 0.018 0.001 -10000 0 -10000 0 0
GSK3B 0.017 0.001 -10000 0 -10000 0 0
FRAT1 0.008 0.068 -10000 0 -0.47 10 10
PPP2R5D 0.028 0.035 0.25 6 -10000 0 6
APC 0.026 0.062 -10000 0 -0.24 23 23
WNT1/LRP6/FZD1 0.037 0.06 -10000 0 -0.24 10 10
CREBBP 0.032 0.051 0.21 2 -0.52 2 4
Calcium signaling in the CD4+ TCR pathway

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 -0.002 0.077 -9999 0 -0.3 26 26
NFATC2 0.013 0.043 -9999 0 -0.3 5 5
NFATC3 0.015 0.03 -9999 0 -10000 0 0
CD40LG -0.097 0.25 -9999 0 -0.55 86 86
PTGS2 -0.11 0.26 -9999 0 -0.56 87 87
JUNB 0.011 0.055 -9999 0 -0.36 10 10
CaM/Ca2+/Calcineurin A alpha-beta B1 0.008 0.018 -9999 0 -10000 0 0
CaM/Ca2+ 0.008 0.018 -9999 0 -10000 0 0
CALM1 0.016 0.009 -9999 0 -10000 0 0
JUN -0.035 0.15 -9999 0 -0.46 57 57
mol:Ca2+ -0.004 0.011 -9999 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.011 0.011 -9999 0 -0.14 2 2
FOSL1 0.016 0.024 -9999 0 -0.25 4 4
CREM 0.016 0.017 -9999 0 -0.26 2 2
Jun/NFAT1-c-4/p21SNFT -0.024 0.15 -9999 0 -0.35 52 52
FOS -0.11 0.2 -9999 0 -0.37 171 171
IFNG -0.14 0.3 -9999 0 -0.59 119 119
AP-1/NFAT1-c-4 -0.1 0.3 -9999 0 -0.62 95 95
FASLG -0.12 0.3 -9999 0 -0.61 113 113
NFAT1-c-4/ICER1 0.008 0.095 -9999 0 -0.31 14 14
IL2RA -0.11 0.28 -9999 0 -0.56 106 106
FKBP12/FK506 0.012 0.011 -9999 0 -0.17 2 2
CSF2 -0.099 0.26 -9999 0 -0.54 91 91
JunB/Fra1/NFAT1-c-4 0.016 0.1 -9999 0 -0.33 14 14
IL4 -0.095 0.25 -9999 0 -0.54 86 86
IL2 -0.005 0.1 -9999 0 -1.3 3 3
IL3 0.008 0.021 -9999 0 -10000 0 0
FKBP1A 0.017 0.017 -9999 0 -0.25 2 2
BATF3 0 0 -9999 0 -10000 0 0
mol:FK506 0 0 -9999 0 -10000 0 0
POU2F1 0.026 0 -9999 0 -10000 0 0
BCR signaling pathway

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN -0.061 0.16 -10000 0 -0.4 69 69
IKBKB 0.005 0.077 -10000 0 -0.25 10 10
AKT1 -0.017 0.098 0.21 10 -0.22 45 55
IKBKG 0.008 0.078 -10000 0 -0.25 12 12
CALM1 -0.03 0.13 -10000 0 -0.36 45 45
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
MAP3K1 -0.075 0.19 -10000 0 -0.49 63 63
MAP3K7 0.016 0.02 -10000 0 -0.25 3 3
mol:Ca2+ -0.039 0.14 0.21 11 -0.39 46 57
DOK1 0.002 0.083 -10000 0 -0.41 19 19
AP-1 -0.045 0.1 0.18 1 -0.24 68 69
LYN 0.014 0.031 -10000 0 -0.25 7 7
BLNK -0.012 0.12 -10000 0 -0.51 30 30
SHC1 0.017 0.023 -10000 0 -0.52 1 1
BCR complex -0.033 0.13 -10000 0 -0.34 71 71
CD22 -0.055 0.19 -10000 0 -0.55 48 48
CAMK2G -0.022 0.12 -10000 0 -0.38 32 32
CSNK2A1 0.017 0.023 -10000 0 -0.52 1 1
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 -0.057 0.11 -10000 0 -0.44 21 21
GO:0007205 -0.04 0.14 0.21 11 -0.39 46 57
SYK -0.023 0.14 -10000 0 -0.48 43 43
ELK1 -0.032 0.13 -10000 0 -0.39 38 38
NFATC1 -0.04 0.16 -10000 0 -0.41 50 50
B-cell antigen/BCR complex -0.033 0.13 -10000 0 -0.34 71 71
PAG1/CSK 0.009 0.074 -10000 0 -0.37 16 16
NFKBIB 0.014 0.031 0.097 1 -0.11 3 4
HRAS -0.028 0.13 -10000 0 -0.38 35 35
NFKBIA 0.015 0.03 0.097 1 -0.11 2 3
NF-kappa-B/RelA/I kappa B beta 0.02 0.027 0.099 1 -0.16 1 2
RasGAP/Csk -0.026 0.14 -10000 0 -0.31 77 77
mol:GDP -0.038 0.13 0.22 4 -0.38 45 49
PTEN -0.002 0.1 -10000 0 -0.52 19 19
CD79B -0.042 0.15 -10000 0 -0.36 84 84
NF-kappa-B/RelA/I kappa B alpha 0.02 0.027 0.099 1 -0.16 1 2
GRB2 0.016 0.024 -10000 0 -0.25 4 4
PI3K/BCAP/CD19 -0.063 0.18 -10000 0 -0.5 53 53
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
mol:IP3 -0.041 0.14 0.21 11 -0.4 46 57
CSK 0.015 0.031 -10000 0 -0.32 4 4
FOS -0.078 0.15 -10000 0 -0.4 60 60
CHUK 0.001 0.094 -10000 0 -0.32 21 21
IBTK 0.016 0.033 -10000 0 -0.52 2 2
CARD11/BCL10/MALT1/TAK1 -0.023 0.12 -10000 0 -0.4 29 29
PTPN6 -0.046 0.18 -10000 0 -0.52 47 47
RELA 0.018 0 -10000 0 -10000 0 0
BCL2A1 0.013 0.03 -10000 0 -0.095 10 10
VAV2 -0.065 0.19 -10000 0 -0.56 49 49
ubiquitin-dependent protein catabolic process 0.019 0.03 0.1 1 -0.11 2 3
BTK -0.036 0.2 -10000 0 -1.1 18 18
CD19 -0.073 0.2 -10000 0 -0.48 71 71
MAP4K1 0.012 0.04 -10000 0 -0.25 12 12
CD72 -0.03 0.14 -10000 0 -0.37 65 65
PAG1 -0.005 0.097 -10000 0 -0.38 30 30
MAPK14 -0.057 0.16 -10000 0 -0.42 58 58
SH3BP5 -0.005 0.1 -10000 0 -0.44 26 26
PIK3AP1 -0.045 0.16 0.23 11 -0.45 47 58
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.055 0.19 -10000 0 -0.46 64 64
RAF1 -0.02 0.12 -10000 0 -0.37 31 31
RasGAP/p62DOK/SHIP -0.036 0.15 -10000 0 -0.32 79 79
CD79A -0.011 0.084 -10000 0 -0.26 54 54
re-entry into mitotic cell cycle -0.045 0.1 0.18 1 -0.24 68 69
RASA1 0.004 0.078 -10000 0 -0.42 16 16
MAPK3 -0.003 0.1 -10000 0 -0.32 24 24
MAPK1 -0.003 0.1 -10000 0 -0.32 25 25
CD72/SHP1 -0.055 0.19 -10000 0 -0.51 60 60
NFKB1 0.017 0.023 -10000 0 -0.52 1 1
MAPK8 -0.058 0.17 -10000 0 -0.43 55 55
actin cytoskeleton organization -0.049 0.17 -10000 0 -0.48 47 47
NF-kappa-B/RelA 0.043 0.054 0.19 1 -0.23 3 4
Calcineurin -0.023 0.12 -10000 0 -0.39 30 30
PI3K -0.087 0.14 -10000 0 -0.4 64 64
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.043 0.15 0.24 11 -0.43 46 57
SOS1 0.017 0.023 -10000 0 -0.52 1 1
Bam32/HPK1 -0.13 0.31 -10000 0 -0.75 96 96
DAPP1 -0.16 0.35 -10000 0 -0.86 95 95
cytokine secretion -0.037 0.15 -10000 0 -0.38 51 51
mol:DAG -0.041 0.14 0.21 11 -0.4 46 57
PLCG2 -0.017 0.11 -10000 0 -0.32 55 55
MAP2K1 -0.011 0.11 -10000 0 -0.35 28 28
B-cell antigen/BCR complex/FcgammaRIIB -0.045 0.15 -10000 0 -0.32 106 106
mol:PI-3-4-5-P3 -0.058 0.11 0.25 13 -0.29 61 74
ETS1 -0.019 0.12 -10000 0 -0.4 25 25
B-cell antigen/BCR complex/LYN/SYK/BLNK -0.031 0.15 -10000 0 -0.31 86 86
B-cell antigen/BCR complex/LYN -0.077 0.18 -10000 0 -0.54 50 50
MALT1 0.011 0.053 -10000 0 -0.37 9 9
TRAF6 0.017 0.023 -10000 0 -0.52 1 1
RAC1 -0.053 0.18 -10000 0 -0.51 47 47
B-cell antigen/BCR complex/LYN/SYK -0.053 0.19 -10000 0 -0.51 57 57
CARD11 -0.038 0.14 -10000 0 -0.42 40 40
FCGR2B -0.031 0.15 -10000 0 -0.5 50 50
PPP3CA 0.006 0.073 -10000 0 -0.44 13 13
BCL10 0.017 0.012 -10000 0 -0.25 1 1
IKK complex 0.012 0.04 0.11 1 -0.11 8 9
PTPRC -0.04 0.15 -10000 0 -0.41 71 71
PDPK1 -0.017 0.091 0.2 9 -0.22 37 46
PPP3CB 0.016 0.026 -10000 0 -0.39 2 2
PPP3CC -0.001 0.098 -10000 0 -0.51 19 19
POU2F2 0.019 0.021 -10000 0 -0.098 1 1
Ras signaling in the CD4+ TCR pathway

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.034 0.14 -9999 0 -0.33 76 76
MAP3K8 -0.038 0.15 -9999 0 -0.39 70 70
FOS -0.014 0.092 -9999 0 -0.29 13 13
PRKCA 0.01 0.034 -9999 0 -0.26 8 8
PTPN7 0.006 0.049 -9999 0 -0.28 14 14
HRAS 0.011 0.051 -9999 0 -0.41 7 7
PRKCB -0.003 0.007 -9999 0 -0.013 169 169
NRAS 0.004 0.076 -9999 0 -0.41 16 16
RAS family/GTP 0.013 0.064 -9999 0 -0.28 20 20
MAPK3 0.002 0.057 -9999 0 -0.45 2 2
MAP2K1 -0.005 0.064 -9999 0 -0.22 12 12
ELK1 0.01 0.038 -9999 0 -0.39 4 4
BRAF 0.004 0.057 -9999 0 -0.41 7 7
mol:GTP -0.001 0.002 -9999 0 -0.004 171 171
MAPK1 0.001 0.06 -9999 0 -0.43 3 3
RAF1 0.011 0.028 -9999 0 -10000 0 0
KRAS 0.008 0.065 -9999 0 -0.44 10 10
Glypican 1 network

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer -0.045 0.14 -10000 0 -0.37 67 67
fibroblast growth factor receptor signaling pathway -0.045 0.14 -10000 0 -0.36 67 67
LAMA1 0.015 0.026 -10000 0 -0.25 5 5
PRNP 0.006 0.073 -10000 0 -0.44 13 13
GPC1/SLIT2 -0.025 0.14 -10000 0 -0.39 60 60
SMAD2 0.012 0.084 -10000 0 -0.28 36 36
GPC1/PrPc/Cu2+ 0.002 0.083 -10000 0 -0.33 30 30
GPC1/Laminin alpha1 0.007 0.082 -10000 0 -0.37 22 22
TDGF1 0.017 0.012 -10000 0 -0.25 1 1
CRIPTO/GPC1 0.009 0.08 -10000 0 -0.37 22 22
APP/GPC1 -0.025 0.13 -10000 0 -0.38 57 57
mol:NO 0 0 -10000 0 -10000 0 0
YES1 0.01 0.081 -10000 0 -0.31 30 30
FLT1 0.004 0.08 -10000 0 -0.45 15 15
GPC1/TGFB/TGFBR1/TGFBR2 0.009 0.093 -10000 0 -0.32 35 35
SERPINC1 0.007 0.054 -10000 0 -0.27 19 19
FYN 0.01 0.079 -10000 0 -0.31 29 29
FGR 0.015 0.068 -10000 0 -0.3 22 22
positive regulation of MAPKKK cascade -0.012 0.12 -10000 0 -0.36 42 42
SLIT2 -0.029 0.15 -10000 0 -0.48 50 50
GPC1/NRG 0.002 0.089 -10000 0 -0.38 23 23
NRG1 0.008 0.053 -10000 0 -0.27 18 18
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.002 0.097 -10000 0 -0.32 37 37
LYN 0.014 0.071 -10000 0 -0.31 22 22
mol:Spermine -0.005 0.079 -10000 0 -0.35 25 25
cell growth -0.045 0.14 -10000 0 -0.36 67 67
BMP signaling pathway 0.006 0.11 0.49 25 -10000 0 25
SRC 0.015 0.073 -10000 0 -0.32 23 23
TGFBR1 0.003 0.082 -10000 0 -0.42 18 18
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.054 0.14 -10000 0 -0.3 122 122
GPC1 -0.006 0.11 -10000 0 -0.49 25 25
TGFBR1 (dimer) 0.003 0.082 -10000 0 -0.42 18 18
VEGFA 0 0.075 -10000 0 -0.29 31 31
BLK -0.005 0.092 -10000 0 -0.33 30 30
HCK 0.002 0.095 -10000 0 -0.32 41 41
FGF2 -0.064 0.16 -10000 0 -0.34 122 122
FGFR1 -0.013 0.11 -10000 0 -0.35 44 44
VEGFR1 homodimer 0.004 0.08 -10000 0 -0.45 15 15
TGFBR2 0.013 0.049 -10000 0 -0.43 6 6
cell death -0.025 0.13 -10000 0 -0.38 57 57
ATIII/GPC1 0.002 0.088 -10000 0 -0.38 23 23
PLA2G2A/GPC1 -0.041 0.12 -10000 0 -0.39 41 41
LCK -0.039 0.13 -10000 0 -0.32 82 82
neuron differentiation 0.002 0.089 -10000 0 -0.38 23 23
PrPc/Cu2+ 0.005 0.053 -10000 0 -0.31 13 13
APP -0.029 0.14 -10000 0 -0.43 56 56
TGFBR2 (dimer) 0.013 0.049 -10000 0 -0.43 6 6
Glypican 2 network

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK -0.016 0.12 -9999 0 -0.37 46 46
GPC2 0 0 -9999 0 -10000 0 0
GPC2/Midkine -0.011 0.083 -9999 0 -0.26 46 46
neuron projection morphogenesis -0.011 0.083 -9999 0 -0.26 46 46
E-cadherin signaling in the nascent adherens junction

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN -0.037 0.17 -9999 0 -0.45 74 74
KLHL20 -0.015 0.099 -9999 0 -0.25 26 26
CYFIP2 -0.042 0.16 -9999 0 -0.47 65 65
Rac1/GDP 0.006 0.11 -9999 0 -0.25 74 74
ENAH -0.036 0.18 -9999 0 -0.45 76 76
AP1M1 0.017 0.023 -9999 0 -0.52 1 1
RAP1B 0.013 0.044 -9999 0 -0.32 8 8
RAP1A 0.012 0.057 -9999 0 -0.52 6 6
CTNNB1 0.001 0.09 -9999 0 -0.45 19 19
CDC42/GTP -0.032 0.069 -9999 0 -0.3 10 10
ABI1/Sra1/Nap1 -0.042 0.054 -9999 0 -0.17 37 37
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin -0.005 0.12 -9999 0 -0.28 79 79
RAPGEF1 -0.015 0.15 -9999 0 -0.38 74 74
CTNND1 0.016 0.029 -9999 0 -0.34 3 3
regulation of calcium-dependent cell-cell adhesion -0.039 0.17 -9999 0 -0.46 74 74
CRK -0.024 0.16 -9999 0 -0.41 75 75
E-cadherin/gamma catenin/alpha catenin -0.01 0.12 -9999 0 -0.31 65 65
alphaE/beta7 Integrin 0.023 0.038 -9999 0 -0.37 5 5
IQGAP1 0.018 0 -9999 0 -10000 0 0
NCKAP1 0.015 0.031 -9999 0 -0.32 4 4
Rap1/GTP/I-afadin 0.014 0.073 -9999 0 -0.28 28 28
DLG1 -0.031 0.17 -9999 0 -0.44 74 74
ChemicalAbstracts:7440-70-2 0 0 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 -0.028 0.055 -9999 0 -0.22 15 15
MLLT4 -0.006 0.11 -9999 0 -0.46 26 26
ARF6/GTP/NME1/Tiam1 0.023 0.052 -9999 0 -0.3 10 10
PI3K -0.036 0.07 -9999 0 -0.28 15 15
ARF6 0.016 0.033 -9999 0 -0.52 2 2
mol:Ca2+ 0 0 -9999 0 -10000 0 0
E-cadherin/gamma catenin -0.027 0.13 -9999 0 -0.37 64 64
TIAM1 0.006 0.073 -9999 0 -0.44 13 13
E-cadherin(dimer)/Ca2+ -0.005 0.11 -9999 0 -0.26 76 76
AKT1 -0.022 0.043 -9999 0 -0.17 15 15
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
CDH1 -0.049 0.17 -9999 0 -0.48 70 70
RhoA/GDP 0.003 0.12 -9999 0 -0.26 78 78
actin cytoskeleton organization -0.009 0.075 -9999 0 -0.18 26 26
CDC42/GDP 0.008 0.11 -9999 0 -0.25 74 74
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin -0.007 0.09 -9999 0 -0.24 66 66
ITGB7 0.018 0 -9999 0 -10000 0 0
RAC1 0.018 0 -9999 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin -0.005 0.11 -9999 0 -0.28 76 76
E-cadherin/Ca2+/beta catenin/alpha catenin -0.014 0.1 -9999 0 -0.27 75 75
mol:GDP -0.004 0.13 -9999 0 -0.3 75 75
CDC42/GTP/IQGAP1 0.024 0 -9999 0 -10000 0 0
JUP 0.011 0.056 -9999 0 -0.42 8 8
p120 catenin/RhoA/GDP 0.002 0.12 -9999 0 -0.32 26 26
RAC1/GTP/IQGAP1 0.024 0 -9999 0 -10000 0 0
PIP5K1C/AP1M1 0.023 0.035 -9999 0 -0.37 4 4
RHOA 0.005 0.08 -9999 0 -0.52 12 12
CDC42 0.018 0 -9999 0 -10000 0 0
CTNNA1 0.017 0.023 -9999 0 -0.52 1 1
positive regulation of S phase of mitotic cell cycle -0.027 0.094 -9999 0 -0.2 97 97
NME1 0.012 0.039 -9999 0 -0.25 11 11
clathrin coat assembly 0 0 -9999 0 -10000 0 0
TJP1 -0.033 0.17 -9999 0 -0.44 75 75
regulation of cell-cell adhesion -0.029 0.061 -9999 0 -0.26 10 10
WASF2 -0.021 0.031 -9999 0 -0.13 4 4
Rap1/GTP -0.038 0.08 -9999 0 -0.34 10 10
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.009 0.1 -9999 0 -0.25 70 70
CCND1 -0.035 0.12 -9999 0 -0.26 97 97
VAV2 -0.022 0.16 -9999 0 -0.4 74 74
RAP1/GDP 0.005 0.11 -9999 0 -0.36 9 9
adherens junction assembly -0.031 0.17 -9999 0 -0.43 75 75
homophilic cell adhesion 0 0 -9999 0 -10000 0 0
ABI1 0.016 0.02 -9999 0 -0.25 3 3
PIP5K1C 0.014 0.042 -9999 0 -0.45 4 4
regulation of heterotypic cell-cell adhesion 0.006 0.11 -9999 0 -0.37 5 5
E-cadherin/beta catenin -0.045 0.11 -9999 0 -0.34 66 66
mol:GTP 0 0 -9999 0 -10000 0 0
SRC -0.033 0.17 -9999 0 -0.44 75 75
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
Rac1/GTP -0.078 0.12 -9999 0 -0.39 31 31
E-cadherin/beta catenin/alpha catenin -0.017 0.12 -9999 0 -0.31 75 75
ITGAE 0.013 0.052 -9999 0 -0.52 5 5
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.04 0.18 -9999 0 -0.47 74 74
Coregulation of Androgen receptor activity

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 -0.042 0.16 -9999 0 -0.46 67 67
SVIL -0.004 0.1 -9999 0 -0.43 27 27
ZNF318 0.014 0.005 -9999 0 -10000 0 0
JMJD2C 0.023 0.032 -9999 0 -0.32 4 4
T-DHT/AR/Ubc9 -0.065 0.14 -9999 0 -0.33 103 103
CARM1 0.014 0.039 -9999 0 -0.36 5 5
PRDX1 0.012 0.05 -9999 0 -0.43 6 6
PELP1 0.017 0.001 -9999 0 -10000 0 0
CTNNB1 0.002 0.09 -9999 0 -0.45 19 19
AKT1 0.01 0.053 -9999 0 -0.37 9 9
PTK2B 0.017 0.017 -9999 0 -0.25 2 2
MED1 -0.001 0.066 -9999 0 -0.25 34 34
MAK -0.018 0.094 -9999 0 -0.28 57 57
response to oxidative stress 0 0 -9999 0 -10000 0 0
HIP1 0.019 0.012 -9999 0 -0.25 1 1
GSN 0 0.095 -9999 0 -0.43 23 23
NCOA2 0.009 0.063 -9999 0 -0.4 11 11
NCOA6 0.019 0.012 -9999 0 -0.25 1 1
DNA-PK 0.029 0.029 -9999 0 -0.31 2 2
NCOA4 0.008 0.069 -9999 0 -0.45 11 11
PIAS3 0.019 0.002 -9999 0 -10000 0 0
cell proliferation -0.043 0.092 -9999 0 -0.84 5 5
XRCC5 0.017 0.001 -9999 0 -10000 0 0
UBE3A 0.018 0.033 -9999 0 -0.52 2 2
T-DHT/AR/SNURF -0.076 0.14 -9999 0 -0.32 119 119
FHL2 -0.15 0.34 -9999 0 -0.97 70 70
RANBP9 0.019 0.012 -9999 0 -0.25 1 1
JMJD1A -0.002 0.055 -9999 0 -10000 0 0
CDK6 -0.019 0.1 -9999 0 -0.29 63 63
TGFB1I1 -0.003 0.1 -9999 0 -0.48 23 23
T-DHT/AR/CyclinD1 -0.12 0.21 -9999 0 -0.42 150 150
XRCC6 0.016 0.012 -9999 0 -0.26 1 1
T-DHT/AR -0.085 0.17 -9999 0 -0.33 140 140
CTDSP1 0.016 0.033 -9999 0 -0.52 2 2
CTDSP2 0.011 0.044 -9999 0 -0.42 5 5
BRCA1 0.001 0.094 -9999 0 -0.48 19 19
TCF4 -0.01 0.12 -9999 0 -0.51 26 26
CDKN2A -0.055 0.15 -9999 0 -0.33 108 108
SRF 0 0.054 -9999 0 -0.28 4 4
NKX3-1 -0.056 0.11 -9999 0 -0.24 105 105
KLK3 0.022 0.055 -9999 0 -10000 0 0
TMF1 0.018 0.001 -9999 0 -10000 0 0
HNRNPA1 0.015 0.023 -9999 0 -0.52 1 1
AOF2 0.018 0.026 -9999 0 -0.39 2 2
APPL1 0.015 0.054 -9999 0 -0.37 9 9
T-DHT/AR/Caspase 8 -0.066 0.14 -9999 0 -0.33 103 103
AR -0.11 0.21 -9999 0 -0.53 104 104
UBA3 0 0.001 -9999 0 -10000 0 0
PATZ1 0.003 0.084 -9999 0 -0.5 14 14
PAWR 0.001 0.091 -9999 0 -0.44 20 20
PRKDC 0.011 0.045 -9999 0 -0.31 9 9
PA2G4 0.016 0.012 -9999 0 -0.26 1 1
UBE2I 0.018 0 -9999 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 -0.059 0.13 -9999 0 -0.3 103 103
RPS6KA3 0.011 0.057 -9999 0 -0.34 12 12
T-DHT/AR/ARA70 -0.071 0.15 -9999 0 -0.32 124 124
LATS2 0.004 0.078 -9999 0 -0.48 13 13
T-DHT/AR/PRX1 -0.062 0.13 -9999 0 -0.31 106 106
Cyclin D3/CDK11 p58 0.013 0.008 -9999 0 -0.17 1 1
VAV3 -0.082 0.2 -9999 0 -0.48 108 108
KLK2 -0.013 0.075 -9999 0 -0.4 1 1
CASP8 0.017 0.001 -9999 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.054 0.14 -9999 0 -0.3 111 111
TMPRSS2 -0.18 0.38 -9999 0 -0.91 105 105
CCND1 -0.089 0.2 -9999 0 -0.44 124 124
PIAS1 0.019 0.012 -9999 0 -0.25 1 1
mol:T-DHT -0.018 0.037 -9999 0 -0.077 130 130
CDC2L1 0 0 -9999 0 -10000 0 0
PIAS4 0.016 0.05 -9999 0 -0.43 6 6
T-DHT/AR/CDK6 -0.085 0.17 -9999 0 -0.37 118 118
CMTM2 0.016 0.023 -9999 0 -0.52 1 1
SNURF 0 0 -9999 0 -10000 0 0
ZMIZ1 -0.003 0.049 -9999 0 -0.31 6 6
CCND3 0.017 0.012 -9999 0 -0.25 1 1
TGIF1 0.006 0.073 -9999 0 -0.52 10 10
FKBP4 0.013 0.055 -9999 0 -0.44 7 7
IL1-mediated signaling events

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.012 0.011 -9999 0 -0.17 2 2
PRKCZ 0 0 -9999 0 -10000 0 0
MAP3K7IP2 0.014 0.047 -9999 0 -0.52 4 4
ERC1 0.011 0.056 -9999 0 -0.42 8 8
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.024 0.11 -9999 0 -0.32 40 40
IRAK/TOLLIP 0.029 0.019 -9999 0 -0.23 1 1
IKBKB 0.012 0.047 -9999 0 -0.31 10 10
IKBKG 0.018 0 -9999 0 -10000 0 0
IL1 alpha/IL1R2 -0.025 0.12 -9999 0 -0.36 46 46
IL1A 0.006 0.063 -9999 0 -0.31 18 18
IL1B -0.067 0.18 -9999 0 -0.43 86 86
IRAK/TRAF6/p62/Atypical PKCs 0.031 0.053 -9999 0 -0.23 18 18
IL1R2 -0.045 0.15 -9999 0 -0.35 89 89
IL1R1 -0.046 0.16 -9999 0 -0.4 80 80
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.018 0.12 -9999 0 -0.29 61 61
TOLLIP 0.017 0.012 -9999 0 -0.25 1 1
TICAM2 0 0 -9999 0 -10000 0 0
MAP3K3 0.017 0.012 -9999 0 -0.25 1 1
TAK1/TAB1/TAB2 0.033 0.034 -9999 0 -0.34 4 4
IKK complex/ELKS 0.051 0.075 -9999 0 -0.36 7 7
JUN 0.014 0.093 -9999 0 -0.44 4 4
MAP3K7 0.016 0.02 -9999 0 -0.25 3 3
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.059 0.18 -9999 0 -0.34 120 120
IL1 alpha/IL1R1/IL1RAP/MYD88 -0.002 0.1 -9999 0 -0.28 57 57
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 0.005 0.1 -9999 0 -0.26 57 57
IL1 beta fragment/IL1R1/IL1RAP -0.069 0.18 -9999 0 -0.36 120 120
NFKB1 0.017 0.023 -9999 0 -0.52 1 1
MAPK8 0.032 0.063 -9999 0 -0.37 2 2
IRAK1 0.019 0.018 -9999 0 -10000 0 0
IL1RN/IL1R1 -0.061 0.17 -9999 0 -0.41 87 87
IRAK4 0.014 0.044 -9999 0 -0.41 5 5
PRKCI 0.002 0.085 -9999 0 -0.43 18 18
TRAF6 0.017 0.023 -9999 0 -0.52 1 1
PI3K 0.005 0.082 -9999 0 -0.37 21 21
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.032 0.13 -9999 0 -0.36 47 47
CHUK 0.005 0.081 -9999 0 -0.5 13 13
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.069 0.18 -9999 0 -0.36 120 120
IL1 beta/IL1R2 -0.082 0.18 -9999 0 -0.36 128 128
IRAK/TRAF6/TAK1/TAB1/TAB2 0.048 0.033 -9999 0 -0.33 1 1
NF kappa B1 p50/RelA -0.082 0.14 -9999 0 -0.44 54 54
IRAK3 -0.018 0.099 -9999 0 -0.28 64 64
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.056 0.17 -9999 0 -0.34 110 110
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP 0.004 0.089 -9999 0 -0.38 4 4
IL1 alpha/IL1R1/IL1RAP -0.013 0.11 -9999 0 -0.31 53 53
RELA 0.018 0 -9999 0 -10000 0 0
MAP3K7IP1 0.018 0 -9999 0 -10000 0 0
SQSTM1 0.012 0.053 -9999 0 -0.48 6 6
MYD88 0.013 0.048 -9999 0 -0.47 5 5
IRAK/TRAF6/MEKK3 0.038 0.021 -9999 0 -0.25 1 1
IL1RAP 0.012 0.044 -9999 0 -0.28 11 11
UBE2N 0.017 0.017 -9999 0 -0.25 2 2
IRAK/TRAF6 -0.069 0.12 -9999 0 -0.39 49 49
CASP1 -0.051 0.17 -9999 0 -0.42 84 84
IL1RN/IL1R2 -0.06 0.16 -9999 0 -0.39 82 82
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.057 0.17 -9999 0 -0.35 111 111
TMEM189-UBE2V1 0 0 -9999 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP 0.003 0.1 -9999 0 -0.3 50 50
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
IL1RN -0.043 0.16 -9999 0 -0.4 76 76
TRAF6/TAK1/TAB1/TAB2 0.04 0.031 -9999 0 -0.26 5 5
MAP2K6 0.028 0.063 -9999 0 -0.4 2 2
E-cadherin signaling in keratinocytes

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation 0.011 0.088 -10000 0 -0.29 24 24
adherens junction organization -0.013 0.11 -10000 0 -0.25 78 78
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.019 0.11 -10000 0 -0.34 21 21
FMN1 -0.008 0.1 -10000 0 -0.24 78 78
mol:IP3 0.006 0.081 -10000 0 -0.24 25 25
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.008 0.11 -10000 0 -0.25 78 78
CTNNB1 0.002 0.09 -10000 0 -0.45 19 19
AKT1 0.007 0.092 -10000 0 -0.31 13 13
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.018 0.15 -10000 0 -0.38 76 76
CTNND1 0.016 0.029 -10000 0 -0.34 3 3
mol:PI-4-5-P2 0 0.1 -10000 0 -0.33 10 10
VASP -0.007 0.11 -10000 0 -0.32 20 20
ZYX -0.006 0.11 -10000 0 -0.24 86 86
JUB -0.023 0.13 -10000 0 -0.25 112 112
EGFR(dimer) -0.043 0.13 -10000 0 -0.25 126 126
E-cadherin/beta catenin-gamma catenin -0.019 0.12 -10000 0 -0.3 78 78
mol:PI-3-4-5-P3 0.003 0.092 -10000 0 -0.26 28 28
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
PI3K 0.004 0.093 -10000 0 -0.26 28 28
FYN 0.015 0.085 -10000 0 -0.3 15 15
mol:Ca2+ 0.006 0.08 -10000 0 -0.24 25 25
JUP 0.012 0.056 -10000 0 -0.42 8 8
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
mol:DAG 0.006 0.081 -10000 0 -0.24 25 25
CDH1 -0.049 0.17 -10000 0 -0.48 70 70
RhoA/GDP -0.025 0.12 -10000 0 -0.35 28 28
establishment of polarity of embryonic epithelium -0.006 0.11 -10000 0 -0.32 20 20
SRC 0.015 0.035 -10000 0 -0.43 3 3
RAC1 0.018 0 -10000 0 -10000 0 0
RHOA 0.005 0.08 -10000 0 -0.52 12 12
EGFR -0.079 0.18 -10000 0 -0.35 139 139
CASR 0.012 0.078 -10000 0 -0.31 7 7
RhoA/GTP 0.008 0.086 -10000 0 -0.32 11 11
AKT2 0.009 0.087 -10000 0 -0.32 7 7
actin cable formation -0.007 0.1 -10000 0 -0.31 20 20
apoptosis -0.006 0.089 0.26 26 -10000 0 26
CTNNA1 0.017 0.024 -10000 0 -0.52 1 1
mol:GDP -0.03 0.12 -10000 0 -0.36 22 22
PIP5K1A -0.001 0.1 -10000 0 -0.34 10 10
PLCG1 0.006 0.082 -10000 0 -0.25 25 25
Rac1/GTP -0.034 0.12 -10000 0 -0.32 32 32
homophilic cell adhesion 0 0.003 -10000 0 -10000 0 0
Class IB PI3K non-lipid kinase events

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
cAMP biosynthetic process 0.004 0.088 0.33 33 -10000 0 33
PI3K Class IB/PDE3B -0.004 0.088 -10000 0 -0.33 33 33
PDE3B -0.004 0.088 -10000 0 -0.33 33 33
Cellular roles of Anthrax toxin

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 -0.024 0.14 -10000 0 -0.46 46 46
ANTXR2 0.002 0.09 -10000 0 -0.5 16 16
negative regulation of myeloid dendritic cell antigen processing and presentation -0.007 0.021 -10000 0 -0.074 44 44
monocyte activation -0.022 0.12 -10000 0 -0.41 41 41
MAP2K2 0.007 0.06 -10000 0 -0.77 3 3
MAP2K1 0.005 0.021 -10000 0 -0.095 7 7
MAP2K7 0.005 0.024 -10000 0 -0.27 1 1
MAP2K6 -0.009 0.063 -10000 0 -0.29 21 21
CYAA -0.014 0.092 -10000 0 -0.3 44 44
MAP2K4 -0.006 0.056 -10000 0 -0.21 31 31
IL1B -0.03 0.095 -10000 0 -0.26 63 63
Channel -0.009 0.1 -10000 0 -0.32 44 44
NLRP1 0.002 0.036 -10000 0 -0.32 4 4
CALM1 0.018 0 -10000 0 -10000 0 0
negative regulation of phagocytosis 0.007 0.027 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.007 0.021 0.074 44 -10000 0 44
MAPK3 0.005 0.024 -10000 0 -0.27 1 1
MAPK1 0.004 0.027 -10000 0 -0.27 2 2
PGR -0.14 0.12 -10000 0 -0.2 368 368
PA/Cellular Receptors -0.011 0.11 -10000 0 -0.35 44 44
apoptosis -0.007 0.021 -10000 0 -0.074 44 44
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) -0.008 0.094 -10000 0 -0.3 44 44
macrophage activation 0.011 0.028 -10000 0 -0.25 3 3
TNF -0.004 0.094 -10000 0 -0.36 31 31
VCAM1 -0.022 0.12 -10000 0 -0.42 41 41
platelet activation 0.007 0.027 -10000 0 -10000 0 0
MAPKKK cascade -0.001 0.034 0.12 18 -10000 0 18
IL18 -0.031 0.11 -10000 0 -0.31 58 58
negative regulation of macrophage activation -0.007 0.021 -10000 0 -0.074 44 44
LEF -0.007 0.021 -10000 0 -0.074 44 44
CASP1 -0.006 0.042 -10000 0 -0.15 24 24
mol:cAMP 0.007 0.027 -10000 0 -10000 0 0
necrosis -0.007 0.021 -10000 0 -0.074 44 44
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) -0.008 0.095 -10000 0 -0.3 44 44
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
Signaling mediated by p38-gamma and p38-delta

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K 0.018 0.062 -9999 0 -0.31 17 17
SNTA1 0.011 0.058 -9999 0 -0.48 7 7
response to hypoxia 0 0 -9999 0 -10000 0 0
STMN1 0.004 0.086 -9999 0 -0.32 31 31
MAPK12 -0.004 0.092 -9999 0 -0.28 46 46
CCND1 -0.07 0.17 -9999 0 -0.42 91 91
p38 gamma/SNTA1 0.002 0.093 -9999 0 -0.28 35 35
MAP2K3 0.014 0.037 -9999 0 -0.29 7 7
PKN1 0.013 0.045 -9999 0 -0.39 6 6
G2/M transition checkpoint -0.004 0.091 -9999 0 -0.28 46 46
MAP2K6 -0.005 0.091 -9999 0 -0.3 43 43
MAPT -0.054 0.15 -9999 0 -0.32 120 120
MAPK13 0.011 0.071 -9999 0 -0.38 16 16
hyperosmotic response 0 0 -9999 0 -10000 0 0
ZAK 0.003 0.072 -9999 0 -0.33 23 23
Regulation of nuclear SMAD2/3 signaling

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.019 0.049 -10000 0 -0.51 4 4
HSPA8 0.001 0.09 -10000 0 -0.52 15 15
SMAD3/SMAD4/ER alpha -0.091 0.2 -10000 0 -0.37 157 157
AKT1 0.01 0.056 -10000 0 -0.37 9 9
GSC -0.2 0.49 -10000 0 -1.4 77 77
NKX2-5 -0.018 0.093 -10000 0 -0.26 67 67
muscle cell differentiation 0.066 0.16 0.47 46 -10000 0 46
SMAD2-3/SMAD4/SP1 -0.006 0.18 -10000 0 -0.44 53 53
SMAD4 -0.015 0.1 -10000 0 -0.33 31 31
CBFB 0.015 0.037 -10000 0 -0.39 4 4
SAP18 0.017 0.002 -10000 0 -10000 0 0
Cbp/p300/MSG1 0.014 0.075 -10000 0 -0.29 8 8
SMAD3/SMAD4/VDR 0.027 0.12 -10000 0 -0.36 27 27
MYC -0.024 0.14 -10000 0 -0.44 49 49
CDKN2B -0.047 0.3 -10000 0 -1.4 24 24
AP1 -0.068 0.23 -10000 0 -0.55 75 75
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.037 0.066 -10000 0 -0.28 2 2
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 0.004 0.12 -10000 0 -0.36 31 31
SP3 0.014 0.02 -10000 0 -10000 0 0
CREB1 0.017 0.023 -10000 0 -0.52 1 1
FOXH1 -0.001 0.042 -10000 0 -10000 0 0
SMAD3/SMAD4/GR -0.004 0.13 -10000 0 -0.36 44 44
GATA3 -0.099 0.22 -10000 0 -0.5 124 124
SKI/SIN3/HDAC complex/NCoR1 0.042 0.037 -10000 0 -10000 0 0
MEF2C/TIF2 -0.028 0.17 -10000 0 -0.51 40 40
endothelial cell migration 0.018 0.24 1.3 16 -10000 0 16
MAX 0.018 0.009 -10000 0 -10000 0 0
RBBP7 0.01 0.051 -10000 0 -0.3 13 13
RBBP4 0.016 0.026 -10000 0 -0.39 2 2
RUNX2 0.013 0.049 -10000 0 -0.43 6 6
RUNX3 -0.062 0.18 -10000 0 -0.4 101 101
RUNX1 -0.027 0.14 -10000 0 -0.42 54 54
CTBP1 0.017 0.017 -10000 0 -0.25 2 2
NR3C1 -0.001 0.099 -10000 0 -0.51 19 19
VDR -0.003 0.1 -10000 0 -0.51 21 21
CDKN1A -0.03 0.27 -10000 0 -1.2 21 21
KAT2B 0.001 0.006 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 -0.016 0.13 -10000 0 -0.31 58 58
DCP1A 0.017 0.023 -10000 0 -0.52 1 1
SKI 0.016 0.017 -10000 0 -0.25 2 2
SERPINE1 -0.019 0.24 -10000 0 -1.3 16 16
SMAD3/SMAD4/ATF2 0.006 0.11 -10000 0 -0.33 29 29
SMAD3/SMAD4/ATF3 -0.017 0.14 -10000 0 -0.36 54 54
SAP30 0.012 0.053 -10000 0 -0.48 6 6
Cbp/p300/PIAS3 0.047 0.053 -10000 0 -0.29 6 6
JUN -0.07 0.22 -10000 0 -0.54 75 75
SMAD3/SMAD4/IRF7 0.002 0.13 -10000 0 -0.4 30 30
TFE3 0.018 0.026 -10000 0 -10000 0 0
COL1A2 -0.1 0.37 -10000 0 -1 72 72
mesenchymal cell differentiation -0.003 0.11 0.38 27 -10000 0 27
DLX1 -0.009 0.081 -10000 0 -0.25 53 53
TCF3 0.013 0.044 -10000 0 -0.32 8 8
FOS -0.11 0.2 -10000 0 -0.38 171 171
SMAD3/SMAD4/Max 0.008 0.11 -10000 0 -0.33 29 29
Cbp/p300/SNIP1 0.035 0.046 -10000 0 -0.3 9 9
ZBTB17 0.019 0.012 -10000 0 -10000 0 0
LAMC1 0.003 0.15 -10000 0 -0.54 29 29
TGIF2/HDAC complex/SMAD3/SMAD4 0.001 0.12 -10000 0 -0.36 32 32
IRF7 0.007 0.079 -10000 0 -0.49 12 12
ESR1 -0.15 0.24 -10000 0 -0.46 181 181
HNF4A 0.016 0.033 -10000 0 -0.52 2 2
MEF2C -0.035 0.18 -10000 0 -0.54 40 40
SMAD2-3/SMAD4 -0.008 0.12 -10000 0 -0.36 35 35
Cbp/p300/Src-1 0.036 0.055 -10000 0 -0.28 12 12
IGHV3OR16-13 -0.017 0.039 -10000 0 -0.52 1 1
TGIF2/HDAC complex 0.009 0.066 -10000 0 -0.42 11 11
CREBBP 0.019 0.034 -10000 0 -0.51 2 2
SKIL 0.005 0.07 -10000 0 -0.34 19 19
HDAC1 0.016 0.023 -10000 0 -0.52 1 1
HDAC2 0.008 0.053 -10000 0 -0.29 15 15
SNIP1 0.014 0.041 -10000 0 -0.52 3 3
GCN5L2 0.018 0.044 -10000 0 -0.46 4 4
SMAD3/SMAD4/TFE3 0.014 0.12 -10000 0 -0.36 34 34
MSG1/HSC70 -0.019 0.097 -10000 0 -0.41 16 16
SMAD2 -0.002 0.051 -10000 0 -0.51 1 1
SMAD3 -0.004 0.1 -10000 0 -0.49 16 16
SMAD3/E2F4-5/DP1/p107/SMAD4 0.008 0.097 -10000 0 -0.32 20 20
SMAD2/SMAD2/SMAD4 -0.007 0.055 -10000 0 -0.3 10 10
NCOR1 0.015 0.033 -10000 0 -0.52 2 2
NCOA2 0.009 0.063 -10000 0 -0.4 11 11
NCOA1 0.012 0.057 -10000 0 -0.52 6 6
MYOD/E2A -0.001 0.097 -10000 0 -0.37 31 31
SMAD2-3/SMAD4/SP1/MIZ-1 0.007 0.17 -10000 0 -0.44 44 44
IFNB1 0.005 0.13 -10000 0 -0.45 25 25
SMAD3/SMAD4/MEF2C -0.027 0.2 -10000 0 -0.56 45 45
CITED1 -0.029 0.1 -10000 0 -0.26 89 89
SMAD2-3/SMAD4/ARC105 0.009 0.12 -10000 0 -0.34 25 25
RBL1 0.01 0.048 -10000 0 -0.27 14 14
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB 0.001 0.15 -10000 0 -0.48 34 34
RUNX1-3/PEBPB2 -0.042 0.14 -10000 0 -0.34 86 86
SMAD7 -0.042 0.23 -10000 0 -0.61 47 47
MYC/MIZ-1 -0.003 0.1 -10000 0 -0.36 34 34
SMAD3/SMAD4 0.046 0.14 0.31 34 -0.41 14 48
IL10 -0.046 0.18 -10000 0 -0.43 59 59
PIASy/HDAC complex 0.009 0.051 -10000 0 -0.44 6 6
PIAS3 0.019 0.005 -10000 0 -10000 0 0
CDK2 0.015 0.048 -10000 0 -0.3 10 10
IL5 -0.047 0.18 -10000 0 -0.4 70 70
CDK4 0.019 0.029 -10000 0 -0.25 5 5
PIAS4 0.009 0.051 -10000 0 -0.44 6 6
ATF3 -0.02 0.13 -10000 0 -0.41 47 47
SMAD3/SMAD4/SP1 -0.01 0.18 -10000 0 -0.43 56 56
FOXG1 -0.007 0.083 -10000 0 -0.27 45 45
FOXO3 0.015 0.061 -10000 0 -0.4 8 8
FOXO1 0.007 0.081 -10000 0 -0.37 20 20
FOXO4 0.019 0.047 -10000 0 -0.37 5 5
heart looping -0.034 0.17 -10000 0 -0.53 40 40
CEBPB 0.004 0.073 -10000 0 -0.34 20 20
SMAD3/SMAD4/DLX1 -0.01 0.12 -10000 0 -0.35 32 32
MYOD1 -0.015 0.13 -10000 0 -0.47 36 36
SMAD3/SMAD4/HNF4 0.005 0.11 -10000 0 -0.34 28 28
SMAD3/SMAD4/GATA3 -0.062 0.2 -10000 0 -0.38 126 126
SnoN/SIN3/HDAC complex/NCoR1 0.005 0.07 -10000 0 -0.34 19 19
SMAD3/SMAD4/RUNX1-3/PEBPB2 -0.036 0.17 -10000 0 -0.39 69 69
SMAD3/SMAD4/SP1-3 -0.001 0.19 -10000 0 -0.51 44 44
MED15 0.018 0 -10000 0 -10000 0 0
SP1 -0.002 0.069 -10000 0 -0.32 5 5
SIN3B 0.017 0.012 -10000 0 -0.25 1 1
SIN3A 0.017 0.002 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 -0.02 0.15 -10000 0 -0.38 46 46
ITGB5 -0.032 0.23 -10000 0 -0.66 55 55
TGIF/SIN3/HDAC complex/CtBP 0.041 0.042 -10000 0 -0.22 1 1
SMAD3/SMAD4/AR -0.061 0.19 -10000 0 -0.39 117 117
AR -0.088 0.21 -10000 0 -0.52 104 104
negative regulation of cell growth -0.002 0.12 -10000 0 -0.38 29 29
SMAD3/SMAD4/MYOD -0.016 0.13 -10000 0 -0.32 59 59
E2F5 -0.014 0.12 -10000 0 -0.39 41 41
E2F4 0.017 0.017 -10000 0 -0.25 2 2
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.01 0.11 -10000 0 -0.3 24 24
SMAD2-3/SMAD4/FOXO1-3a-4 0.005 0.13 -10000 0 -0.36 41 41
TFDP1 0.011 0.042 -10000 0 -0.25 13 13
SMAD3/SMAD4/AP1 -0.064 0.24 -10000 0 -0.55 75 75
SMAD3/SMAD4/RUNX2 0.003 0.12 -10000 0 -0.38 27 27
TGIF2 0.009 0.066 -10000 0 -0.42 11 11
TGIF1 0.008 0.073 -10000 0 -0.52 10 10
ATF2 0.018 0 -10000 0 -10000 0 0
Presenilin action in Notch and Wnt signaling

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.025 0.076 -10000 0 -0.64 6 6
HDAC1 0.022 0.03 -10000 0 -0.53 1 1
AES 0.019 0.006 -10000 0 -10000 0 0
FBXW11 0.015 0.035 -10000 0 -0.43 3 3
DTX1 0.012 0.049 -10000 0 -0.34 9 9
LRP6/FZD1 0.009 0.076 -10000 0 -0.36 19 19
TLE1 -0.031 0.15 -10000 0 -0.45 56 56
AP1 -0.05 0.13 -10000 0 -0.3 82 82
NCSTN 0.017 0.023 -10000 0 -0.52 1 1
ADAM10 0.013 0.045 -10000 0 -0.39 6 6
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 -0.041 0.13 -10000 0 -0.42 8 8
NICD/RBPSUH 0.027 0.076 -10000 0 -0.63 6 6
WIF1 -0.024 0.098 -10000 0 -0.25 81 81
NOTCH1 -0.003 0.077 -10000 0 -0.67 6 6
PSENEN 0.017 0.012 -10000 0 -0.25 1 1
KREMEN2 -0.19 0.23 -10000 0 -0.41 257 257
DKK1 -0.12 0.19 -10000 0 -0.34 199 199
beta catenin/beta TrCP1 0.004 0.084 0.24 3 -0.35 17 20
APH1B 0.001 0.093 -10000 0 -0.51 17 17
APH1A 0.003 0.067 -10000 0 -0.29 25 25
AXIN1 0.006 0.04 0.24 8 -0.23 3 11
CtBP/CBP/TCF1/TLE1/AES 0.036 0.1 0.26 9 -0.26 1 10
PSEN1 0.013 0.052 -10000 0 -0.52 5 5
FOS -0.11 0.2 -10000 0 -0.37 171 171
JUN -0.034 0.15 -10000 0 -0.46 57 57
MAP3K7 0.019 0.022 -10000 0 -0.26 3 3
CTNNB1 -0.005 0.084 0.23 6 -0.38 15 21
MAPK3 0.016 0.026 -10000 0 -0.39 2 2
DKK2/LRP6/Kremen 2 -0.12 0.16 -10000 0 -0.33 186 186
HNF1A 0.017 0.026 -10000 0 -0.24 5 5
CTBP1 0.018 0.018 -10000 0 -0.26 2 2
MYC -0.086 0.34 -10000 0 -1.4 34 34
NKD1 0.01 0.059 -10000 0 -0.38 11 11
FZD1 0.003 0.082 -10000 0 -0.43 17 17
NOTCH1 precursor/Deltex homolog 1 0.024 0.085 -10000 0 -0.69 6 6
apoptosis -0.05 0.12 -10000 0 -0.3 82 82
Delta 1/NOTCHprecursor 0.027 0.076 -10000 0 -0.63 6 6
DLL1 0.017 0.012 -10000 0 -0.25 1 1
PPARD 0.004 0.045 -10000 0 -10000 0 0
Gamma Secretase 0.031 0.069 -10000 0 -0.25 25 25
APC 0.002 0.055 0.25 6 -0.4 5 11
DVL1 0.022 0.038 -10000 0 -0.38 3 3
CSNK2A1 0.016 0.023 -10000 0 -0.52 1 1
MAP3K7IP1 0.02 0.008 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.17 0.17 -10000 0 -0.34 249 249
LRP6 0.008 0.065 -10000 0 -0.38 13 13
CSNK1A1 0.016 0.024 -10000 0 -0.52 1 1
NLK 0.032 0.03 -10000 0 -0.26 1 1
CCND1 -0.22 0.51 -10000 0 -1.4 87 87
WNT1 0.017 0.023 -10000 0 -0.52 1 1
Axin1/APC/beta catenin 0.017 0.074 0.28 4 -0.35 6 10
DKK2 -0.026 0.14 -10000 0 -0.42 52 52
NOTCH1 precursor/DVL1 0.036 0.077 -10000 0 -0.57 6 6
GSK3B 0.018 0.001 -10000 0 -10000 0 0
FRAT1 0.01 0.068 -10000 0 -0.47 10 10
NOTCH/Deltex homolog 1 0.022 0.085 -10000 0 -0.7 6 6
PPP2R5D 0.013 0.036 0.27 5 -10000 0 5
MAPK1 0.016 0.033 -10000 0 -0.52 2 2
WNT1/LRP6/FZD1 0.009 0.079 -10000 0 -0.27 21 21
RBPJ 0.018 0 -10000 0 -10000 0 0
CREBBP 0.013 0.035 -10000 0 -0.52 2 2
TRAIL signaling pathway

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TNFSF10 -0.042 0.16 -10000 0 -0.46 67 67
positive regulation of NF-kappaB transcription factor activity -0.019 0.12 -10000 0 -0.37 52 52
MAP2K4 -0.013 0.12 -10000 0 -0.38 28 28
IKBKB 0.012 0.047 -10000 0 -0.31 10 10
TNFRSF10B 0.005 0.079 -10000 0 -0.46 14 14
TNFRSF10A -0.004 0.1 -10000 0 -0.47 24 24
SMPD1 -0.008 0.086 -10000 0 -0.4 10 10
IKBKG 0.018 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
TNFRSF10D 0.015 0.031 -10000 0 -0.32 4 4
TRAIL/TRAILR2 -0.026 0.14 -10000 0 -0.4 57 57
TRAIL/TRAILR3 -0.032 0.13 -10000 0 -0.37 54 54
TRAIL/TRAILR1 -0.032 0.14 -10000 0 -0.4 64 64
TRAIL/TRAILR4 -0.019 0.12 -10000 0 -0.37 52 52
TRAIL/TRAILR1/DAP3/GTP -0.013 0.12 -10000 0 -0.3 65 65
IKK complex -0.028 0.082 -10000 0 -0.4 17 17
RIPK1 0.017 0.023 -10000 0 -0.52 1 1
response to oxidative stress 0 0 -10000 0 -10000 0 0
DAP3/GTP 0.012 0.019 -10000 0 -0.27 2 2
MAPK3 -0.019 0.12 -10000 0 -0.37 52 52
MAP3K1 -0.01 0.12 -10000 0 -0.29 59 59
TRAILR4 (trimer) 0.015 0.031 -10000 0 -0.32 4 4
TRADD 0.016 0.026 -10000 0 -0.39 2 2
TRAILR1 (trimer) -0.004 0.1 -10000 0 -0.46 24 24
TRAIL/TRAILR1/FADD/TRADD/RIP/TRAF2 -0.004 0.11 -10000 0 -0.26 67 67
CFLAR 0.009 0.065 -10000 0 -0.44 10 10
MAPK1 -0.02 0.12 -10000 0 -0.37 53 53
TRAIL/TRAILR1/FADD/TRADD/RIP -0.002 0.12 -10000 0 -0.29 64 64
mol:ceramide -0.008 0.086 -10000 0 -0.4 10 10
FADD 0 0.067 -10000 0 -0.25 35 35
MAPK8 -0.007 0.12 -10000 0 -0.39 23 23
TRAF2 0.014 0.042 -10000 0 -0.45 4 4
TRAILR3 (trimer) -0.004 0.075 -10000 0 -0.26 41 41
CHUK 0.005 0.081 -10000 0 -0.5 13 13
TRAIL/TRAILR1/FADD -0.025 0.13 -10000 0 -0.34 65 65
DAP3 0.016 0.026 -10000 0 -0.39 2 2
CASP10 -0.05 0.12 0.26 1 -0.36 55 56
JNK cascade -0.019 0.12 -10000 0 -0.37 52 52
TRAIL (trimer) -0.042 0.16 -10000 0 -0.46 67 67
TNFRSF10C -0.004 0.075 -10000 0 -0.26 41 41
TRAIL/TRAILR1/DAP3/GTP/FADD -0.011 0.12 -10000 0 -0.29 66 66
TRAIL/TRAILR2/FADD -0.019 0.13 -10000 0 -0.34 58 58
cell death -0.008 0.086 -10000 0 -0.4 10 10
TRAIL/TRAILR2/FADD/TRADD/RIP/TRAF2 0 0.11 -10000 0 -0.27 59 59
TRAILR2 (trimer) 0.005 0.079 -10000 0 -0.46 14 14
CASP8 0.01 0.042 -10000 0 -10000 0 0
negative regulation of caspase activity 0 0 -10000 0 -10000 0 0
TRAIL/TRAILR2/FADD/TRADD/RIP 0.003 0.12 -10000 0 -0.29 56 56
Syndecan-3-mediated signaling events

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.003 0.068 -9999 0 -0.28 26 26
Syndecan-3/Src/Cortactin -0.046 0.16 -9999 0 -0.52 35 35
Syndecan-3/Neurocan -0.007 0.13 -9999 0 -0.57 24 24
POMC 0.001 0.072 -9999 0 -0.28 30 30
EGFR -0.079 0.18 -9999 0 -0.35 139 139
Syndecan-3/EGFR -0.049 0.16 -9999 0 -0.39 68 68
AGRP 0.016 0.029 -9999 0 -0.34 3 3
NCSTN 0.017 0.023 -9999 0 -0.52 1 1
PSENEN 0.017 0.012 -9999 0 -0.25 1 1
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B 0.001 0.093 -9999 0 -0.51 17 17
APH1A 0.003 0.067 -9999 0 -0.29 25 25
NCAN 0.007 0.053 -9999 0 -0.25 21 21
long-term memory -0.003 0.13 -9999 0 -0.55 25 25
Syndecan-3/IL8 -0.045 0.16 -9999 0 -0.42 58 58
PSEN1 0.013 0.052 -9999 0 -0.52 5 5
Src/Cortactin 0.014 0.054 -9999 0 -0.37 5 5
FYN 0.008 0.067 -9999 0 -0.41 12 12
limb bud formation -0.031 0.12 -9999 0 -0.59 24 24
MC4R 0.014 0.039 -9999 0 -0.36 5 5
SRC 0.015 0.035 -9999 0 -0.43 3 3
PTN -0.099 0.19 -9999 0 -0.37 158 158
FGFR/FGF/Syndecan-3 -0.032 0.12 -9999 0 -0.6 24 24
neuron projection morphogenesis -0.045 0.16 -9999 0 -0.5 35 35
Syndecan-3/AgRP -0.003 0.13 -9999 0 -0.56 25 25
Syndecan-3/AgRP/MC4R 0.006 0.13 -9999 0 -0.56 24 24
Fyn/Cortactin 0.009 0.068 -9999 0 -0.38 10 10
SDC3 -0.032 0.13 -9999 0 -0.61 24 24
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration -0.044 0.15 -9999 0 -0.41 58 58
IL8 -0.072 0.17 -9999 0 -0.34 135 135
Syndecan-3/Fyn/Cortactin -0.003 0.13 -9999 0 -0.57 25 25
Syndecan-3/CASK -0.03 0.12 -9999 0 -0.58 24 24
alpha-MSH/MC4R 0.012 0.057 -9999 0 -0.37 5 5
Gamma Secretase 0.033 0.069 -9999 0 -0.25 25 25
Nectin adhesion pathway

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.01 0.066 -9999 0 -0.52 8 8
alphaV beta3 Integrin 0.001 0.094 -9999 0 -0.4 22 22
PTK2 -0.001 0.15 -9999 0 -0.46 42 42
positive regulation of JNK cascade -0.028 0.086 -9999 0 -0.31 43 43
CDC42/GDP 0.021 0.13 -9999 0 -0.42 41 41
Rac1/GDP 0.023 0.13 -9999 0 -0.41 41 41
RAP1B 0.013 0.044 -9999 0 -0.32 8 8
RAP1A 0.012 0.057 -9999 0 -0.52 6 6
CTNNB1 0.001 0.09 -9999 0 -0.45 19 19
CDC42/GTP -0.033 0.11 -9999 0 -0.38 43 43
nectin-3/I-afadin -0.016 0.12 -9999 0 -0.41 41 41
RAPGEF1 0.009 0.15 -9999 0 -0.47 41 41
mol:GTP 0 0 -9999 0 -10000 0 0
CRK -0.001 0.17 -9999 0 -0.54 42 42
PDGFB-D/PDGFRB 0.01 0.066 -9999 0 -0.52 8 8
TLN1 0.004 0.099 -9999 0 -0.4 20 20
Rap1/GTP -0.031 0.093 -9999 0 -0.33 42 42
IQGAP1 0.018 0 -9999 0 -10000 0 0
Rap1/GTP/I-afadin 0.015 0.073 -9999 0 -0.28 28 28
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin -0.016 0.12 -9999 0 -0.41 41 41
PVR 0.008 0.059 -9999 0 -0.33 14 14
Necl-5(dimer) 0.008 0.059 -9999 0 -0.33 14 14
mol:GDP 0.011 0.16 -9999 0 -0.51 41 41
MLLT4 -0.006 0.11 -9999 0 -0.46 26 26
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
PI3K 0.001 0.13 -9999 0 -0.32 60 60
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.007 0.082 -9999 0 -0.38 21 21
positive regulation of lamellipodium assembly -0.028 0.088 -9999 0 -0.32 41 41
PVRL1 0.014 0.035 -9999 0 -0.3 6 6
PVRL3 -0.019 0.12 -9999 0 -0.4 46 46
PVRL2 0.002 0.089 -9999 0 -0.52 15 15
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
CDH1 -0.049 0.17 -9999 0 -0.48 70 70
CLDN1 -0.11 0.21 -9999 0 -0.4 165 165
JAM-A/CLDN1 -0.065 0.16 -9999 0 -0.32 128 128
SRC -0.01 0.18 -9999 0 -0.6 42 42
ITGB3 0.002 0.075 -9999 0 -0.32 25 25
nectin-1(dimer)/I-afadin/I-afadin 0.007 0.082 -9999 0 -0.38 21 21
FARP2 0.006 0.16 -9999 0 -0.51 43 43
RAC1 0.018 0 -9999 0 -10000 0 0
CTNNA1 0.017 0.023 -9999 0 -0.52 1 1
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) -0.006 0.11 -9999 0 -0.35 44 44
nectin-1/I-afadin 0.007 0.082 -9999 0 -0.38 21 21
nectin-2/I-afadin -0.002 0.1 -9999 0 -0.39 33 33
RAC1/GTP/IQGAP1/filamentous actin 0.024 0 -9999 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin -0.002 0.11 -9999 0 -0.34 43 43
CDC42/GTP/IQGAP1/filamentous actin 0.024 0 -9999 0 -10000 0 0
F11R 0.011 0.055 -9999 0 -0.36 10 10
positive regulation of filopodium formation -0.028 0.086 -9999 0 -0.31 43 43
alphaV/beta3 Integrin/Talin 0.006 0.13 -9999 0 -0.48 20 20
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin -0.002 0.1 -9999 0 -0.39 33 33
nectin-2(dimer)/I-afadin/I-afadin -0.002 0.1 -9999 0 -0.39 33 33
PIP5K1C -0.004 0.1 -9999 0 -0.42 21 21
VAV2 0.006 0.16 -9999 0 -0.52 41 41
RAP1/GDP 0.019 0.13 -9999 0 -0.38 42 42
ITGAV -0.002 0.1 -9999 0 -0.48 21 21
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin -0.01 0.12 -9999 0 -0.35 53 53
nectin-3(dimer)/I-afadin/I-afadin -0.016 0.12 -9999 0 -0.41 41 41
Rac1/GTP -0.032 0.11 -9999 0 -0.4 41 41
PTPRM -0.011 0.11 -9999 0 -0.31 47 47
E-cadherin/beta catenin/alpha catenin -0.012 0.13 -9999 0 -0.46 11 11
adherens junction assembly 0 0 -9999 0 -10000 0 0
CDC42 0.018 0 -9999 0 -10000 0 0
Regulation of Telomerase

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex -0.1 0.22 -10000 0 -0.56 74 74
RAD9A 0.018 0 -10000 0 -10000 0 0
AP1 -0.1 0.19 -10000 0 -0.43 107 107
IFNAR2 0.013 0.036 -10000 0 -0.3 6 6
AKT1 -0.053 0.12 -10000 0 -0.26 72 72
ER alpha/Oestrogen -0.12 0.18 -10000 0 -0.33 199 199
NFX1/SIN3/HDAC complex 0.038 0.048 -10000 0 -0.28 3 3
EGF -0.14 0.23 -10000 0 -0.42 193 193
SMG5 0.016 0.029 -10000 0 -0.34 3 3
SMG6 0.017 0.023 -10000 0 -0.52 1 1
SP3/HDAC2 0.019 0.041 -10000 0 -0.28 4 4
TERT/c-Abl -0.089 0.21 -10000 0 -0.53 69 69
SAP18 0.017 0.001 -10000 0 -10000 0 0
MRN complex 0.03 0.045 -10000 0 -0.3 9 9
WT1 -0.1 0.19 -10000 0 -0.35 172 172
WRN 0.012 0.049 -10000 0 -0.34 9 9
SP1 0.016 0.025 -10000 0 -0.53 1 1
SP3 0.017 0.003 -10000 0 -10000 0 0
TERF2IP 0.018 0 -10000 0 -10000 0 0
Telomerase/Nucleolin -0.099 0.17 -10000 0 -0.5 53 53
Mad/Max 0.021 0.023 -10000 0 -10000 0 0
TERT -0.1 0.23 -10000 0 -0.58 71 71
CCND1 -0.2 0.44 -10000 0 -1.1 89 89
MAX 0.017 0.004 -10000 0 -10000 0 0
RBBP7 0.01 0.051 -10000 0 -0.3 13 13
RBBP4 0.016 0.026 -10000 0 -0.39 2 2
TERF2 0.014 0.036 -10000 0 -0.46 3 3
PTGES3 0.016 0.026 -10000 0 -0.39 2 2
SIN3A 0.017 0.001 -10000 0 -10000 0 0
Telomerase/911 0.026 0.046 -10000 0 -0.35 2 2
CDKN1B -0.072 0.19 -10000 0 -0.43 84 84
RAD1 0.016 0.033 -10000 0 -0.52 2 2
XRCC5 0.018 0 -10000 0 -10000 0 0
XRCC6 0.017 0.012 -10000 0 -0.25 1 1
SAP30 0.012 0.053 -10000 0 -0.48 6 6
TRF2/PARP2 0.024 0.03 -10000 0 -0.36 3 3
UBE3A 0.015 0.033 -10000 0 -0.52 2 2
JUN -0.034 0.15 -10000 0 -0.46 57 57
E6 -0.001 0.003 -10000 0 -10000 0 0
HPV-16 E6/E6AP 0.011 0.025 -10000 0 -0.38 2 2
FOS -0.11 0.2 -10000 0 -0.37 171 171
IFN-gamma/IRF1 -0.075 0.16 -10000 0 -0.36 103 103
PARP2 0.017 0.012 -10000 0 -0.25 1 1
BLM -0.021 0.13 -10000 0 -0.4 48 48
Telomerase 0.025 0.06 -10000 0 -0.34 3 3
IRF1 -0.017 0.12 -10000 0 -0.37 40 40
ESR1 -0.16 0.24 -10000 0 -0.46 199 199
KU/TER 0.026 0.008 -10000 0 -10000 0 0
ATM/TRF2 0.025 0.023 -10000 0 -0.26 3 3
ubiquitin-dependent protein catabolic process 0.043 0.051 -10000 0 -0.31 3 3
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.043 0.052 -10000 0 -0.32 3 3
HDAC1 0.016 0.023 -10000 0 -0.52 1 1
HDAC2 0.008 0.055 -10000 0 -0.3 15 15
ATM 0.001 0.017 0.21 3 -10000 0 3
SMAD3 0.015 0.059 -10000 0 -0.36 11 11
ABL1 0.018 0 -10000 0 -10000 0 0
MXD1 0.014 0.031 -10000 0 -0.25 7 7
MRE11A 0.018 0 -10000 0 -10000 0 0
HUS1 0.016 0.02 -10000 0 -0.25 3 3
RPS6KB1 0.008 0.049 -10000 0 -0.25 18 18
TERT/NF kappa B1/14-3-3 -0.091 0.22 -10000 0 -0.55 74 74
NR2F2 -0.05 0.17 -10000 0 -0.44 79 79
MAPK3 0.019 0.041 -10000 0 -0.37 4 4
MAPK1 0.018 0.044 -10000 0 -0.37 5 5
TGFB1/TGF beta receptor Type II 0.017 0.023 -10000 0 -0.52 1 1
NFKB1 0.017 0.023 -10000 0 -0.52 1 1
HNRNPC 0.018 0 -10000 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0.001 0.017 0.21 3 -10000 0 3
NBN 0.015 0.035 -10000 0 -0.43 3 3
EGFR -0.079 0.18 -10000 0 -0.35 139 139
mol:Oestrogen 0 0.002 -10000 0 -10000 0 0
EGF/EGFR -0.15 0.2 -10000 0 -0.42 173 173
MYC -0.027 0.14 -10000 0 -0.43 52 52
IL2 0.01 0.052 -10000 0 -0.34 10 10
KU 0.026 0.008 -10000 0 -10000 0 0
RAD50 0.011 0.062 -10000 0 -0.52 7 7
HSP90AA1 0.013 0.045 -10000 0 -0.39 6 6
TGFB1 0.017 0.024 -10000 0 -0.52 1 1
TRF2/BLM -0.002 0.091 -10000 0 -0.35 30 30
FRAP1 0.018 0 -10000 0 -10000 0 0
KU/TERT -0.08 0.21 -10000 0 -0.55 57 57
SP1/HDAC2 0.019 0.048 -10000 0 -0.25 11 11
PINX1 0.016 0.02 -10000 0 -0.25 3 3
Telomerase/EST1A -0.1 0.17 -10000 0 -0.5 52 52
Smad3/Myc -0.003 0.099 -10000 0 -0.31 46 46
911 complex 0.034 0.024 -10000 0 -0.3 2 2
IFNG -0.092 0.18 -10000 0 -0.33 161 161
Telomerase/PinX1 -0.099 0.17 -10000 0 -0.5 53 53
Telomerase/AKT1/mTOR/p70S6K -0.008 0.092 -10000 0 -0.47 5 5
SIN3B 0.017 0.012 -10000 0 -0.25 1 1
YWHAE 0.016 0.029 -10000 0 -0.34 3 3
Telomerase/EST1B -0.1 0.17 -10000 0 -0.5 58 58
response to DNA damage stimulus 0.004 0.005 -10000 0 -10000 0 0
MRN complex/TRF2/Rap1 0.044 0.047 -10000 0 -0.27 11 11
TRF2/WRN 0.02 0.043 -10000 0 -0.35 6 6
Telomerase/hnRNP C1/C2 -0.099 0.17 -10000 0 -0.5 53 53
E2F1 0.005 0.071 -10000 0 -0.37 16 16
ZNFX1 0.007 0.071 -10000 0 -0.42 13 13
PIF1 0.015 0.026 -10000 0 -0.25 5 5
NCL 0.018 0 -10000 0 -10000 0 0
DKC1 0.016 0.02 -10000 0 -0.25 3 3
telomeric DNA binding 0 0 -10000 0 -10000 0 0
PDGFR-alpha signaling pathway

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.025 0.13 -9999 0 -0.5 37 37
PDGF/PDGFRA/CRKL -0.006 0.1 -9999 0 -0.37 36 36
positive regulation of JUN kinase activity 0.019 0.077 -9999 0 -0.26 34 34
CRKL 0.014 0.047 -9999 0 -0.52 4 4
PDGF/PDGFRA/Caveolin-3 -0.004 0.097 -9999 0 -0.37 33 33
AP1 -0.18 0.34 -9999 0 -0.91 84 84
mol:IP3 -0.015 0.1 -9999 0 -0.39 33 33
PLCG1 -0.015 0.1 -9999 0 -0.39 33 33
PDGF/PDGFRA/alphaV Integrin -0.017 0.12 -9999 0 -0.4 47 47
RAPGEF1 0.018 0 -9999 0 -10000 0 0
CRK 0.016 0.033 -9999 0 -0.52 2 2
mol:Ca2+ -0.015 0.1 -9999 0 -0.39 33 33
CAV3 0.016 0.029 -9999 0 -0.34 3 3
CAV1 -0.001 0.083 -9999 0 -0.33 29 29
SHC/Grb2/SOS1 0.02 0.077 -9999 0 -0.27 34 34
PDGF/PDGFRA/Shf -0.009 0.1 -9999 0 -0.34 42 42
FOS -0.17 0.34 -9999 0 -0.89 84 84
JUN -0.051 0.11 -9999 0 -0.38 52 52
oligodendrocyte development -0.017 0.12 -9999 0 -0.4 47 47
GRB2 0.016 0.024 -9999 0 -0.25 4 4
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
mol:DAG -0.015 0.1 -9999 0 -0.39 33 33
PDGF/PDGFRA -0.025 0.13 -9999 0 -0.5 37 37
actin cytoskeleton reorganization -0.01 0.11 -9999 0 -0.39 38 38
SRF 0.028 0.025 -9999 0 -0.35 1 1
SHC1 0.017 0.023 -9999 0 -0.52 1 1
PI3K -0.007 0.11 -9999 0 -0.34 49 49
PDGF/PDGFRA/Crk/C3G 0.01 0.085 -9999 0 -0.31 33 33
JAK1 -0.009 0.1 -9999 0 -0.38 37 37
ELK1/SRF 0.012 0.083 -9999 0 -0.29 34 34
SHB 0.008 0.067 -9999 0 -0.41 12 12
SHF 0.01 0.049 -9999 0 -0.27 15 15
CSNK2A1 0.025 0.029 -9999 0 -0.49 1 1
GO:0007205 -0.018 0.11 -9999 0 -0.42 33 33
SOS1 0.017 0.023 -9999 0 -0.52 1 1
Ras protein signal transduction 0.019 0.077 -9999 0 -0.26 34 34
PDGF/PDGFRA/SHB -0.01 0.11 -9999 0 -0.39 38 38
PDGF/PDGFRA/Caveolin-1 -0.016 0.12 -9999 0 -0.41 37 37
ITGAV -0.002 0.1 -9999 0 -0.48 21 21
ELK1 -0.018 0.1 -9999 0 -0.36 36 36
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
PDGF/PDGFRA/Crk -0.004 0.1 -9999 0 -0.38 33 33
JAK-STAT cascade -0.009 0.1 -9999 0 -0.38 37 37
cell proliferation -0.009 0.1 -9999 0 -0.34 42 42
Visual signal transduction: Cones

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.019 0.061 -9999 0 -0.27 21 21
RGS9BP -0.072 0.18 -9999 0 -0.41 111 111
mol:GTP 0 0 -9999 0 -10000 0 0
GRK1 0 0 -9999 0 -10000 0 0
mol:Na + -0.016 0.089 -9999 0 -0.33 24 24
mol:ADP 0.011 0.025 -9999 0 -0.31 3 3
GNAT2 -0.004 0.1 -9999 0 -0.49 23 23
RGS9-1/Gbeta5/R9AP -0.056 0.15 -9999 0 -0.34 96 96
mol:GDP 0 0 -9999 0 -10000 0 0
PDE6H/GNAT2/GTP -0.001 0.089 -9999 0 -0.33 33 33
GRK7 0.015 0.035 -9999 0 -0.43 3 3
CNGB3 -0.006 0.086 -9999 0 -0.3 39 39
Cone Metarhodopsin II/X-Arrestin 0.013 0.008 -9999 0 -0.17 1 1
mol:Ca2+ -0.009 0.083 -9999 0 -0.29 27 27
Cone PDE6 -0.043 0.14 -9999 0 -0.29 105 105
Cone Metarhodopsin II 0.01 0.019 -9999 0 -0.29 2 2
Na + (4 Units) -0.005 0.085 -9999 0 -0.29 27 27
GNAT2/GDP -0.049 0.14 -9999 0 -0.29 112 112
GNB5 0.005 0.081 -9999 0 -0.5 13 13
mol:GMP (4 units) 0.001 0.091 -9999 0 -0.31 37 37
Cone Transducin 0.02 0.065 -9999 0 -0.29 21 21
SLC24A2 0.014 0.044 -9999 0 -0.41 5 5
GNB3/GNGT2 0.025 0.026 -9999 0 -0.37 2 2
GNB3 0.017 0.012 -9999 0 -0.25 1 1
GNAT2/GTP -0.003 0.076 -9999 0 -0.35 23 23
CNGA3 -0.028 0.12 -9999 0 -0.31 73 73
ARR3 0.017 0.012 -9999 0 -0.25 1 1
absorption of light 0 0 -9999 0 -10000 0 0
cGMP/Cone CNG Channel -0.016 0.089 -9999 0 -0.33 24 24
mol:Pi -0.056 0.15 -9999 0 -0.34 96 96
Cone CNG Channel -0.014 0.11 -9999 0 -0.3 53 53
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
mol:K + 0.014 0.044 -9999 0 -0.41 5 5
RGS9 -0.033 0.13 -9999 0 -0.31 81 81
PDE6C 0.008 0.065 -9999 0 -0.38 13 13
GNGT2 0.016 0.033 -9999 0 -0.52 2 2
mol:cGMP (4 units) 0 0 -9999 0 -10000 0 0
PDE6H -0.001 0.093 -9999 0 -0.44 21 21
Class I PI3K signaling events

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP 0.019 0.071 0.24 15 -0.23 28 43
DAPP1 -0.038 0.14 -10000 0 -0.43 42 42
Src family/SYK family/BLNK-LAT/BTK-ITK -0.051 0.22 -10000 0 -0.54 62 62
mol:DAG 0.001 0.1 0.19 9 -0.23 49 58
HRAS 0.012 0.051 -10000 0 -0.41 7 7
RAP1A 0.012 0.057 -10000 0 -0.52 6 6
ARF5/GDP -0.016 0.11 -10000 0 -0.28 40 40
PLCG2 -0.017 0.11 -10000 0 -0.32 55 55
PLCG1 0.016 0.026 -10000 0 -0.39 2 2
ARF5 0.015 0.04 -10000 0 -0.52 3 3
mol:GTP -0.006 0.068 0.22 15 -0.25 25 40
ARF1/GTP -0.006 0.067 0.22 15 -0.24 25 40
RHOA 0.005 0.08 -10000 0 -0.52 12 12
YES1 0.007 0.07 -10000 0 -0.43 12 12
RAP1A/GTP 0.015 0.069 0.22 15 -0.25 25 40
ADAP1 -0.006 0.065 0.21 15 -0.24 25 40
ARAP3 -0.006 0.067 0.22 15 -0.25 25 40
INPPL1 0.012 0.055 -10000 0 -0.44 7 7
PREX1 -0.089 0.2 -10000 0 -0.44 124 124
ARHGEF6 -0.019 0.13 -10000 0 -0.41 45 45
ARHGEF7 0.016 0.02 -10000 0 -0.25 3 3
ARF1 0.017 0.023 -10000 0 -0.52 1 1
NRAS 0.005 0.076 -10000 0 -0.4 16 16
FYN 0.008 0.067 -10000 0 -0.41 12 12
ARF6 0.016 0.033 -10000 0 -0.52 2 2
FGR 0.017 0.017 -10000 0 -0.25 2 2
mol:Ca2+ 0.006 0.054 -10000 0 -10000 0 0
mol:IP4 0 0 -10000 0 -10000 0 0
TIAM1 0.006 0.073 -10000 0 -0.44 13 13
ZAP70 0.005 0.06 -10000 0 -0.26 24 24
mol:IP3 0.004 0.073 -10000 0 -0.18 24 24
LYN 0.014 0.031 -10000 0 -0.25 7 7
ARF1/GDP -0.015 0.1 -10000 0 -0.3 34 34
RhoA/GDP 0.003 0.099 0.23 6 -0.3 36 42
PDK1/Src/Hsp90 0.031 0.039 -10000 0 -0.3 6 6
BLNK -0.012 0.12 -10000 0 -0.51 30 30
actin cytoskeleton reorganization -0.006 0.12 0.23 6 -0.37 30 36
SRC 0.015 0.035 -10000 0 -0.43 3 3
PLEKHA2 0.014 0.043 -10000 0 -0.31 8 8
RAC1 0.018 0 -10000 0 -10000 0 0
PTEN -0.003 0.096 -10000 0 -0.5 19 19
HSP90AA1 0.013 0.045 -10000 0 -0.39 6 6
ARF6/GTP 0.019 0.069 0.24 14 -0.23 26 40
RhoA/GTP 0.015 0.082 0.22 14 -0.26 32 46
Src family/SYK family/BLNK-LAT -0.032 0.17 -10000 0 -0.47 47 47
BLK -0.019 0.1 -10000 0 -0.29 63 63
PDPK1 0.016 0.026 -10000 0 -0.39 2 2
CYTH1 -0.006 0.065 0.21 15 -0.24 25 40
HCK -0.005 0.11 -10000 0 -0.47 25 25
CYTH3 -0.006 0.065 0.21 15 -0.24 25 40
CYTH2 -0.006 0.065 0.21 15 -0.24 25 40
KRAS 0.009 0.065 -10000 0 -0.44 10 10
GO:0030676 0 0 -10000 0 -10000 0 0
FOXO3 0.025 0.052 0.18 12 -0.22 5 17
SGK1 -0.004 0.047 0.18 14 -0.21 6 20
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP -0.025 0.11 -10000 0 -0.29 41 41
SOS1 0.017 0.023 -10000 0 -0.52 1 1
SYK -0.023 0.14 -10000 0 -0.48 43 43
ARF6/GDP 0.005 0.085 0.24 6 -0.3 20 26
mol:PI-3-4-5-P3 -0.004 0.074 0.25 19 -0.25 25 44
ARAP3/RAP1A/GTP 0.014 0.07 0.22 15 -0.25 25 40
VAV1 -0.014 0.12 -10000 0 -0.39 42 42
mol:PI-3-4-P2 0.008 0.039 -10000 0 -0.32 7 7
RAS family/GTP/PI3K Class I 0.022 0.069 0.18 15 -0.25 25 40
PLEKHA1 0.012 0.052 -10000 0 -0.32 12 12
Rac1/GDP -0.014 0.1 -10000 0 -0.3 33 33
LAT 0.002 0.068 -10000 0 -0.27 29 29
Rac1/GTP -0.03 0.14 -10000 0 -0.4 42 42
ITK -0.008 0.1 0.22 14 -0.25 61 75
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma -0.008 0.13 0.22 8 -0.32 50 58
LCK -0.074 0.18 -10000 0 -0.4 117 117
BTK 0.007 0.091 0.22 14 -0.27 37 51
Insulin Pathway

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP -0.048 0.1 -9999 0 -0.26 87 87
TC10/GTP -0.022 0.063 -9999 0 -0.23 39 39
Insulin Receptor/Insulin/IRS1/Shp2 0.005 0.11 -9999 0 -0.29 63 63
HRAS 0.012 0.051 -9999 0 -0.41 7 7
APS homodimer 0 0 -9999 0 -10000 0 0
GRB14 -0.16 0.21 -9999 0 -0.36 247 247
FOXO3 -0.021 0.065 -9999 0 -0.71 4 4
AKT1 -0.068 0.14 -9999 0 -0.36 45 45
INSR 0.015 0.038 -9999 0 -0.38 4 4
Insulin Receptor/Insulin 0.036 0.079 -9999 0 -0.49 4 4
mol:GTP 0 0 -9999 0 -10000 0 0
GRB10 -0.003 0.097 -9999 0 -0.43 24 24
SORBS1 -0.032 0.14 -9999 0 -0.39 65 65
CRK 0.016 0.033 -9999 0 -0.52 2 2
PTPN1 0.023 0.075 -9999 0 -0.48 4 4
CAV1 -0.012 0.11 -9999 0 -0.27 69 69
CBL/APS/CAP/Crk-II/C3G 0.014 0.078 -9999 0 -0.25 35 35
Insulin Receptor/Insulin/IRS1/NCK2 0.004 0.11 -9999 0 -0.29 62 62
mol:GDP 0 0 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 -0.011 0.11 -9999 0 -0.25 80 80
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B 0.013 0.09 -9999 0 -0.46 6 6
RPS6KB1 -0.06 0.13 -9999 0 -0.33 50 50
PARD6A 0.004 0.081 -9999 0 -0.44 16 16
CBL 0.017 0.012 -9999 0 -0.25 1 1
tumor necrosis factor-mediated signaling pathway 0 0 -9999 0 -10000 0 0
DOK1 -0.014 0.11 -9999 0 -0.78 11 11
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
Insulin Receptor/Insuli/IRS1/GRB2/Shc -0.082 0.11 -9999 0 -0.33 51 51
HRAS/GTP -0.028 0.073 -9999 0 -0.33 7 7
Insulin Receptor 0.015 0.037 -9999 0 -0.38 4 4
Insulin Receptor/Insuli/IRS1/GRB2/SHC 0.014 0.1 -9999 0 -0.26 63 63
PRKCI -0.033 0.1 -9999 0 -0.52 21 21
Insulin Receptor/Insulin/GRB14/PDK1 -0.098 0.12 -9999 0 -0.36 50 50
SHC1 0.017 0.023 -9999 0 -0.52 1 1
negative regulation of MAPKKK cascade 0.009 0.12 -9999 0 -0.7 11 11
PI3K -0.005 0.11 -9999 0 -0.26 80 80
NCK2 0.015 0.026 -9999 0 -0.25 5 5
RHOQ 0.012 0.053 -9999 0 -0.48 6 6
mol:H2O2 -0.002 0.008 -9999 0 -10000 0 0
HRAS/GDP 0.009 0.036 -9999 0 -0.29 7 7
AKT2 -0.065 0.13 -9999 0 -0.36 43 43
PRKCZ -0.028 0.074 -9999 0 -0.53 9 9
SH2B2 0 0 -9999 0 -10000 0 0
SHC/SHIP -0.002 0.093 -9999 0 -0.25 63 63
F2RL2 -0.074 0.19 -9999 0 -0.44 105 105
TRIP10 0.013 0.048 -9999 0 -0.47 5 5
Insulin Receptor/Insulin/Shc 0.032 0.029 -9999 0 -0.27 4 4
TC10/GTP/CIP4/Exocyst 0.018 0.045 -9999 0 -0.31 9 9
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0.05 0.036 -9999 0 -0.3 4 4
RAPGEF1 0.018 0 -9999 0 -10000 0 0
RASA1 0.004 0.078 -9999 0 -0.42 16 16
NCK1 0.011 0.045 -9999 0 -0.28 12 12
CBL/APS/CAP/Crk-II 0.005 0.082 -9999 0 -0.28 35 35
TC10/GDP 0.009 0.039 -9999 0 -0.34 6 6
Insulin Receptor/Insulin/SHC/GRB10 0.032 0.064 -9999 0 -0.27 20 20
INPP5D -0.014 0.096 -9999 0 -0.27 62 62
SOS1 0.017 0.023 -9999 0 -0.52 1 1
SGK1 -0.01 0.012 -9999 0 -10000 0 0
mol:cAMP 0 0 -9999 0 -10000 0 0
PTPN11 0.017 0.023 -9999 0 -0.52 1 1
IRS1 -0.048 0.17 -9999 0 -0.49 68 68
p62DOK/RasGAP 0.009 0.12 -9999 0 -0.71 11 11
INS 0.017 0.025 -9999 0 -0.52 1 1
mol:PI-3-4-P2 -0.013 0.096 -9999 0 -0.27 62 62
GRB2 0.016 0.024 -9999 0 -0.25 4 4
EIF4EBP1 -0.067 0.13 -9999 0 -0.34 57 57
PTPRA 0.017 0.028 -9999 0 -0.4 2 2
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
TC10/GTP/CIP4 0.018 0.045 -9999 0 -0.31 9 9
PDPK1 0.016 0.026 -9999 0 -0.39 2 2
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos 0.009 0.095 -9999 0 -0.37 7 7
Insulin Receptor/Insulin/IRS1 -0.006 0.11 -9999 0 -0.29 62 62
Insulin Receptor/Insulin/IRS3 0.024 0.034 -9999 0 -0.37 3 3
Par3/Par6 -0.02 0.13 -9999 0 -0.29 86 86
IFN-gamma pathway

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 -0.012 0.1 -10000 0 -0.26 56 56
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
CRKL 0.014 0.047 -10000 0 -0.52 4 4
STAT1 (dimer)/Cbp/p300 -0.01 0.15 -10000 0 -0.46 27 27
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.015 0.061 -10000 0 -0.35 10 10
antigen processing and presentation of peptide antigen via MHC class I -0.055 0.1 -10000 0 -0.29 64 64
CaM/Ca2+ -0.007 0.097 -10000 0 -0.32 16 16
RAP1A 0.012 0.057 -10000 0 -0.52 6 6
STAT1 (dimer)/SHP2 -0.027 0.13 -10000 0 -0.36 35 35
AKT1 -0.012 0.11 -10000 0 -0.35 20 20
MAP2K1 -0.024 0.12 -10000 0 -0.35 34 34
MAP3K11 -0.011 0.098 -10000 0 -0.32 18 18
IFNGR1 0.01 0.034 -10000 0 -0.27 7 7
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII -0.03 0.14 -10000 0 -0.38 46 46
Rap1/GTP -0.03 0.07 -10000 0 -0.36 10 10
CRKL/C3G 0.023 0.034 -10000 0 -0.37 4 4
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP -0.009 0.11 -10000 0 -0.27 52 52
CEBPB -0.01 0.16 -10000 0 -0.45 32 32
STAT3 0.015 0.04 -10000 0 -0.52 3 3
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 0.001 0.11 -10000 0 -0.67 4 4
STAT1 -0.029 0.13 -10000 0 -0.37 35 35
CALM1 0.018 0 -10000 0 -10000 0 0
IFN-gamma (dimer) -0.086 0.17 -10000 0 -0.33 161 161
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
STAT1 (dimer)/PIAS1 -0.019 0.12 -10000 0 -0.4 24 24
CEBPB/PTGES2/Cbp/p300 -0.043 0.11 -10000 0 -0.38 33 33
mol:Ca2+ -0.014 0.1 -10000 0 -0.26 56 56
MAPK3 -0.016 0.14 -10000 0 -0.5 12 12
STAT1 (dimer) -0.07 0.15 -10000 0 -0.42 60 60
MAPK1 -0.017 0.14 -10000 0 -0.53 13 13
JAK2 0.007 0.056 -10000 0 -0.34 12 12
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
JAK1 0.008 0.059 -10000 0 -0.54 6 6
CAMK2D -0.005 0.1 -10000 0 -0.4 29 29
DAPK1 0 0.14 -10000 0 -0.51 20 20
SMAD7 0.004 0.073 -10000 0 -0.18 21 21
CBL/CRKL/C3G 0.005 0.095 -10000 0 -0.35 11 11
PI3K -0.022 0.11 -10000 0 -0.35 23 23
IFNG -0.086 0.17 -10000 0 -0.33 161 161
apoptosis -0.007 0.12 0.27 2 -0.38 23 25
CAMK2G 0.017 0.017 -10000 0 -0.25 2 2
STAT3 (dimer) 0.015 0.04 -10000 0 -0.52 3 3
CAMK2A 0.017 0.023 -10000 0 -0.52 1 1
CAMK2B -0.078 0.18 -10000 0 -0.36 133 133
FRAP1 -0.004 0.1 -10000 0 -0.34 16 16
PRKCD -0.01 0.11 -10000 0 -0.36 18 18
RAP1B 0.013 0.044 -10000 0 -0.32 8 8
negative regulation of cell growth -0.055 0.1 -10000 0 -0.29 64 64
PTPN2 0.016 0.024 -10000 0 -0.25 4 4
EP300 0.014 0.047 -10000 0 -0.52 4 4
IRF1 -0.007 0.15 -10000 0 -0.47 35 35
STAT1 (dimer)/PIASy -0.024 0.13 -10000 0 -0.42 24 24
SOCS1 0.01 0.064 -10000 0 -1.4 1 1
mol:GDP 0.003 0.091 -10000 0 -0.33 11 11
CASP1 -0.017 0.12 -10000 0 -0.27 71 71
PTGES2 0.017 0.012 -10000 0 -0.25 1 1
IRF9 0.017 0.085 -10000 0 -0.32 19 19
mol:PI-3-4-5-P3 -0.048 0.089 -10000 0 -0.33 24 24
RAP1/GDP -0.03 0.071 -10000 0 -0.37 10 10
CBL -0.01 0.097 -10000 0 -0.33 16 16
MAP3K1 -0.033 0.12 -10000 0 -0.35 39 39
PIAS1 0.017 0.012 -10000 0 -0.25 1 1
PIAS4 0.012 0.05 -10000 0 -0.43 6 6
antigen processing and presentation of peptide antigen via MHC class II -0.055 0.1 -10000 0 -0.29 64 64
PTPN11 -0.019 0.1 -10000 0 -0.26 56 56
CREBBP 0.016 0.033 -10000 0 -0.52 2 2
RAPGEF1 0.018 0 -10000 0 -10000 0 0
Ceramide signaling pathway

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.01 0.074 -10000 0 -0.37 18 18
MAP4K4 -0.003 0.11 -10000 0 -0.45 12 12
BAG4 0.002 0.07 -10000 0 -0.28 28 28
PKC zeta/ceramide -0.025 0.04 0.13 8 -0.12 1 9
NFKBIA 0.014 0.042 -10000 0 -0.45 4 4
BIRC3 -0.085 0.19 -10000 0 -0.41 128 128
BAX -0.003 0.022 -10000 0 -10000 0 0
RIPK1 0.017 0.023 -10000 0 -0.52 1 1
AKT1 0.017 0.051 -10000 0 -0.34 9 9
BAD -0.018 0.041 0.15 8 -0.18 1 9
SMPD1 0.008 0.06 -10000 0 -0.24 19 19
RB1 -0.028 0.07 0.15 8 -0.32 20 28
FADD/Caspase 8 0.007 0.1 -10000 0 -0.43 11 11
MAP2K4 -0.043 0.092 0.15 3 -0.28 55 58
NSMAF 0.009 0.065 -10000 0 -0.44 10 10
response to UV 0 0 -10000 0 -10000 0 0
RAF1 -0.01 0.04 0.15 8 -0.18 1 9
EGF -0.14 0.23 -10000 0 -0.42 193 193
mol:ceramide -0.027 0.044 0.15 9 -0.12 1 10
MADD 0.018 0 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid -0.028 0.13 -10000 0 -0.38 56 56
ASAH1 -0.036 0.15 -10000 0 -0.42 65 65
negative regulation of cell cycle -0.027 0.069 0.15 8 -0.31 20 28
cell proliferation -0.036 0.097 -10000 0 -0.23 83 83
BID -0.013 0.12 -10000 0 -0.55 17 17
MAP3K1 -0.041 0.084 0.15 7 -0.3 38 45
EIF2A -0.013 0.059 0.15 1 -0.24 18 19
TRADD 0.016 0.026 -10000 0 -0.39 2 2
CRADD 0.01 0.063 -10000 0 -0.49 8 8
MAPK3 0.002 0.039 0.15 2 -0.18 2 4
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 0.001 0.04 0.15 4 -0.18 2 6
Cathepsin D/ceramide -0.022 0.055 0.14 7 -0.23 11 18
FADD -0.006 0.11 -10000 0 -0.38 19 19
KSR1 -0.017 0.042 0.15 8 -0.2 1 9
MAPK8 -0.03 0.069 0.14 5 -0.19 53 58
PRKRA -0.017 0.042 0.15 8 -0.12 1 9
PDGFA -0.003 0.099 -10000 0 -0.44 24 24
TRAF2 0.014 0.042 -10000 0 -0.45 4 4
IGF1 -0.1 0.2 -10000 0 -0.41 146 146
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.026 0.044 0.15 9 -0.12 1 10
CTSD 0.002 0.075 -10000 0 -0.32 24 24
regulation of nitric oxide biosynthetic process 0.026 0.017 -10000 0 -0.37 1 1
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta -0.035 0.11 -10000 0 -0.25 83 83
PRKCD 0.014 0.042 -10000 0 -0.45 4 4
PRKCZ 0 0 -10000 0 -10000 0 0
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine -0.028 0.13 -10000 0 -0.38 56 56
RelA/NF kappa B1 0.026 0.017 -10000 0 -0.37 1 1
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0 0.091 -10000 0 -0.44 20 20
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD -0.005 0.11 -10000 0 -0.45 13 13
TNFR1A/BAG4/TNF-alpha 0.012 0.074 -10000 0 -0.31 18 18
mol:Sphingosine-1-phosphate 0.01 0.074 -10000 0 -0.37 18 18
MAP2K1 -0.002 0.039 -10000 0 -0.17 1 1
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.018 0 -10000 0 -10000 0 0
CYCS 0.027 0.065 0.16 76 -10000 0 76
TNFRSF1A 0.016 0.033 -10000 0 -0.52 2 2
NFKB1 0.017 0.023 -10000 0 -0.52 1 1
TNFR1A/BAG4 0.014 0.054 -10000 0 -0.37 5 5
EIF2AK2 -0.02 0.061 0.15 7 -0.26 18 25
TNF-alpha/TNFR1A/FAN 0.016 0.073 -10000 0 -0.31 21 21
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 0.02 0.062 -10000 0 -0.26 7 7
MAP2K2 -0.003 0.043 -10000 0 -0.24 4 4
SMPD3 0.005 0.072 -10000 0 -0.26 20 20
TNF -0.004 0.094 -10000 0 -0.36 31 31
PKC zeta/PAR4 0.001 0.065 -10000 0 -0.32 20 20
mol:PHOSPHOCHOLINE 0.055 0.1 0.22 132 -10000 0 132
NF kappa B1/RelA/I kappa B alpha 0.03 0.055 -10000 0 -0.25 18 18
AIFM1 0.027 0.065 0.16 76 -10000 0 76
BCL2 -0.11 0.22 -10000 0 -0.47 144 144
Reelin signaling pathway

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.023 0.028 -9999 0 -0.37 1 1
VLDLR -0.061 0.17 -9999 0 -0.4 100 100
CRKL 0.014 0.047 -9999 0 -0.52 4 4
LRPAP1 0.016 0.026 -9999 0 -0.39 2 2
FYN 0.008 0.067 -9999 0 -0.41 12 12
ITGA3 -0.003 0.096 -9999 0 -0.41 25 25
RELN/VLDLR/Fyn -0.023 0.12 -9999 0 -0.32 64 64
MAPK8IP1/MKK7/MAP3K11/JNK1 0.038 0.061 -9999 0 -0.26 18 18
AKT1 -0.011 0.11 -9999 0 -0.42 15 15
MAP2K7 0.017 0.023 -9999 0 -0.52 1 1
RAPGEF1 0.018 0 -9999 0 -10000 0 0
DAB1 0.018 0 -9999 0 -10000 0 0
RELN/LRP8/DAB1 -0.011 0.094 -9999 0 -0.28 42 42
LRPAP1/LRP8 -0.027 0.11 -9999 0 -0.37 37 37
RELN/LRP8/DAB1/Fyn -0.006 0.096 -9999 0 -0.26 48 48
DAB1/alpha3/beta1 Integrin -0.067 0.11 -9999 0 -0.37 26 26
long-term memory -0.002 0.1 -9999 0 -0.39 6 6
DAB1/LIS1 -0.028 0.12 -9999 0 -0.38 15 15
DAB1/CRLK/C3G -0.059 0.097 -9999 0 -0.37 16 16
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
DAB1/NCK2 -0.029 0.12 -9999 0 -0.36 16 16
ARHGEF2 0.004 0.079 -9999 0 -0.41 17 17
mol:Src family inhibitors PP1 and PP2 0 0 -9999 0 -10000 0 0
GRIN2A 0.017 0.012 -9999 0 -0.25 1 1
CDK5R1 0.014 0.031 -9999 0 -0.25 7 7
RELN 0.01 0.059 -9999 0 -0.38 11 11
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
RELN/LRP8/Fyn -0.02 0.11 -9999 0 -0.32 48 48
GRIN2A/RELN/LRP8/DAB1/Fyn 0.004 0.097 -9999 0 -0.26 47 47
MAPK8 0.015 0.04 -9999 0 -0.52 3 3
RELN/VLDLR/DAB1 -0.014 0.1 -9999 0 -0.28 59 59
ITGB1 0.014 0.044 -9999 0 -0.41 5 5
MAP1B -0.058 0.15 -9999 0 -0.42 40 40
RELN/LRP8 -0.015 0.1 -9999 0 -0.31 43 43
GRIN2B/RELN/LRP8/DAB1/Fyn -0.009 0.11 -9999 0 -0.26 65 65
PI3K 0.005 0.082 -9999 0 -0.37 21 21
mol:PP2 0 0 -9999 0 -10000 0 0
alpha3/beta1 Integrin 0.009 0.078 -9999 0 -0.39 17 17
RAP1A -0.019 0.12 -9999 0 -0.36 17 17
PAFAH1B1 0.017 0.023 -9999 0 -0.52 1 1
MAPK8IP1 0.011 0.048 -9999 0 -0.3 11 11
CRLK/C3G 0.023 0.034 -9999 0 -0.37 4 4
GRIN2B -0.007 0.1 -9999 0 -0.44 28 28
NCK2 0.015 0.026 -9999 0 -0.25 5 5
neuron differentiation 0.011 0.079 -9999 0 -0.31 5 5
neuron adhesion -0.016 0.12 -9999 0 -0.44 10 10
LRP8 -0.057 0.16 -9999 0 -0.34 110 110
GSK3B -0.004 0.1 -9999 0 -0.4 14 14
RELN/VLDLR/DAB1/Fyn -0.009 0.11 -9999 0 -0.27 64 64
MAP3K11 0.015 0.035 -9999 0 -0.43 3 3
RELN/VLDLR/DAB1/P13K -0.016 0.11 -9999 0 -0.26 74 74
CDK5 0.016 0.026 -9999 0 -0.39 2 2
MAPT -0.089 0.2 -9999 0 -0.48 107 107
neuron migration -0.013 0.12 -9999 0 -0.36 24 24
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 0.011 0.079 -9999 0 -0.32 5 5
RELN/VLDLR -0.045 0.14 -9999 0 -0.28 113 113
Effects of Botulinum toxin

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A 0.009 0.027 -9999 0 -0.17 12 12
UniProt:P19321 0 0 -9999 0 -10000 0 0
RIMS1/UNC13B 0.007 0.062 -9999 0 -0.4 3 3
STXBP1 0.017 0.017 -9999 0 -0.25 2 2
ACh/CHRNA1 0.008 0.046 -9999 0 -0.3 9 9
RAB3GAP2/RIMS1/UNC13B 0.019 0.054 -9999 0 -0.32 4 4
mol:Ca2+ 0 0 -9999 0 -10000 0 0
UniProt:P30996 0 0 -9999 0 -10000 0 0
UniProt:Q60393 0 0 -9999 0 -10000 0 0
CST086 0 0 -9999 0 -10000 0 0
RIMS1 -0.003 0.073 -9999 0 -0.25 41 41
mol:ACh 0.002 0.026 -9999 0 -0.1 24 24
RAB3GAP2 0.017 0.023 -9999 0 -0.52 1 1
STX1A/SNAP25/VAMP2 0.018 0.053 -9999 0 -0.25 3 3
UniProt:P10844 0 0 -9999 0 -10000 0 0
muscle contraction 0.008 0.046 -9999 0 -0.29 9 9
UNC13B 0.011 0.049 -9999 0 -0.3 12 12
CHRNA1 0.01 0.064 -9999 0 -0.46 9 9
UniProt:P10845 0 0 -9999 0 -10000 0 0
ACh/Synaptotagmin 1 -0.1 0.14 -9999 0 -0.22 265 265
SNAP25 -0.008 0.055 -9999 0 -0.29 15 15
VAMP2 0.007 0.011 -9999 0 -0.26 1 1
SYT1 -0.17 0.21 -9999 0 -0.36 265 265
UniProt:Q00496 0 0 -9999 0 -10000 0 0
STXIA/STXBP1 0.019 0.026 -9999 0 -0.27 1 1
STX1A/SNAP25 fragment 1/VAMP2 0.018 0.053 -9999 0 -0.25 3 3
IL2 signaling events mediated by STAT5

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.01 0.048 -9999 0 -0.25 17 17
ELF1 -0.012 0.12 -9999 0 -0.37 43 43
CCNA2 -0.026 0.13 -9999 0 -0.39 57 57
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
JAK3 0.018 0 -9999 0 -10000 0 0
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
JAK1 0.012 0.057 -9999 0 -0.52 6 6
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.01 0.14 -9999 0 -0.45 23 23
SHC1 0.018 0.023 -9999 0 -0.52 1 1
SP1 0.015 0.07 -9999 0 -0.36 16 16
IL2RA -0.035 0.2 -9999 0 -0.68 43 43
IL2RB -0.016 0.12 -9999 0 -0.43 40 40
SOS1 0.017 0.023 -9999 0 -0.52 1 1
IL2RG -0.001 0.078 -9999 0 -0.28 35 35
G1/S transition of mitotic cell cycle -0.026 0.2 -9999 0 -0.57 47 47
PTPN11 0.018 0.023 -9999 0 -0.52 1 1
CCND2 0.009 0.14 -9999 0 -0.77 16 16
LCK -0.073 0.18 -9999 0 -0.4 117 117
GRB2 0.016 0.024 -9999 0 -0.25 4 4
IL2 0.012 0.051 -9999 0 -0.33 10 10
CDK6 -0.019 0.1 -9999 0 -0.29 63 63
CCND3 0.021 0.12 -9999 0 -0.45 13 13
FOXA2 and FOXA3 transcription factor networks

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL 0.019 0.27 -9999 0 -0.76 29 29
PCK1 0.019 0.2 -9999 0 -0.95 6 6
HNF4A 0.033 0.27 -9999 0 -0.76 23 23
KCNJ11 -0.015 0.38 -9999 0 -1 50 50
AKT1 0.011 0.17 -9999 0 -0.43 30 30
response to starvation 0.006 0.003 -9999 0 -10000 0 0
DLK1 0.019 0.3 -9999 0 -0.77 30 30
NKX2-1 0.074 0.14 -9999 0 -10000 0 0
ACADM 0.01 0.29 -9999 0 -0.77 36 36
TAT 0.018 0.17 -9999 0 -0.53 8 8
CEBPB 0.01 0.071 -9999 0 -0.33 20 20
CEBPA 0.011 0.085 -9999 0 -0.5 14 14
TTR -0.041 0.28 -9999 0 -0.75 40 40
PKLR 0.022 0.26 -9999 0 -0.72 27 27
APOA1 0.032 0.3 -9999 0 -0.83 25 25
CPT1C 0 0.3 -9999 0 -0.82 39 39
ALAS1 0.039 0.19 -9999 0 -1.6 2 2
TFRC -0.047 0.39 -9999 0 -1.2 45 45
FOXF1 -0.002 0.062 -9999 0 -0.3 20 20
NF1 0.023 0.039 -9999 0 -0.46 3 3
HNF1A (dimer) 0.03 0.047 -9999 0 -0.24 5 5
CPT1A 0.007 0.3 -9999 0 -0.84 33 33
HMGCS1 0.018 0.27 -9999 0 -0.72 30 30
NR3C1 0.007 0.1 -9999 0 -0.5 19 19
CPT1B 0.022 0.26 -9999 0 -0.73 27 27
chromatin remodeling 0 0 -9999 0 -10000 0 0
SP1 0.02 0.04 -9999 0 -0.26 7 7
GCK 0.017 0.27 -9999 0 -0.73 31 31
CREB1 0.02 0.036 -9999 0 -0.51 1 1
IGFBP1 0.028 0.16 -9999 0 -0.73 4 4
PDX1 0.035 0.26 -9999 0 -1.1 14 14
UCP2 -0.025 0.35 -9999 0 -0.88 54 54
ALDOB 0.024 0.29 -9999 0 -0.79 27 27
AFP -0.049 0.15 -9999 0 -0.53 11 11
BDH1 0.011 0.28 -9999 0 -0.74 36 36
HADH 0.021 0.3 -9999 0 -0.8 31 31
F2 0.032 0.3 -9999 0 -0.83 24 24
HNF1A 0.03 0.047 -9999 0 -0.24 5 5
G6PC 0.035 0.096 -9999 0 -1.3 1 1
SLC2A2 0.042 0.22 -9999 0 -0.84 9 9
INS 0.002 0.028 -9999 0 -0.53 1 1
FOXA1 -0.081 0.21 -9999 0 -0.49 108 108
FOXA3 -0.016 0.13 -9999 0 -0.44 20 20
FOXA2 0.032 0.35 -9999 0 -0.85 33 33
ABCC8 -0.2 0.52 -9999 0 -0.9 170 170
ALB -0.055 0.17 -9999 0 -0.76 12 12
RXR and RAR heterodimerization with other nuclear receptor

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.003 0.062 -9999 0 -1.2 1 1
VDR -0.003 0.1 -9999 0 -0.51 21 21
FAM120B 0.016 0.033 -9999 0 -0.52 2 2
RXRs/LXRs/DNA/9cRA 0.012 0.13 -9999 0 -0.41 22 22
RXRs/LXRs/DNA/Oxysterols -0.001 0.18 -9999 0 -0.44 69 69
MED1 0 0.067 -9999 0 -0.25 34 34
mol:9cRA -0.001 0.021 -9999 0 -10000 0 0
RARs/THRs/DNA/Src-1 -0.003 0.11 -9999 0 -0.28 62 62
RXRs/NUR77 0.031 0.076 -9999 0 -0.28 19 19
RXRs/PPAR 0.008 0.093 -9999 0 -0.33 19 19
NCOR2 0.018 0 -9999 0 -10000 0 0
VDR/VDR/Vit D3 -0.002 0.075 -9999 0 -0.37 21 21
RARs/VDR/DNA/Vit D3 0.004 0.095 -9999 0 -0.27 47 47
RARA 0.011 0.057 -9999 0 -0.4 9 9
NCOA1 0.012 0.057 -9999 0 -0.52 6 6
VDR/VDR/DNA -0.003 0.1 -9999 0 -0.51 21 21
RARs/RARs/DNA/9cRA 0.005 0.077 -9999 0 -0.27 29 29
RARG 0.017 0.023 -9999 0 -0.52 1 1
RPS6KB1 0.004 0.055 -9999 0 -0.4 1 1
RARs/THRs/DNA/SMRT 0 0.1 -9999 0 -0.27 57 57
THRA -0.01 0.11 -9999 0 -0.38 37 37
mol:Bile acids 0 0 -9999 0 -10000 0 0
VDR/Vit D3/DNA -0.002 0.075 -9999 0 -0.37 21 21
RXRs/PPAR/9cRA/PGJ2/DNA 0.022 0.084 -9999 0 -0.29 18 18
NR1H4 0.015 0.031 -9999 0 -0.32 4 4
RXRs/LXRs/DNA 0.037 0.11 -9999 0 -0.42 10 10
NR1H2 0.018 0.017 -9999 0 -10000 0 0
NR1H3 0.008 0.07 -9999 0 -0.44 11 11
RXRs/VDR/DNA/Vit D3 0.021 0.088 -9999 0 -0.27 37 37
NR4A1 0.01 0.049 -9999 0 -0.27 15 15
mol:ATRA 0 0 -9999 0 -10000 0 0
RXRs/FXR/9cRA/MED1 0.016 0.063 -9999 0 -0.26 9 9
RXRG 0.004 0.084 -9999 0 -0.47 15 15
RXR alpha/CCPG 0.023 0.041 -9999 0 -0.38 5 5
RXRA 0.014 0.045 -9999 0 -0.54 3 3
RXRB 0.014 0.045 -9999 0 -0.52 3 3
THRB -0.001 0.097 -9999 0 -0.48 20 20
PPARG -0.036 0.14 -9999 0 -0.33 81 81
PPARD 0.017 0.017 -9999 0 -0.25 2 2
TNF -0.01 0.23 -9999 0 -0.8 28 28
mol:Oxysterols 0 0.018 -9999 0 -10000 0 0
cholesterol transport 0 0.18 -9999 0 -0.43 69 69
PPARA 0.012 0.047 -9999 0 -0.31 10 10
mol:Vit D3 0 0 -9999 0 -10000 0 0
RARB -0.025 0.13 -9999 0 -0.36 60 60
RXRs/NUR77/BCL2 -0.04 0.12 -9999 0 -0.24 130 130
SREBF1 -0.052 0.33 -9999 0 -1 51 51
RXRs/RXRs/DNA/9cRA 0.022 0.084 -9999 0 -0.29 18 18
ABCA1 -0.01 0.24 -9999 0 -0.84 28 28
RARs/THRs 0.001 0.12 -9999 0 -0.29 57 57
RXRs/FXR 0.034 0.074 -9999 0 -0.28 19 19
BCL2 -0.11 0.22 -9999 0 -0.47 144 144
TCGA08_rtk_signaling

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.017 0.13 -10000 0 -0.48 37 37
HRAS 0.012 0.051 -10000 0 -0.41 7 7
EGFR -0.079 0.18 -10000 0 -0.35 139 139
AKT 0.014 0.079 -10000 0 -0.27 24 24
FOXO3 0.011 0.053 -10000 0 -0.37 9 9
AKT1 0.011 0.053 -10000 0 -0.37 9 9
FOXO1 0 0.092 -10000 0 -0.46 19 19
AKT3 -0.006 0.084 -10000 0 -0.28 43 43
FOXO4 0.017 0.023 -10000 0 -0.52 1 1
MET 0 0.075 -10000 0 -0.29 31 31
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
PIK3CB 0.012 0.055 -10000 0 -0.44 7 7
NRAS 0.005 0.076 -10000 0 -0.4 16 16
PIK3CG -0.007 0.1 -10000 0 -0.41 31 31
PIK3R3 0 0.091 -10000 0 -0.43 21 21
PIK3R2 0.018 0 -10000 0 -10000 0 0
NF1 0.015 0.035 -10000 0 -0.43 3 3
RAS -0.027 0.097 0.21 1 -0.27 47 48
ERBB2 -0.027 0.12 -10000 0 -0.31 72 72
proliferation/survival/translation -0.028 0.057 0.23 10 -0.17 3 13
PI3K -0.019 0.099 0.18 5 -0.24 62 67
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
KRAS 0.009 0.065 -10000 0 -0.44 10 10
FOXO 0.039 0.038 -10000 0 -0.18 2 2
AKT2 0.017 0.012 -10000 0 -0.25 1 1
PTEN -0.002 0.1 -10000 0 -0.52 19 19
Aurora B signaling

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex 0.01 0.079 -9999 0 -0.29 24 24
STMN1 0.002 0.088 -9999 0 -0.38 22 22
Aurora B/RasGAP/Survivin -0.011 0.12 -9999 0 -0.34 53 53
Chromosomal passenger complex/Cul3 protein complex -0.052 0.14 -9999 0 -0.37 49 49
BIRC5 -0.038 0.16 -9999 0 -0.43 67 67
DES -0.026 0.13 -9999 0 -0.68 16 16
Aurora C/Aurora B/INCENP 0.015 0.062 -9999 0 -0.29 14 14
Aurora B/TACC1 -0.005 0.088 -9999 0 -0.32 32 32
Aurora B/PP2A 0.019 0.042 -9999 0 -0.39 3 3
mol:GTP 0 0 -9999 0 -10000 0 0
CBX5 0.011 0.033 -9999 0 -0.21 9 9
mitotic metaphase/anaphase transition 0 0.005 -9999 0 -10000 0 0
NDC80 -0.014 0.12 -9999 0 -0.4 39 39
Cul3 protein complex -0.048 0.14 -9999 0 -0.33 93 93
KIF2C -0.061 0.24 -9999 0 -0.61 64 64
PEBP1 0.013 0.047 -9999 0 -0.53 4 4
KIF20A -0.027 0.14 -9999 0 -0.46 49 49
mol:GDP 0 0 -9999 0 -10000 0 0
Aurora B/RasGAP 0.011 0.07 -9999 0 -0.38 13 13
SEPT1 0.008 0.052 -9999 0 -0.27 17 17
SMC2 0.003 0.077 -9999 0 -0.36 20 20
SMC4 0.014 0.04 -9999 0 -0.34 6 6
NSUN2/NPM1/Nucleolin 0.015 0.082 -9999 0 -0.87 3 3
PSMA3 0.017 0.012 -9999 0 -0.25 1 1
G2/M transition of mitotic cell cycle 0 0.003 -9999 0 -10000 0 0
H3F3B 0.013 0.04 -9999 0 -0.33 5 5
AURKB 0.009 0.058 -9999 0 -0.32 14 14
AURKC 0.008 0.053 -9999 0 -0.27 18 18
CDCA8 -0.016 0.12 -9999 0 -0.4 42 42
cytokinesis -0.049 0.26 -9999 0 -0.74 49 49
Aurora B/Septin1 -0.036 0.23 -9999 0 -0.7 45 45
AURKA -0.012 0.11 -9999 0 -0.41 36 36
INCENP 0.001 0.082 -9999 0 -0.37 22 22
KLHL13 -0.095 0.2 -9999 0 -0.39 146 146
BUB1 -0.052 0.17 -9999 0 -0.44 81 81
hSgo1/Aurora B/Survivin -0.016 0.14 -9999 0 -0.38 52 52
EVI5 0.013 0.047 -9999 0 -0.52 4 4
RhoA/GTP -0.045 0.24 -9999 0 -0.67 54 54
SGOL1 -0.01 0.11 -9999 0 -0.38 37 37
CENPA -0.041 0.21 -9999 0 -0.6 49 49
NCAPG 0 0 -9999 0 -10000 0 0
Aurora B/HC8 Proteasome 0.02 0.041 -9999 0 -0.39 3 3
NCAPD2 0.012 0.04 -9999 0 -0.25 12 12
Aurora B/PP1-gamma 0.018 0.05 -9999 0 -0.38 6 6
RHOA 0.005 0.08 -9999 0 -0.52 12 12
NCAPH -0.008 0.11 -9999 0 -0.46 29 29
NPM1 0.012 0.052 -9999 0 -0.6 3 3
RASA1 0.004 0.078 -9999 0 -0.42 16 16
KLHL9 -0.001 0.096 -9999 0 -0.49 19 19
mitotic prometaphase -0.001 0.005 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.02 0.041 -9999 0 -0.38 3 3
PPP1CC 0.015 0.04 -9999 0 -0.52 3 3
Centraspindlin -0.053 0.27 -9999 0 -0.69 60 60
RhoA/GDP 0.004 0.058 -9999 0 -0.38 12 12
NSUN2 0.012 0.054 -9999 0 -0.6 3 3
MYLK 0.003 0.07 -9999 0 -0.33 20 20
KIF23 -0.024 0.14 -9999 0 -0.45 47 47
VIM -0.01 0.11 -9999 0 -0.38 34 34
RACGAP1 -0.004 0.1 -9999 0 -0.5 22 22
mitosis 0 0 -9999 0 -10000 0 0
NCL 0.013 0.052 -9999 0 -0.6 3 3
Chromosomal passenger complex -0.045 0.22 -9999 0 -0.59 54 54
Chromosomal passenger complex/EVI5 -0.012 0.15 -9999 0 -0.36 62 62
TACC1 -0.022 0.13 -9999 0 -0.41 49 49
PPP2R5D 0.016 0.02 -9999 0 -0.25 3 3
CUL3 0.01 0.06 -9999 0 -0.43 9 9
response to DNA damage stimulus 0 0 -9999 0 -10000 0 0
p75(NTR)-mediated signaling

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.019 0.05 -10000 0 -0.37 8 8
Necdin/E2F1 -0.027 0.14 -10000 0 -0.38 62 62
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E -0.01 0.11 -10000 0 -0.27 78 78
NGF (dimer)/p75(NTR)/BEX1 -0.016 0.075 -10000 0 -0.29 12 12
NT-4/5 (dimer)/p75(NTR) 0.004 0.045 -10000 0 -0.2 23 23
IKBKB 0.012 0.047 -10000 0 -0.31 10 10
AKT1 0.01 0.072 -10000 0 -0.25 30 30
IKBKG 0.018 0 -10000 0 -10000 0 0
BDNF -0.016 0.091 -10000 0 -0.26 64 64
MGDIs/NGR/p75(NTR)/LINGO1 -0.003 0.086 -10000 0 -0.31 22 22
FURIN 0.004 0.076 -10000 0 -0.37 19 19
proBDNF (dimer)/p75(NTR)/Sortilin 0.004 0.075 -10000 0 -0.33 11 11
LINGO1 -0.019 0.095 -10000 0 -0.26 69 69
Sortilin/TRAF6/NRIF -0.017 0.056 -10000 0 -0.33 5 5
proBDNF (dimer) -0.016 0.09 -10000 0 -0.26 64 64
NTRK1 0.01 0.053 -10000 0 -0.32 12 12
RTN4R 0.001 0.087 -10000 0 -0.41 21 21
neuron apoptosis 0.003 0.1 -10000 0 -0.47 7 7
IRAK1 0.015 0.029 -10000 0 -0.25 6 6
SHC1 0.013 0.04 -10000 0 -0.31 4 4
ARHGDIA 0.016 0.029 -10000 0 -0.34 3 3
RhoA/GTP 0.004 0.058 -10000 0 -0.38 12 12
Gamma Secretase 0.033 0.069 -10000 0 -0.25 25 25
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 0.001 0.095 -10000 0 -0.3 43 43
MAGEH1 -0.019 0.14 -10000 0 -0.52 36 36
proNGF (dimer)/p75(NTR)/Sortilin/Necdin -0.013 0.11 -10000 0 -0.3 65 65
Mammalian IAPs/DIABLO -0.024 0.11 -10000 0 -0.28 76 76
proNGF (dimer) 0 0 -10000 0 -10000 0 0
MAGED1 -0.008 0.11 -10000 0 -0.48 27 27
APP -0.029 0.14 -10000 0 -0.43 56 56
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
ZNF274 0.013 0.044 -10000 0 -0.32 8 8
RhoA/GDP/RHOGDI 0.017 0.057 -10000 0 -0.27 16 16
NGF 0 0 -10000 0 -10000 0 0
cell cycle arrest 0.006 0.054 -10000 0 -0.26 10 10
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK 0.026 0.04 -10000 0 -0.23 9 9
NT-4/5 (dimer)/p75(NTR)/TRAF6 0.016 0.041 -10000 0 -0.31 4 4
NCSTN 0.017 0.023 -10000 0 -0.52 1 1
mol:GTP -0.016 0.089 -10000 0 -0.31 31 31
PSENEN 0.017 0.012 -10000 0 -0.25 1 1
mol:ceramide 0.014 0.056 -10000 0 -0.29 12 12
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs 0.022 0.049 -10000 0 -0.26 1 1
p75(NTR)/beta APP -0.017 0.11 -10000 0 -0.37 39 39
BEX1 -0.039 0.11 -10000 0 -0.26 108 108
mol:GDP 0.002 0.037 -10000 0 -0.32 3 3
NGF (dimer) -0.038 0.13 -10000 0 -0.29 101 101
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI 0.009 0.081 -10000 0 -0.28 23 23
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
RAC1/GTP 0.015 0.032 -10000 0 -0.27 3 3
MYD88 0.013 0.048 -10000 0 -0.47 5 5
CHUK 0.005 0.081 -10000 0 -0.5 13 13
NGF (dimer)/p75(NTR)/PKA -0.016 0.09 -10000 0 -0.31 31 31
RHOB -0.041 0.17 -10000 0 -0.52 58 58
RHOA 0.005 0.08 -10000 0 -0.52 12 12
MAGE-G1/E2F1 0.018 0.051 -10000 0 -0.37 7 7
NT3 (dimer) -0.021 0.11 -10000 0 -0.28 68 68
TP53 -0.001 0.098 -10000 0 -0.37 12 12
PRDM4 0.017 0.049 -10000 0 -0.28 10 10
BDNF (dimer) -0.12 0.2 -10000 0 -0.37 173 173
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
SORT1 0.009 0.065 -10000 0 -0.44 10 10
activation of caspase activity -0.013 0.11 -10000 0 -0.27 78 78
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 0.022 0.052 -10000 0 -0.28 11 11
RHOC 0.015 0.04 -10000 0 -0.52 3 3
XIAP 0 0 -10000 0 -10000 0 0
MAPK10 0 0.095 -10000 0 -0.32 11 11
DIABLO 0.018 0 -10000 0 -10000 0 0
SMPD2 0.014 0.056 -10000 0 -0.3 12 12
APH1B 0.001 0.093 -10000 0 -0.51 17 17
APH1A 0.003 0.067 -10000 0 -0.29 25 25
proNGF (dimer)/p75(NTR)/Sortilin 0.011 0.055 -10000 0 -0.31 10 10
PSEN1 0.013 0.052 -10000 0 -0.52 5 5
APAF-1/Pro-Caspase 9 0.022 0.041 -10000 0 -0.37 5 5
NT3 (dimer)/p75(NTR) -0.009 0.09 -10000 0 -0.4 13 13
MAPK8 0.014 0.08 -10000 0 -0.3 6 6
MAPK9 0.005 0.096 -10000 0 -0.37 10 10
APAF1 0.012 0.051 -10000 0 -0.41 7 7
NTF3 -0.021 0.11 -10000 0 -0.28 68 68
NTF4 0 0 -10000 0 -10000 0 0
NDN -0.044 0.17 -10000 0 -0.49 65 65
RAC1/GDP 0.013 0 -10000 0 -10000 0 0
RhoA-B-C/GDP -0.028 0.12 -10000 0 -0.25 96 96
p75 CTF/Sortilin/TRAF6/NRIF 0.036 0.048 -10000 0 -0.27 10 10
RhoA-B-C/GTP -0.016 0.089 -10000 0 -0.31 31 31
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.021 0.07 -10000 0 -0.26 14 14
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 0.015 0.071 -10000 0 -0.29 12 12
PRKACB -0.036 0.14 -10000 0 -0.34 79 79
proBDNF (dimer)/p75 ECD 0.002 0.064 -10000 0 -0.34 2 2
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
BIRC3 -0.085 0.19 -10000 0 -0.41 128 128
BIRC2 0.016 0.02 -10000 0 -0.25 3 3
neuron projection morphogenesis -0.033 0.11 0.2 2 -0.35 36 38
BAD 0.008 0.091 -10000 0 -0.32 10 10
RIPK2 0.013 0.04 -10000 0 -0.28 9 9
NGFR 0.004 0.065 -10000 0 -0.29 23 23
CYCS 0.01 0.074 -10000 0 -0.25 33 33
ADAM17 0.016 0.024 -10000 0 -0.25 4 4
NGF (dimer)/p75(NTR)/TRAF6/RIP2 0.024 0.044 -10000 0 -0.27 6 6
BCL2L11 0.008 0.091 -10000 0 -0.32 10 10
BDNF (dimer)/p75(NTR) -0.006 0.075 -10000 0 -0.4 4 4
PI3K 0.011 0.072 -10000 0 -0.28 25 25
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 0.022 0.05 -10000 0 -0.28 10 10
NDNL2 0.018 0 -10000 0 -10000 0 0
YWHAE 0.016 0.029 -10000 0 -0.34 3 3
PRKCI 0.002 0.085 -10000 0 -0.43 18 18
NGF (dimer)/p75(NTR) 0.004 0.045 -10000 0 -0.2 23 23
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE 0.008 0.08 -10000 0 -0.28 33 33
TRAF6 0.017 0.023 -10000 0 -0.52 1 1
RAC1 0.018 0 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
PLG 0.016 0.033 -10000 0 -0.52 2 2
oligodendrocyte cell fate commitment 0 0 -10000 0 -10000 0 0
CASP6 0.005 0.07 -10000 0 -0.29 17 17
SQSTM1 0.012 0.053 -10000 0 -0.48 6 6
NGFRAP1 -0.055 0.18 -10000 0 -0.52 72 72
CASP3 0.01 0.087 -10000 0 -0.3 10 10
E2F1 0.006 0.07 -10000 0 -0.37 16 16
CASP9 0.017 0.023 -10000 0 -0.52 1 1
IKK complex -0.013 0.047 -10000 0 -0.34 3 3
NGF (dimer)/TRKA 0.008 0.037 -10000 0 -0.22 12 12
MMP7 -0.095 0.21 -10000 0 -0.44 129 129
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.028 0.054 -10000 0 -0.25 13 13
MMP3 -0.13 0.22 -10000 0 -0.42 177 177
APAF-1/Caspase 9 -0.046 0.077 -10000 0 -0.31 10 10
Regulation of Androgen receptor activity

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.025 0.017 -9999 0 -0.37 1 1
SMARCC1 -0.003 0.12 -9999 0 -1.3 4 4
REL 0 0.087 -9999 0 -0.41 21 21
HDAC7 -0.025 0.13 -9999 0 -0.39 30 30
JUN -0.033 0.15 -9999 0 -0.46 57 57
EP300 0.014 0.047 -9999 0 -0.52 4 4
KAT2B 0 0 -9999 0 -10000 0 0
KAT5 0 0 -9999 0 -10000 0 0
MAPK14 0.002 0.084 -9999 0 -0.38 20 20
FOXO1 0.001 0.092 -9999 0 -0.46 19 19
T-DHT/AR -0.019 0.15 -9999 0 -0.41 30 30
MAP2K6 -0.013 0.11 -9999 0 -0.4 37 37
BRM/BAF57 0.026 0.028 -9999 0 -0.37 2 2
MAP2K4 -0.007 0.1 -9999 0 -0.39 31 31
SMARCA2 0.016 0.033 -9999 0 -0.52 2 2
PDE9A -0.026 0.16 -9999 0 -0.88 9 9
NCOA2 0.01 0.063 -9999 0 -0.4 11 11
CEBPA 0.004 0.084 -9999 0 -0.5 14 14
EHMT2 0.018 0.001 -9999 0 -10000 0 0
cell proliferation 0.007 0.13 -9999 0 -0.37 21 21
NR0B1 -0.01 0.087 -9999 0 -0.27 51 51
EGR1 -0.1 0.2 -9999 0 -0.39 156 156
RXRs/9cRA 0.025 0.057 -9999 0 -0.28 18 18
AR/RACK1/Src 0.003 0.1 -9999 0 -0.34 20 20
AR/GR -0.038 0.13 -9999 0 -0.29 75 75
GNB2L1 0.015 0.04 -9999 0 -0.52 3 3
PKN1 0.013 0.045 -9999 0 -0.39 6 6
RCHY1 0.002 0.09 -9999 0 -0.5 16 16
epidermal growth factor receptor activity 0 0.001 -9999 0 -0.005 5 5
MAPK8 0.004 0.08 -9999 0 -0.38 18 18
T-DHT/AR/TIF2/CARM1 0 0.11 -9999 0 -0.36 22 22
SRC 0.005 0.09 -9999 0 -0.28 38 38
NR3C1 -0.001 0.098 -9999 0 -0.51 19 19
KLK3 -0.038 0.11 -9999 0 -0.47 5 5
APPBP2 0.009 0.042 -9999 0 -0.25 13 13
TRIM24 0.017 0.024 -9999 0 -0.25 4 4
T-DHT/AR/TIP60 -0.021 0.1 -9999 0 -0.31 42 42
TMPRSS2 -0.18 0.43 -9999 0 -1.1 95 95
RXRG 0.004 0.083 -9999 0 -0.47 15 15
mol:9cRA 0 0 -9999 0 -10000 0 0
RXRA 0.015 0.04 -9999 0 -0.52 3 3
RXRB 0.015 0.04 -9999 0 -0.52 3 3
CARM1 0.015 0.039 -9999 0 -0.36 5 5
NR2C2 0.016 0.02 -9999 0 -0.25 3 3
KLK2 0.021 0.095 -9999 0 -0.4 4 4
AR -0.04 0.13 -9999 0 -0.27 114 114
SENP1 0.018 0 -9999 0 -10000 0 0
HSP90AA1 0.013 0.045 -9999 0 -0.39 6 6
MDM2 0.009 0.044 -9999 0 -0.26 14 14
SRY 0.001 0.085 -9999 0 -0.43 18 18
GATA2 -0.007 0.093 -9999 0 -0.31 40 40
MYST2 0.011 0.047 -9999 0 -0.31 10 10
HOXB13 -0.074 0.13 -9999 0 -0.25 182 182
T-DHT/AR/RACK1/Src -0.002 0.11 -9999 0 -0.35 20 20
positive regulation of transcription -0.007 0.093 -9999 0 -0.31 40 40
DNAJA1 0.012 0.043 -9999 0 -0.46 4 4
proteasomal ubiquitin-dependent protein catabolic process 0.02 0.06 -9999 0 -0.31 16 16
NCOA1 0.016 0.063 -9999 0 -0.55 6 6
SPDEF -0.081 0.21 -9999 0 -0.52 98 98
T-DHT/AR/TIF2 0.009 0.08 -9999 0 -0.3 11 11
T-DHT/AR/Hsp90 -0.012 0.11 -9999 0 -0.31 40 40
GSK3B 0.018 0.003 -9999 0 -10000 0 0
NR2C1 0.01 0.062 -9999 0 -0.52 7 7
mol:T-DHT -0.002 0.095 -9999 0 -0.3 36 36
SIRT1 0.016 0.029 -9999 0 -0.34 3 3
ZMIZ2 0.016 0.002 -9999 0 -10000 0 0
POU2F1 0.014 0.038 -9999 0 -10000 0 0
T-DHT/AR/DAX-1 -0.022 0.12 -9999 0 -0.31 45 45
CREBBP 0.016 0.033 -9999 0 -0.52 2 2
SMARCE1 0.017 0.021 -9999 0 -0.26 3 3
Sphingosine 1-phosphate (S1P) pathway

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.017 0.023 -9999 0 -0.52 1 1
SPHK1 -0.027 0.14 -9999 0 -0.42 54 54
GNAI2 0.006 0.075 -9999 0 -0.48 12 12
mol:S1P -0.001 0.087 -9999 0 -0.3 35 35
GNAO1 0.016 0.024 -9999 0 -0.25 4 4
mol:Sphinganine-1-P -0.007 0.1 -9999 0 -0.38 33 33
growth factor activity 0 0 -9999 0 -10000 0 0
S1P/S1P2/G12/G13 0.015 0.075 -9999 0 -0.39 8 8
GNAI3 0.018 0 -9999 0 -10000 0 0
G12/G13 0.021 0.039 -9999 0 -0.37 4 4
S1PR3 0 0 -9999 0 -10000 0 0
S1PR2 0 0 -9999 0 -10000 0 0
EDG1 -0.019 0.12 -9999 0 -0.4 46 46
S1P1/S1P -0.012 0.11 -9999 0 -0.29 57 57
S1PR5 0 0 -9999 0 -10000 0 0
S1PR4 0 0 -9999 0 -10000 0 0
GNAI1 -0.017 0.12 -9999 0 -0.38 46 46
S1P/S1P5/G12 0.008 0.07 -9999 0 -0.23 35 35
S1P/S1P3/Gq -0.026 0.11 -9999 0 -0.28 66 66
S1P/S1P4/Gi 0.006 0.087 -9999 0 -0.32 20 20
GNAQ 0 0 -9999 0 -10000 0 0
GNAZ 0.001 0.088 -9999 0 -0.44 19 19
GNA14 -0.079 0.18 -9999 0 -0.35 140 140
GNA15 0.002 0.076 -9999 0 -0.34 23 23
GNA12 0.018 0 -9999 0 -10000 0 0
GNA13 0.011 0.055 -9999 0 -0.36 10 10
GNA11 0.014 0.047 -9999 0 -0.52 4 4
ABCC1 0.012 0.051 -9999 0 -0.41 7 7
JNK signaling in the CD4+ TCR pathway

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 0.02 0.089 -9999 0 -0.3 33 33
MAP4K1 0.012 0.04 -9999 0 -0.25 12 12
MAP3K8 -0.036 0.15 -9999 0 -0.39 70 70
PRKCB 0 0 -9999 0 -10000 0 0
DBNL 0.014 0.039 -9999 0 -0.36 5 5
CRKL 0.014 0.047 -9999 0 -0.52 4 4
MAP3K1 0.006 0.099 -9999 0 -0.26 44 44
JUN -0.008 0.092 -9999 0 -0.28 47 47
MAP3K7 0.029 0.065 -9999 0 -0.28 6 6
GRAP2 0.012 0.042 -9999 0 -0.28 10 10
CRK 0.016 0.033 -9999 0 -0.52 2 2
MAP2K4 0.006 0.094 -9999 0 -0.33 19 19
LAT 0.002 0.068 -9999 0 -0.27 29 29
LCP2 -0.004 0.097 -9999 0 -0.4 27 27
MAPK8 0.011 0.052 -9999 0 -0.58 3 3
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family 0.024 0.069 -9999 0 -0.24 24 24
LAT/GRAP2/SLP76/HPK1/HIP-55 0.026 0.087 -9999 0 -0.3 27 27
Arf6 downstream pathway

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR -0.022 0.26 -10000 0 -1.1 30 30
regulation of axonogenesis -0.012 0.065 0.35 8 -10000 0 8
myoblast fusion 0.003 0.1 0.4 31 -10000 0 31
mol:GTP -0.002 0.062 -10000 0 -0.24 32 32
regulation of calcium-dependent cell-cell adhesion -0.018 0.082 0.25 39 -10000 0 39
ARF1/GTP 0.012 0.05 -10000 0 -0.26 5 5
mol:GM1 0 0.047 -10000 0 -0.18 31 31
mol:Choline 0.007 0.075 -10000 0 -0.34 16 16
lamellipodium assembly -0.001 0.11 -10000 0 -0.43 32 32
MAPK3 0.009 0.089 -10000 0 -0.33 33 33
ARF6/GTP/NME1/Tiam1 0.019 0.083 -10000 0 -0.25 39 39
ARF1 0.017 0.023 -10000 0 -0.52 1 1
ARF6/GDP -0.003 0.1 -10000 0 -0.4 31 31
ARF1/GDP 0.006 0.097 -10000 0 -0.36 33 33
ARF6 0.007 0.05 -10000 0 -0.62 2 2
RAB11A 0.016 0.029 -10000 0 -0.34 3 3
TIAM1 0.007 0.074 -10000 0 -0.44 13 13
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 0.009 0.09 -10000 0 -0.33 34 34
actin filament bundle formation 0.001 0.11 0.35 41 -10000 0 41
KALRN -0.022 0.078 -10000 0 -0.3 34 34
RAB11FIP3/RAB11A 0.019 0.05 -10000 0 -0.37 8 8
RhoA/GDP -0.001 0.11 -10000 0 -0.36 41 41
NME1 0.012 0.039 -10000 0 -0.25 11 11
Rac1/GDP 0.005 0.096 -10000 0 -0.36 32 32
substrate adhesion-dependent cell spreading -0.002 0.062 -10000 0 -0.24 32 32
cortical actin cytoskeleton organization -0.002 0.11 -10000 0 -0.43 32 32
RAC1 0.018 0 -10000 0 -10000 0 0
liver development -0.002 0.062 -10000 0 -0.24 32 32
ARF6/GTP -0.002 0.062 -10000 0 -0.24 32 32
RhoA/GTP 0.004 0.074 -10000 0 -0.36 14 14
mol:GDP -0.003 0.1 -10000 0 -0.4 32 32
ARF6/GTP/RAB11FIP3/RAB11A 0.019 0.058 -10000 0 -0.28 10 10
RHOA 0.005 0.08 -10000 0 -0.52 12 12
PLD1 0.001 0.078 -10000 0 -0.36 14 14
RAB11FIP3 0.01 0.063 -10000 0 -0.49 8 8
tube morphogenesis -0.001 0.11 -10000 0 -0.43 32 32
ruffle organization 0.012 0.065 -10000 0 -0.35 8 8
regulation of epithelial cell migration -0.002 0.062 -10000 0 -0.24 32 32
PLD2 0.01 0.06 -10000 0 -0.35 7 7
PIP5K1A 0.012 0.065 -10000 0 -0.35 8 8
mol:Phosphatidic acid 0.007 0.075 -10000 0 -0.34 16 16
Rac1/GTP -0.002 0.11 -10000 0 -0.44 32 32
PLK1 signaling events

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion 0.001 0.05 0.23 20 -10000 0 20
BUB1B -0.017 0.12 -10000 0 -0.42 39 39
PLK1 0.002 0.041 -10000 0 -0.13 30 30
PLK1S1 0.002 0.019 -10000 0 -0.054 41 41
KIF2A 0.005 0.054 -10000 0 -0.19 23 23
regulation of mitotic centrosome separation 0.002 0.041 -10000 0 -0.13 30 30
GOLGA2 0.016 0.026 -10000 0 -0.39 2 2
Hec1/SPC24 -0.012 0.094 -10000 0 -0.32 37 37
WEE1 -0.003 0.093 -10000 0 -0.32 30 30
cytokinesis -0.025 0.16 -10000 0 -0.55 40 40
PP2A-alpha B56 -0.059 0.27 -10000 0 -0.76 61 61
AURKA -0.002 0.064 -10000 0 -0.29 22 22
PICH/PLK1 -0.023 0.18 -10000 0 -0.48 54 54
CENPE -0.011 0.096 -10000 0 -0.32 40 40
RhoA/GTP 0.004 0.058 -10000 0 -0.38 12 12
positive regulation of microtubule depolymerization 0.005 0.054 -10000 0 -0.19 23 23
PPP2CA 0.011 0.062 -10000 0 -0.52 7 7
FZR1 0.018 0 -10000 0 -10000 0 0
TPX2 -0.013 0.083 -10000 0 -0.29 40 40
PAK1 -0.023 0.13 -10000 0 -0.38 54 54
SPC24 0 0 -10000 0 -10000 0 0
FBXW11 0.015 0.035 -10000 0 -0.43 3 3
CLSPN 0.002 0.057 -10000 0 -0.35 11 11
GORASP1 0.017 0.023 -10000 0 -0.52 1 1
metaphase 0 0.002 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
NLP 0.002 0.019 -10000 0 -0.054 41 41
G2 phase of mitotic cell cycle -0.001 0.003 0.016 1 -0.013 21 22
STAG2 0.017 0.023 -10000 0 -0.52 1 1
GRASP65/GM130/RAB1/GTP 0.021 0.04 -10000 0 -0.74 1 1
spindle elongation 0.002 0.041 -10000 0 -0.13 30 30
ODF2 0.016 0.024 -10000 0 -0.53 1 1
BUB1 -0.1 0.28 -10000 0 -0.85 60 60
TPT1 0.009 0.019 -10000 0 -10000 0 0
CDC25C -0.016 0.11 -10000 0 -0.44 34 34
CDC25B 0.004 0.069 -10000 0 -0.3 23 23
SGOL1 -0.001 0.051 -10000 0 -0.23 20 20
RHOA 0.005 0.08 -10000 0 -0.52 12 12
CCNB1/CDK1 -0.013 0.15 -10000 0 -0.48 42 42
CDC14B 0.01 0.03 -10000 0 -0.38 3 3
CDC20 -0.02 0.12 -10000 0 -0.37 51 51
PLK1/PBIP1 -0.011 0.083 -10000 0 -0.29 37 37
mitosis 0.002 0.007 0.035 21 -10000 0 21
FBXO5 0.003 0.054 -10000 0 -0.18 22 22
CDC2 -0.012 0.12 -10000 0 -0.45 34 34
NDC80 -0.029 0.14 -10000 0 -0.41 57 57
metaphase plate congression 0.009 0.023 -10000 0 -10000 0 0
ERCC6L -0.026 0.19 -10000 0 -0.57 46 46
NLP/gamma Tubulin 0.005 0.022 -10000 0 -0.077 4 4
microtubule cytoskeleton organization 0.009 0.019 -10000 0 -10000 0 0
G2/M transition DNA damage checkpoint 0 0.002 0.011 5 -10000 0 5
PPP1R12A 0.015 0.031 -10000 0 -0.32 4 4
interphase 0 0.002 0.011 5 -10000 0 5
PLK1/PRC1-2 -0.017 0.14 -10000 0 -0.42 48 48
GRASP65/GM130/RAB1/GTP/PLK1 0.028 0.039 -10000 0 -0.22 3 3
RAB1A 0.017 0.023 -10000 0 -0.52 1 1
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA 0.006 0.039 -10000 0 -0.15 19 19
mitotic prometaphase 0 0.001 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.018 0.058 -10000 0 -0.33 5 5
microtubule-based process -0.011 0.1 -10000 0 -0.34 40 40
Golgi organization 0.002 0.041 -10000 0 -0.13 30 30
Cohesin/SA2 0.009 0.036 -10000 0 -0.17 4 4
PPP1CB/MYPT1 0.023 0.026 -10000 0 -0.37 1 1
KIF20A -0.027 0.14 -10000 0 -0.46 49 49
APC/C/CDC20 -0.007 0.089 -10000 0 -0.33 29 29
PPP2R1A 0.017 0.012 -10000 0 -0.25 1 1
chromosome segregation -0.011 0.082 -10000 0 -0.28 37 37
PRC1 -0.019 0.13 -10000 0 -0.43 43 43
ECT2 -0.001 0.07 -10000 0 -0.31 18 18
C13orf34 0.006 0.037 -10000 0 -0.13 14 14
NUDC 0.009 0.023 -10000 0 -10000 0 0
regulation of attachment of spindle microtubules to kinetochore -0.016 0.12 -10000 0 -0.41 39 39
spindle assembly 0.005 0.031 -10000 0 -0.093 27 27
spindle stabilization 0.002 0.019 -10000 0 -0.053 41 41
APC/C/HCDH1 0.02 0.025 -10000 0 -0.32 3 3
MKLP2/PLK1 -0.011 0.1 -10000 0 -0.34 40 40
CCNB1 -0.016 0.13 -10000 0 -0.5 35 35
PPP1CB 0.016 0.02 -10000 0 -0.25 3 3
BTRC 0.008 0.054 -10000 0 -0.29 16 16
ROCK2 0.008 0.055 -10000 0 -0.36 6 6
TUBG1 0.008 0.02 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.046 0.14 -10000 0 -0.47 42 42
MLF1IP -0.018 0.1 -10000 0 -0.32 49 49
INCENP 0.001 0.081 -10000 0 -0.37 22 22
Angiopoietin receptor Tie2-mediated signaling

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 0.041 0.17 -10000 0 -0.9 12 12
NCK1/PAK1/Dok-R -0.032 0.083 -10000 0 -0.44 12 12
NCK1/Dok-R 0.029 0.18 -10000 0 -1.1 11 11
PIK3CA 0.015 0.029 -10000 0 -0.34 3 3
mol:beta2-estradiol -0.009 0.02 0.24 1 -10000 0 1
RELA 0.018 0 -10000 0 -10000 0 0
SHC1 0.017 0.024 -10000 0 -0.52 1 1
Rac/GDP 0.013 0 -10000 0 -10000 0 0
F2 0.006 0.021 0.26 1 -10000 0 1
TNIP2 0.012 0.052 -10000 0 -0.39 8 8
NF kappa B/RelA 0.052 0.15 -10000 0 -0.9 11 11
FN1 -0.048 0.17 -10000 0 -0.46 73 73
PLD2 0.037 0.16 -10000 0 -1 11 11
PTPN11 0.017 0.023 -10000 0 -0.52 1 1
GRB14 -0.16 0.21 -10000 0 -0.36 247 247
ELK1 0.046 0.15 -10000 0 -0.92 11 11
GRB7 -0.017 0.1 -10000 0 -0.29 59 59
PAK1 -0.022 0.13 -10000 0 -0.37 54 54
Tie2/Ang1/alpha5/beta1 Integrin 0.022 0.19 -10000 0 -0.98 12 12
CDKN1A 0.02 0.2 -10000 0 -0.76 28 28
ITGA5 0.015 0.035 -10000 0 -0.43 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R 0.026 0.18 -10000 0 -1 12 12
CRK 0.016 0.033 -10000 0 -0.52 2 2
mol:NO 0.05 0.14 -10000 0 -0.66 12 12
PLG 0.039 0.16 -10000 0 -1 11 11
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis 0.048 0.16 -10000 0 -0.87 11 11
GRB2 0.016 0.024 -10000 0 -0.25 4 4
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
ANGPT2 -0.018 0.16 -10000 0 -0.69 12 12
BMX 0.012 0.19 -10000 0 -1.2 11 11
ANGPT1 0.021 0.085 -10000 0 -1.2 1 1
tube development 0.026 0.17 -10000 0 -0.71 18 18
ANGPT4 0.017 0.026 -10000 0 -0.39 2 2
response to hypoxia 0.003 0.011 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 -0.045 0.19 -10000 0 -1.1 11 11
alpha5/beta1 Integrin 0.022 0.041 -10000 0 -0.37 5 5
FGF2 -0.065 0.16 -10000 0 -0.34 122 122
STAT5A (dimer) 0.026 0.21 -10000 0 -0.78 26 26
mol:L-citrulline 0.05 0.14 -10000 0 -0.66 12 12
AGTR1 -0.15 0.21 -10000 0 -0.36 231 231
MAPK14 0.035 0.18 -10000 0 -1.1 11 11
Tie2/SHP2 0.027 0.16 -10000 0 -1.1 10 10
TEK 0.024 0.18 -10000 0 -1.2 10 10
RPS6KB1 0.04 0.16 -10000 0 -0.88 11 11
Angiotensin II/AT1 -0.099 0.15 -10000 0 -0.25 231 231
Tie2/Ang1/GRB2 0.04 0.16 -10000 0 -1 11 11
MAPK3 0.043 0.15 -10000 0 -0.92 11 11
MAPK1 0.042 0.15 -10000 0 -0.92 11 11
Tie2/Ang1/GRB7 0.025 0.17 -10000 0 -1 11 11
NFKB1 0.017 0.023 -10000 0 -0.52 1 1
MAPK8 0.038 0.16 -10000 0 -1 11 11
PI3K 0.035 0.19 -10000 0 -1.1 11 11
FES 0.031 0.19 -10000 0 -1.1 12 12
Crk/Dok-R 0.031 0.18 -10000 0 -1 11 11
Tie2/Ang1/ABIN2 0.038 0.16 -10000 0 -1 11 11
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity 0.043 0.16 -10000 0 -0.8 12 12
STAT5A 0.011 0.056 -10000 0 -0.42 8 8
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 0.043 0.16 -10000 0 -0.88 11 11
Tie2/Ang2 0.015 0.22 -10000 0 -1 16 16
Tie2/Ang1 0.034 0.17 -10000 0 -1.1 11 11
FOXO1 0.043 0.17 -10000 0 -0.77 16 16
ELF1 0.017 0.073 -10000 0 -0.49 10 10
ELF2 0.037 0.16 -10000 0 -1 11 11
mol:Choline 0.038 0.16 -10000 0 -0.96 11 11
cell migration -0.023 0.051 -10000 0 -0.22 19 19
FYN 0.023 0.19 -10000 0 -0.83 17 17
DOK2 -0.021 0.13 -10000 0 -0.4 48 48
negative regulation of cell cycle 0.024 0.18 -10000 0 -0.67 28 28
ETS1 0.011 0.075 -10000 0 -0.3 24 24
PXN 0.05 0.14 -10000 0 -0.72 11 11
ITGB1 0.014 0.044 -10000 0 -0.41 5 5
NOS3 0.049 0.15 -10000 0 -0.75 12 12
RAC1 0.018 0 -10000 0 -10000 0 0
TNF 0.004 0.097 -10000 0 -0.35 32 32
MAPKKK cascade 0.038 0.16 -10000 0 -0.96 11 11
RASA1 0.004 0.078 -10000 0 -0.42 16 16
Tie2/Ang1/Shc 0.041 0.16 -10000 0 -1 11 11
NCK1 0.011 0.045 -10000 0 -0.28 12 12
vasculogenesis 0.051 0.13 -10000 0 -0.59 12 12
mol:Phosphatidic acid 0.038 0.16 -10000 0 -0.96 11 11
mol:Angiotensin II 0.002 0.002 -10000 0 -10000 0 0
mol:NADP 0.05 0.14 -10000 0 -0.66 12 12
Rac1/GTP -0.011 0.14 -10000 0 -0.82 11 11
MMP2 0.016 0.19 -10000 0 -1.1 11 11
S1P1 pathway

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0 0.1 -9999 0 -0.36 30 30
PDGFRB 0.01 0.067 -9999 0 -0.53 8 8
SPHK1 -0.054 0.19 -9999 0 -0.76 33 33
mol:S1P -0.049 0.17 -9999 0 -0.65 35 35
S1P1/S1P/Gi -0.002 0.15 -9999 0 -0.56 19 19
GNAO1 0.016 0.024 -9999 0 -0.26 4 4
PDGFB-D/PDGFRB/PLCgamma1 0.008 0.14 -9999 0 -0.51 19 19
PLCG1 0.004 0.14 -9999 0 -0.51 19 19
mol:GTP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB 0.01 0.067 -9999 0 -0.53 8 8
GNAI2 0.007 0.076 -9999 0 -0.48 12 12
GNAI3 0.018 0.003 -9999 0 -10000 0 0
GNAI1 -0.016 0.12 -9999 0 -0.38 46 46
mol:GDP 0 0 -9999 0 -10000 0 0
EDG1 -0.012 0.16 -9999 0 -0.66 25 25
S1P1/S1P -0.026 0.19 -9999 0 -0.52 55 55
negative regulation of cAMP metabolic process -0.001 0.14 -9999 0 -0.54 19 19
MAPK3 0.002 0.16 -9999 0 -0.58 18 18
calcium-dependent phospholipase C activity 0 0.003 -9999 0 -10000 0 0
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
RhoA/GDP 0.004 0.058 -9999 0 -0.38 12 12
KDR 0.006 0.076 -9999 0 -0.65 5 5
PLCB2 -0.015 0.17 -9999 0 -0.45 55 55
RAC1 0.018 0 -9999 0 -10000 0 0
RhoA/GTP -0.061 0.14 -9999 0 -0.42 58 58
receptor internalization -0.024 0.17 -9999 0 -0.47 55 55
PTGS2 -0.001 0.17 -9999 0 -0.94 8 8
Rac1/GTP -0.056 0.14 -9999 0 -0.42 55 55
RHOA 0.005 0.08 -9999 0 -0.52 12 12
VEGFA -0.006 0.085 -9999 0 -0.29 31 31
negative regulation of T cell proliferation -0.001 0.14 -9999 0 -0.54 19 19
GO:0007205 0 0 -9999 0 -10000 0 0
GNAZ 0.002 0.088 -9999 0 -0.44 19 19
MAPK1 0.002 0.16 -9999 0 -0.58 18 18
S1P1/S1P/PDGFB-D/PDGFRB -0.016 0.2 -9999 0 -0.59 38 38
ABCC1 0.012 0.051 -9999 0 -0.41 7 7
Atypical NF-kappaB pathway

Figure S85.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S85.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL3/RelA 0.019 0.052 -9999 0 -0.37 9 9
FBXW11 0.015 0.035 -9999 0 -0.43 3 3
NF kappa B1 p50/c-Rel 0.018 0.062 -9999 0 -0.31 15 15
NF kappa B1 p50/RelA/I kappa B alpha 0 0.11 -9999 0 -0.44 18 18
NFKBIA -0.024 0.12 -9999 0 -0.26 87 87
MAPK14 0.017 0.012 -9999 0 -0.25 1 1
NF kappa B1 p105/p50 0.026 0.038 -9999 0 -0.3 5 5
ARRB2 0.02 0.005 -9999 0 -10000 0 0
REL 0.001 0.087 -9999 0 -0.41 21 21
response to oxidative stress 0 0 -9999 0 -10000 0 0
BCL3/NF kappa B1 p50 0.022 0.054 -9999 0 -0.3 12 12
response to UV 0 0 -9999 0 -10000 0 0
NF kappa B1 p105/RelA 0.028 0.031 -9999 0 -0.3 3 3
PIK3CA 0.016 0.029 -9999 0 -0.34 3 3
NF kappa B1 p50 dimer 0.019 0.037 -9999 0 -0.37 3 3
PIK3R1 -0.009 0.11 -9999 0 -0.42 33 33
NFKB1 0.02 0.037 -9999 0 -0.37 3 3
RELA 0.018 0 -9999 0 -10000 0 0
positive regulation of anti-apoptosis -0.014 0.1 -9999 0 -0.24 64 64
NF kappa B1 p50/RelA/I kappa B alpha/beta Arrestin2 0.005 0.11 -9999 0 -0.44 17 17
SRC 0.015 0.035 -9999 0 -0.43 3 3
PI3K 0.005 0.082 -9999 0 -0.37 21 21
NF kappa B1 p50/RelA -0.014 0.1 -9999 0 -0.25 64 64
IKBKB 0.012 0.047 -9999 0 -0.31 10 10
beta TrCP1/SCF ubiquitin ligase complex 0.015 0.035 -9999 0 -0.43 3 3
SYK -0.023 0.14 -9999 0 -0.48 43 43
I kappa B alpha/PIK3R1 -0.027 0.13 -9999 0 -0.37 39 39
cell death 0.005 0.1 -9999 0 -0.42 17 17
NF kappa B1 p105/c-Rel 0.018 0.062 -9999 0 -0.31 15 15
LCK -0.074 0.18 -9999 0 -0.4 117 117
BCL3 0.008 0.071 -9999 0 -0.5 10 10
EPHB forward signaling

Figure S86.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S86.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 0.011 0.056 -10000 0 -0.3 12 12
cell-cell adhesion 0.038 0.084 0.37 18 -10000 0 18
Ephrin B/EPHB2/RasGAP 0.023 0.087 -10000 0 -0.28 34 34
ITSN1 0.015 0.035 -10000 0 -0.43 3 3
PIK3CA 0.016 0.029 -10000 0 -0.34 3 3
SHC1 0.017 0.023 -10000 0 -0.52 1 1
Ephrin B1/EPHB3 0.006 0.072 -10000 0 -0.32 21 21
Ephrin B1/EPHB1 -0.003 0.07 -10000 0 -0.3 13 13
HRAS/GDP -0.034 0.081 -10000 0 -0.3 28 28
Ephrin B/EPHB1/GRB7 -0.003 0.097 -10000 0 -0.27 34 34
Endophilin/SYNJ1 0.018 0.065 -10000 0 -0.23 27 27
KRAS 0.009 0.065 -10000 0 -0.44 10 10
Ephrin B/EPHB1/Src 0.013 0.089 -10000 0 -0.28 26 26
endothelial cell migration -0.006 0.11 -10000 0 -0.28 59 59
GRB2 0.016 0.024 -10000 0 -0.25 4 4
GRB7 -0.017 0.1 -10000 0 -0.29 59 59
PAK1 0.002 0.093 -10000 0 -0.25 49 49
HRAS 0.012 0.051 -10000 0 -0.41 7 7
RRAS 0.015 0.075 -10000 0 -0.24 34 34
DNM1 0.013 0.047 -10000 0 -0.37 7 7
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK 0.005 0.079 -10000 0 -0.26 27 27
lamellipodium assembly -0.038 0.084 -10000 0 -0.37 18 18
Ephrin B/EPHB1/Src/p52 SHC/GRB2 0.016 0.077 -10000 0 -0.27 23 23
PIK3R1 -0.009 0.11 -10000 0 -0.42 33 33
EPHB2 0.007 0.061 -10000 0 -0.32 16 16
EPHB3 -0.005 0.1 -10000 0 -0.45 26 26
EPHB1 -0.022 0.1 -10000 0 -0.28 72 72
EPHB4 -0.013 0.12 -10000 0 -0.43 36 36
mol:GDP 0 0.1 -10000 0 -0.33 25 25
Ephrin B/EPHB2 0.019 0.07 -10000 0 -0.25 26 26
Ephrin B/EPHB3 0.012 0.086 -10000 0 -0.27 38 38
JNK cascade 0.006 0.082 -10000 0 -0.28 23 23
Ephrin B/EPHB1 0.005 0.084 -10000 0 -0.26 33 33
RAP1/GDP 0.013 0.099 -10000 0 -0.29 29 29
EFNB2 -0.008 0.11 -10000 0 -0.4 33 33
EFNB3 0.018 0 -10000 0 -10000 0 0
EFNB1 0.01 0.051 -10000 0 -0.3 13 13
Ephrin B2/EPHB1-2 -0.007 0.089 -10000 0 </